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Abstract
Abstract
During inflammation, leukocytes are recruited from blood vessels into the site of 
injury or infection. A key event in this process is transendothelial migration (TEM), a 
multi-step process involving various adhesion molecules on both leukocytes and 
endothelial cells. Oxidative stress has been linked to inflammation in the 
development of various diseases.
To investigate the effect of oxidative stress on TEM, leukocytes were treated 
with hydrogen peroxide (H20 2). A defect in TEM was observed across human 
umbilical vein endothelial cells (HUVECs), but not across a porous membrane, 
suggesting that H20 2 affects the interaction between leukocytes and endothelial 
cells. H20 2-treated leukocytes exhibited higher motility and adhesion on HUVECs, 
whereas their adhesion on substrates such as VCAM-1 and ICAM-1 was unaltered. 
The number of leukocytes exhibiting protrusions on HUVECs was decreased after 
H20 2 treatment, which is likely due to the increase in nitric oxide (NO) that was 
detected. Incubation of THP-1 cells with a NO donor led to a decrease in TEM and 
reduction of protrusions. The effects of H20 2 on several signalling molecules 
implicated in cell migration were investigated and changes in the activity of the 
RhoGTPases RhoA, Rac1 and Cdc42 were observed.
CD73 is a 5’-ectonucleotidase expressed on endothelial cells and has been 
postulated to be involved in TEM. The inhibition of endothelial CD73 activity after 
leukocyte binding was reduced when H20 2-treated leukocytes were bound. 
Immunofluorescence staining showed local accumulation of CD73 around 
transmigrating leukocytes. RNAi knock-down of endothelial CD73 led to an 
inflammatory phenotype with elongated cells, increased surface levels of ICAM-1, 
VCAM-1, E- and P-selectin and increased permeability.
Together these findings suggest that ROS have multiple effects on 
leukocytes leading to a defect in TEM, one of which is reduced CD73 inhibition after 
endothelial binding.
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1 Introduction
1
Introduction
1.1 The mammalian immune system
The mammalian immune system is a highly sophisticated arrangement of biological 
mechanisms that has evolved over millions of years in order to protect the organism 
from infection by a diverse range of pathogens.
The immune system can be divided into several layers of defence that range 
from nonspecific and quick responses to very specific responses that take time to 
develop. Firstly, physical barriers such as the skin and mucous membranes lining 
the inner surfaces of the body, e.g. the gut, prevent pathogens from entering the 
body. Secondly, an immediate or ‘innate’ immune response mediates a fast but 
nonspecific attempt at clearing the body of invading pathogens. Thirdly, if these 
measures fail to resolve the problem, the adaptive immune response, composed of 
a cell-mediated and antibody-mediated response, provides a very specific defence 
system. Both innate and adaptive immune responses are mainly mediated by 
leukocytes.
1.2 Cells of the immune system
Immune cells are derived from haematopoietic stem cells of the fetal liver and 
postnatal bone marrow in a process referred to as haematopoiesis. The classical 
model of haematopoiesis as depicted in Figure 1.1 has lately come under scrutiny 
and revised models have been proposed, for expample with a lineage tree that has 
a lymphoid-myeloid branching point (Graf, 2008).
1.2.1 Mononuclear cells
Mononuclear cells include monocytes in the blood and macrophages in the tissue. 
Human monocytes are relatively large (10 -  18 pm diameter), have a horseshoe­
shaped nucleus and contain granules (Male et al., 2006). Monocytes circulate in the 
blood for about eight hours before they enter the tissue and differentiate into 
macrophages, whose main purpose is the phagocytosis of microorganisms (Kindt et 
al., 2006). Killing of the engulfed microorganisms involves fusion of the phagosome
19
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Figure 1.1: Cells of the immune system
Blood cells are derived from a common progenitor, a multipotent haematopoietic 
stem cell (HSC). Differentiation is driven by cytokines such as several members of 
the interleukin (IL) family, stem cell factor (SCF), thrombopoietin (TPO), interferons 
(IFN), erythropoietin (EPO) and colony-stimulating factors (CSFs) (Robb, 2007). 
The differentiation from primitive progenitor cells to committed precursor cells and 
lineage committed cells produces a range of blood cells with a variety of functions. 
While most blood cells are part of the immune system, erythocytes are transport 
vehicles for oxygen and carbon dioxide. Innate immunity is mediated by monocytes, 
macrophages, granulocytes, natural killer (NK) cells, and platelets, while the 
adaptive immune response is mainly mediated by lymphocytes (Male et al., 2006). 
At sites of vascular injury, platelets form hemostatic plugs (or blood clots) when 
collagen is exposed and von Willebrand factor (vWF) is present 
(Michelson, 2003). Granulocytes include neutrophils, eosinophils and basophils 
(Kindt et al., 2006). Neutrophils and eosinophils are phagocytic cells, while 
basophils are non-phagocytic. Granulocytes produce and release anti-microbial 
substances that kill invading pathogens (Male et al., 2006). Lymphocytes comprise 
B and T lymphocytes (B and T cells) and NK cells (Kindt et al., 2006). B cells are 
important in the humoral response, where they are involved in antibody production.
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NK cells are a type of cytotoxic T cell that play an important role in host defence 
against tumour and virus-infected cells.
Abbr.: common lymphoid progenitor (CLP); common myeloid progenitor (CMP); 
T cell natural killer cell progenitor (TNK); B cell progenitor (BCP); T cell progenitor 
(TCP); natural killer progenitor (NKP); megakaryocyte erythroid progenitor (MEP); 
granulocyte-macrophage progenitor (GMP); megakaryocyte progenitors (MkP); 
erythrocyte progenitors (EP). From (Kaushansky, 2006)
with lysosomes to from a phagolysosome. Lysosomes contain H20 2, oxygen-free 
radicals, peroxidase, lysozyme and various hydrolytic enzymes, which digest the 
engulfed material. Phagocytosed antigen is digested within the macrophages into 
peptides that associate with class II major histocompatibility complex (MHC) 
molecules. Complexes of peptide and MHC II are transported to the membrane and 
presented on the macrophage surface. This processing and presentation is 
important for the humoral and cell-mediated immune response.
Monocytes can be subdivided into two main groups, the classical strongly 
CD14 positive (CD14++) cells and the more recently described group of 
CD14+/CD16+ cells (Ziegler-Heitbrock, 2007). Cytokine production seems to be 
increased in the latter group, while both types of monocytes have similar capacities 
in uptake and presentation of foreign antigens.
1.2.2 Lymphocytes and adaptive immune response
Lymphocytes are the main mediators of the adaptive immune response. 
T lymphocytes are produced in the bone marrow and mature in the thymus, 
therefore the name T  lymphocyte (Kindt et al., 2006). T cells are further subdivided 
into T helper (TH) cells, cytotoxic T cells (Tc) and regulatory T cells (Treg or 
T suppressor cells).
Th and Tc cells can be distinguished by the expression of the glycoproteins 
CD4 and CD8 which bind to MHC II and MHC I, respectively. T cells, which are 
CD4+ generally function as TH, whereas CD8+ cells function as Tc. When activated 
by the appropriate MHC complex, TH cells differentiate into effector cells that 
activate Tc cells, macrophages and B cells. Recognition of an antigen-MHC I 
complex by Tc cells induces proliferation and differentiation into a cytotoxic 
T lymphocyte (CTL) or into a memory cell. CTLs recognise and kill infected or 
foreign cells, when foreign antigen is presented with class I MHC. Treg cells express 
CD4 and CD25 and provide self-protection by preventing other T cells from 
attacking self components, thereby preventing autoimmunity.
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1.3 Cell migration
Cell migration is essential for many biological processes, including immune 
responses. The core events during cell migration are the formation of distinct actin- 
based membrane protrusions, such as lamellipodia and filopodia (Ladwein and 
Rottner, 2008). These are linked to the assembly/disassembly of actin filaments and 
adhesion to the underlying substrate. The turnover of actin filaments requires a 
multitude of molecules, that act to stimulate nucleation and elongation, block 
filament growth (capping), mediate crosslinking/bundling or promote 
depolymerisation (Fig. 1.2) (Carlier and Pantaloni, 2007; Pollard and Borisy, 2003). 
A large number of proteins have been implicated in migration-mediating signalling 
events, including members of the mitogen-activated protein kinase (MAPK) 
pathway, lipid kinases, in particular phosphatidylinositide 3-kinase (PI3K), 
phospholipases, serine/threonine and tyrosine kinases and scaffolding proteins. 
However, one family of proteins has emerged as key regulators of cell migration: the 
family of small Rho GTPases.
1.3.1 Rho GTPases
Rho GTPases constitute a distinct family within the superfamily of Ras-related small 
GTPases (Jaffe and Hall, 2005). In mammals, 20 genes encoding Rho GTPases 
belonging to 8 subfamilies have been described so far: RhoA, B and C, Rac1 -  3, 
RhoG, Cdc42, RhoQ/TC10, RhoJ/TCL, RhoD, RhoF/Rif, Rnd1/Rho6, Rnd2/RhoN, 
Rnd3/RhoE, RhoH/TTF, RhoV/Chp, RhoU/Wrch-1, RhoBTBI and RhoBTB2/DBC-2. 
Rho GTPases are found in all eukaryotic cells, but expression of the individual 
members of the family varies.
Like other regulatory GTPases, Rho proteins act as molecular switches and 
most of them cycle between an active, GTP-bound conformation and an inactive, 
GDP-bound conformation (Fig. 1.3). Rho proteins can exchange nucleotides and 
hydrolyse GTP in vitro, but at a very slow rate and to achieve rapid and efficient 
signalling these reactions are catalysed by guanine nucleotide exchange factors 
(GEFs) and GTPase-activating proteins (GAPs), respectively. Additionally, some 
Rho GTPases are regulated by binding to guanine-nucleotide dissociation inhibitors 
(GDIs), which prevent plasma membrane localisation but not necessarily interaction 
with downstream targets (DerMardirossian and Bokoch, 2005). Most family 
members contain a CAAX motif (C denotes cysteine, A represents any aliphatic 
amino acid and X may be any amino acid) at their C-terminus, which serves as a
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Figure 1.2: Actin polymerisation at the leading edge
Extracellular stimuli activate receptors (1) leading to activation of Rho GTPases and 
PIP2 production (2). Rho GTPases activate Arp2/3 complex via WAVE proteins 
leading to actin filament branching (3/4). Polymerisation of actin filaments at the 
barbed ends (5) pushes the membrane forward (6), while capping proteins 
terminate filament elongation (6). Actin filaments age by ATP hydrolysis (white to 
yellow subunits), which is followed by the dissociation of the y phosphate (red 
subunits) (8). ADP/cofilin promotes this phosphate dissociation and severs ADP- 
actin filaments (9). Finally, profilin catalyses the exchange of ADP for ATP and 
monomeric actin enters the cytoplasmic pool and is available again for filament 
polymerisation (11). Actin polymerisation is regulated by Rho GTPase-activated 
PAK and LIM kinase-induced inhibition of ADF/cofilin (12). Adapted from (Pollard 
and Borisy, 2003)
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Figure 1.3: Regulation of Rho GTPases
Rho GTPases are molecular switches that contain a lipid modification to allow 
insertion into the plasma membrane and cycle between GTP-bound (active) and 
GDP-bound (inactive) forms. In their active state Rho GTPases interact with 
downstream effectors and regulate a range of cellular processes. Nucleotide 
exchange and GTP hydrolysis are catalysed by GEFs and GAPs, respectively. 
Additionally, Rho GTPases can be sequestered away from the membrane by 
interacting with RhoGDI, which prevents interaction with downstream effectors. 
Abbr.: Plasma membrane (PM); protein kinase A (PKA); protein kinase G (PKG).
substrate for post-translational modifications (Konstantinopoulos et al., 2007). 
These modifications include the covalent attachment of a non-sterol isoprenoid 
(either farnesyl pyrophosphate or predominantly geranylgeranyl pyrophosphate) to 
the cysteine residue of the CAAX motif by prenylation. This lipidated hydrophobic 
domain allows insertion of the Rho GTPase into the lipid bilayer of membrane 
(mainly the plasma membrane) as well as binding to RhoGDIs. When active, 
membrane-bound Rho GTPases can interact with down-stream effectors, including 
serine/threonine kinases, tyrosine kinases, lipid kinases, lipases, oxidases and 
scaffold proteins and are involved in a variety of biological processes (Bishop and 
Hall, 2000). Rho GTPases are important for actin polymerisation, MAP kinase 
pathway signalling, activation of transcription factors (SRF, NF-kB), regulation of 
nicotinamide adenine dinucleotide phosphate (NADPH) oxidase, cell-cycle 
progression, regulation of cell-cell contacts, secretion, polarity and transformation 
(Bishop and Hall, 2000).
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1.3.1.1 Rho GEFs and GAPs
Only 20 Rho GTPases have been identified, but more than three times more GEFs 
or GAPs, which allows a high degree of specificity of individual pathways.
To date 69 Rho GEFs have been identified that contain a Dbl-homology 
(DH) domain, encoding the catalytic activity and an adjacent pleckstrin homology 
(PH) domain, mediating membrane localisation (Rossman et al., 2005). Additionally, 
a subfamily of 11 GEFs have been identified, the Dock180-related GEFs, which 
contain the Dock homology region (DHR)-2 domain (Cote and Vuori, 2007).
About 70 Rho GAPs have been identified so far (Bernards and Settleman, 
2005). The mechanism by which GAPs increase GTP hydrolysis involves a 20° 
rotation between GTPase and GAP, which allows an arginine residue in the GAP 
protein to enter the GTPase active site and participate in the stabilisation of the 
transition state (Moon and Zheng, 2003). The activity of GAPs can be regulated by 
phosphorylation, lipid binding or protein-protein interactions.
1.3.1.2 Rho GDIs
So far three human Rho GDIs have been identified: the ubiquitously expressed 
RhoGDI (GDIa/GDI1), the hematopoietic cell-selective Ly/D4GDI (GDIJ3/GDI2) and 
RhoGDIy (GDI3), which is expressed in the lung, brain and testis (DerMardirossian 
and Bokoch, 2005). RhoGDI and D4GDI, hereafter referred to as GDIs, are 
cytosolic proteins that form 1:1 complexes with Rho GTPases. RhoGDIy is 
associated with vesicular membranes and specifically binds RhoB and RhoG 
(Zalcman et al., 1996). GDIs form high-affinity complexes with Rho GTPases, 
mainly in their GDP-bound, but also to a lesser extent in their GTP-bound 
conformation, by shielding the geranylgeranyl membrane-targeting moiety at the 
C-terminus of the GTPases in a hydrophobic pocket formed by an immunoglobulin­
like (3 sandwich (DerMardirossian and Bokoch, 2005). GDI binding serves three 
functions: 1) when bound to GDP-bound proteins, it prevents the dissociation of 
GDP from the Rho GTPase, keeping it inactive and preventing the activation by 
GEFs; 2) when bound to GTP-bound proteins, the intrinsic- and GAP-catalysed 
GTPase activity is inhibited and binding to downstream targets is blocked; 3) it 
sequesters Rho GTPases away from the membrane.
The GTPase.GDI complex can be influenced either by GDI dissociation 
factors (GDFs) or by phosphorylation of either the GDI, the GTPase or both 
(DerMardirossian and Bokoch, 2005). Several biologically relevant lipids, including 
saturated and unsaturated fatty acids, phosphatidic acids and phosphoinositides
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have been reported as GDFs (Chuang et al., 1993). Phosphorylation of RhoGDI in 
neutrophils has been shown to stabilize the RhoA-RhoGDI-complex (Bourmeyster 
and Vignais, 1996), while p21-activated kinase 1 (PAKI)-mediated phosphorylation 
of RhoGDI at Ser101 and Ser174 results in the dissociation of Rac1-RhoGDI- 
complexes (DerMardirossian et al., 2004). Src kinase-mediated phosphorylation of 
RhoGDI at Tyr156 on the other hand leads to decreased complex formation with 
RhoA, Rac1 and Cdc42 (DerMardirossian et al., 2006). Phosphorylation of Rho 
GTPases also affects binding to GDIs; phosphorylation of RhoA at Ser188 by cyclic 
adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP)- 
dependent kinases (protein kinase A (PKA) and protein kinase G (PKG)) has been 
shown to increase binding to RhoGDI, independent of the nucleotide binding status 
(Ellerbroek et al., 2003; Rolli-Derkinderen et al., 2005). PKA has also been shown to 
enhance Cdc42-RhoGDI interaction by phosphorylation at Ser188 (Forget et al., 
2002).
The complex regulation of Rho GTPase-RhoGDI interaction by 
phosphorylation at multiple sites ensures specificity of the GTPase activation and 
also provides a mechanism for specific termination of signals.
1.3.2 Regulation of cell migration
Cell migration is usually initiated by extracellular cues, including diffusible factors 
such as growth factors (GFs) and signals from neighbouring cells and/or the 
extracellular matrix (ECM). Steps of cell migration are the extension of a leading 
edge protrusion or lamellipodium, the establishment and turnover of adhesion sites, 
the contraction and translocation of the cell body and tail detachment (Fig. 1.4) 
(Lauffenburger and Horwitz, 1996). Other mechanisms of migration have been 
detected for zebrafish primordial germ cells, where bleb-like protrusions are formed 
by cytoplasmic flow (Blaser et al., 2006). A gradient of the chemokine SDF-1/CXCL 
12 induces calcium (Ca2+) influx leading to contraction of myosin associated with the 
actin cortex and separation of the membrane from the cell cortex. At these sites of 
membrane detachment, cytoplasmic flow leads to the formation of protrusions. This 
type of migration has also been observed in 3D for some cancer cells (Sahai and 
Marshall, 2003).
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Figure 1.4: Cell migration
Cell migration can be divided into distinct steps of leading edge protrusion, including 
extension of lamellipodium and filopodia, formation of new adhesion sites, 
contraction and translocation of the cell body and detachment of the tail. Adapted 
from (Lauffenburger and Horwitz, 1996)
1.3.2.1 Leading edge protrusion
The leading edge of migrating cells is characterised by the protrusion of a 
lamellipodium and filopodia. The lamellipodium is composed of a dense network of 
actin filaments and displays a treadmilling mechanism, with actin polymerisation at 
the interface between the growing filaments and the protruding plasma membrane, 
while the turnover is balanced by nucleation and capping at the front and 
disassembly occurring at the rear (Pollard and Borisy, 2003). Rac1 and Cdc42 have 
been shown to be important for membrane protrusions (Ladwein and Rottner, 
2008), with Rac1 being the main driver in lamellipodium formation and Cdc42 being 
implicated in filopodium formation. GF-induced R ad activation by tyrosine kinases 
and G-protein-coupled receptors (GPCRs) is often dependent on PI3K activity 
(Rickert et al., 2000; Sander et al., 1998). Rad can also be activated in response to 
integrin engagement (del Pozo et al., 2000), which involves Vav family exchange 
factors (del Pozo et al., 2003; Moores et al., 2000). R ad regulates lamellipodium 
extension by stimulating new actin polymerisation through the Arp2/3 complex, 
which initiates actin branching by forming new actin filaments on the side of existing 
ones (Pollard and Borisy, 2003). R ad signals to Arp2/3 via a IRSp53 (insulin 
receptor substrate p53) and WASP/WAVE (Wiscott-Aldrich syndrome 
protein/WASP-family verprolin homology protein) proteins (Fig. 1.5) (Miki et al., 
2000). WASP/WAVE proteins are potent nucleation promoting factors that differ in
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their activation and regulation (Vartiainen and Machesky, 2004). WAVEs are kept 
inactive in a complex with four other proteins, PIR121 /Sra-1, Nap125, HSPC300 
and Abl interactor (Abi). In response to stimuli, this complex is disassembled and 
WAVEs can signal to Arp2/3. WASP proteins on the other hand are autoinhibited 
and need activation, e.g. phosphatidylinositol (4,5)-bisphosphate (Ptdlns(4,5)P2), 
which unmasks the verprolin-homology-connecting acidic (VCA) domain.
Rac1 can also stimulate actin polymerisation by promoting the uncapping of 
proteins, by phosphatidylinositide 4-phosphate 5-kinase (PI(4)P5-K)-induced 
formation of Ptdlns(4,5)P2, which binds to capping proteins, thereby removing them 
from the barbed ends of actin filaments (Carpenter et al., 1999; Tolias et al., 2000). 
Myosins are important players in cell migration and Rac1 has been shown to affect 
phosphorylation of myosin II heavy chain and myosin light chain (MLC) via PAK 
(Daniels and Bokoch, 1999; van Leeuwen et al., 1999). Considering the importance 
of R ad  in migration, it is surprising that Rad-deficient fibroblasts are able to 
migrate, extending pseudopodia-like protrusions without development of 
lamellipodia (Vidali et al., 2006). Deletion or inhibition of Rac2, which is only 
expressed in haematopoietic cells, compromises cell migration and adhesion in 
different haematopoietic cells, except for macrophages (Gu et al., 2003; Wheeler et 
al., 2006). Interestingly, double deletion of Rad and Rac2 in macrophages does not 
compromise migration and cells are able to perform chemotaxis normally (Wheeler 
et al., 2006). Cdc42 might compensate for the loss of Rac in activating Arp2/3 via 
IRSp53 and WAVE proteins (Vartiainen and Machesky, 2004). RhoG, another 
member of the Rac subfamily, is thought to contribute to Rad-mediated 
lamellipodium protrusion by binding to its downstream effector genes in engulfment 
and motility (ELMO), which in turn binds to the R ad activator Dock180 (Cote and 
Vuori, 2007).
As opposed to the network organisation of actin in the lamellipodium, 
filopodia are relatively stiff rods with parallel bundles of actin filaments (Small et al., 
2002). In neuronal growth cones, filopodia play a pivotal role as sensors of the 
extracellular milieu, steering the direction of the axon growth (Gordon-Weeks, 
2004). The Arp2/3 complex is excluded from filopodia, whose rod-like structure is 
generated by fascin- and fimbrin-mediated bundling of actin filaments (Small et al., 
2002). Cdc42 has been shown to play a major role in mediating filopodium 
formation by binding to the formin mDia2 (Faix and Rottner, 2006), which 
accumulates at the tips of filopodia (Mallavarapu and Mitchison, 1999). Additionally,
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Figure 1.5: Regulation of cell migration by Rho GTPases
Cell migration is regulated by Rho GTPases and their downstream effectors. 
Lamellipodium protrusion is mainly regulated by Rac1, which activates the WAVE 
complex via IRSp53 and leads to Arp2/3-mediated actin branching and filament 
polymerisation. Cdc42, which induces filopodium formation via the formin 
mDia2/Drf, has also been shown to interact with IRSp53, feeding into the Arp2/3 
pathway. Rac1 is additionally activated by RhoG, which interacts with its 
downstream effector ELMO, leading to Dock180-mediated activation of R ad. 
Finally, R ad and Cdc42 both activate LIM kinase (LIMK) via PAK, thereby inhibiting 
cofilin-mediated actin depolymerisation. ROCK, a RhoA effector, has also been 
shown to activate LIMK. RhoA and Rad both regulate the activity of 
PI(4)P5-K to induce increases in Ptdlns(4,5)P2 levels, thereby affecting capping 
proteins and actin polymerisation. RhoA activity also leads to increased contractility 
and stress fibre formation by ROCK-induced inhibition of MLC phosphatase and 
subsequent MLC phosphorylation. Additionally, RhoA interacts with mDia to 
contribute to stress fibre formation, which is dependent on Src kinase.
mDia has been implicated in filopodium formation triggered by the Rho GTPase 
RhoF/Rif (Rho in filopodia) (Pellegrin and Mellor, 2005). Interestingly, Cdc42 has 
also been shown to interact directly with the Arp2/3-complex activator WASP, 
thereby linking Cdc42 into the lamellipodium formation pathway (Vartiainen and 
Machesky, 2004). This pathway is also important for membrane trafficking during 
endocytosis.
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1.3.2.2 Formation and turnover of adhesions
Adhesion to the ECM or neighbouring cells is mediated by adhesion sites that vary 
in morphology, size and subcellular distribution depending on the cell type and 
substratum, but share two common features: they are integrin-mediated and interact 
with the actin cytoskeleton (Geiger et al., 2001). Focal adhesions (FA) are the best 
characterised adhesions; they are flat and elongated structures mostly at the 
periphery of cells and mediate adhesion to the substrate by anchoring the actin 
cytoskeleton through a plaque of many different proteins, including vinculin, talin 
and paxillin (Geiger et al., 2001). However, this form of FAs has only been observed 
in slow moving cells. During cell migration the co-ordinated assembly and 
disassembly of FAs is vital for efficient translocation. FAs act as substrate-anchoring 
points for stress fibres and can also act as mechanosensors, maturing with 
increasing tension as the cell moves along. Rac1 and RhoA have been shown to be 
involved in FA assembly and maturation. Rac1 mediates FA assembly in the 
lamellipodium (Allen et al., 1997; Nobes and Hall, 1995), while RhoA-induced 
contractility via Rho-kinase (ROCK) and myosin II leads to FA maturation (Rottner 
et al., 1999; Totsukawa et al., 2000). Rad is also involved in FA disassembly, 
either directly through PAK (Zhao et al., 2000), or by antagonising RhoA activity 
(Sander et al., 1998). Integrin-mediated adhesion seems to be required for R ad 
binding to PAK (del Pozo et al., 2000), indicating that a critical level of integrin 
engagement ultimately leads to FA disassembly. However, adhesion turnover 
involves additional regulatory signals, including FAK and Src (Jones et al., 2000).
1.3.2.3 Cell body contraction
The contraction of the cell body is believed to be dependent on Rho-mediated 
actomyosin contractility (Mitchison and Cramer, 1996). Rho acts via ROCKs to 
induce MLC phosphorylation, by inhibiting MLC phosphatase and directly 
phosphorylating MLC (Kaibuchi et al., 1999). MLC is also phosphorylated by MLC- 
kinase (MLCK) in response to Ca2+ and extracellular signal-regulated kinase (ERK) 
activation (Hansen et al., 2000). RhoA is also linked to the actin cytoskeleton via 
mDia, which interacts with Src to induce stress fibre formation (Tominaga et al., 
2000). Inhibiting Rho proteins has two opposing effects on cell migration depending 
on adherence and cell type: it promotes migration by lowering adhesion due to 
decreased stress fibres, and it reduces migration by reducing contractility.
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1.3.2.4 Tail detachment
Migrating leukocytes exhibit a more or less triangular shape with a ‘uropod’ at the 
rear. A uropod is an actively produced structure that is important in the interplay 
between leukocytes (Fais and Malorni, 2003). Slow migrating fibroblasts have a tail, 
which is formed passively (Lauffenburger and Horwitz, 1996). The mechanism 
regulating uropod or tail detachment depends on the type of cell and strength of 
adhesion (Palecek et al., 1998). The protease calpain, which degrades FA 
components at the rear, plays an important role in tail detachment (Glading et al., 
2000; Palecek et al., 1998). Rho inhibition by C3 transferase has been shown to 
inhibit tail detachment through decreased contractility, leading to the development of 
long tails (Cox and Huttenlocher, 1998; Worthylake et al., 2001). Regulated 
assembly as well as disassembly of adhesions is therefore pivotal for efficient 
migration.
1.3.3 Cell-type specific variations in cell migration mechanisms
Most cell types of the body are capable of migration at a given time and tissue 
space. However, the mechanism of migration can differ between cell types. A large 
range of migration studies have been carried out in mouse fibroblasts and fish 
keratocytes (see reviews by (Geiger et al., 2001; Lauffenburger and Horwitz, 1996; 
Pollard and Borisy, 2003). Fish keratocytes are fast migrating cells that do not 
complete the typical stepwise migration sequence (see Chapter 1.3.2) observed in 
fibroblasts (Svitkina et al., 1997). However, their large lamellipodium makes them 
ideal candidates for studying actin dynamics (Pollard and Borisy, 2003). 
Additionally, a lot of the basic actin biochemistry has been studied in vitro (Pollard 
and Borisy, 2003). Other cellular systems used to study single cell migration include 
leukocytes (Allen et al., 1998; del Pozo et al., 2003; Gu et al., 2003; Moores et al., 
2000; Rickert et al., 2000; Wheeler et al., 2006; Worthylake et al., 2001), epithelial 
ceils (Hansen et al., 2000; Sander et al., 1998), COS7 (Miki et al., 2000), PC12 and 
melanoma cells (van Leeuwen et al., 1999), HeLa (Pellegrin and Mellor, 2005), and 
Chinese hamster ovary cells (CHO) (Palecek et al., 1998). Regulatory pathways 
have also been extensively studied in non-mammalian organisms such as 
Caenorhabditis elegans, Drosophila, Saccharomyces cerevisae and S. pombe 
(Vartiainen and Machesky, 2004).
Although the basic mechanisms regulating cell migration, e.g. actin 
polymerisation or actomyosin-mediated contraction, are believed to be very similar 
between cell types, two distinct mechanisms for single cell migration have been
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described: mesenchymal and amoeboid migration (Friedl, 2004). However, 
variations of these migration mechanisms are possible and cells can change their 
migration behaviour when differentiating or in response to stimuli. Mesenchymal 
migration is relatively slow (0.1 -  2 pm/min) and is characteristic for fibroblasts, 
myoblasts, single endothelial or sarcoma cells (Grinnell, 1994; Tamariz and 
Grinnell, 2002) and is accomplished by completing the complete five-step migration 
sequence (including protase-dependent degradation of ECM). Amoeboid migration, 
which mimics the migration behaviour of the amoeba Dictyostelium discoideum, is 
fast (2 -  30 pm/min) and is carried out by haematopoietic stem cells, leukocytes and 
certain tumour cells (Francis et al., 2002; Friedl et al., 2001; Wang et al., 2002). 
Amoeboid migration can be described as a four-step process: 1) leading edge 
protrusion by actin flow; 2) interaction of surface receptors with substrate; 3) 
actomyosin-mediated contraction of the cell body; 4) forward movement of rear of 
cell. While mesenchymal migration is dependent on focalised integrin-mediated 
adhesion in FAs (Ballestrem et al., 2001; Maaser et al., 1999; Sims et al., 1992; 
Tamariz and Grinnell, 2002) and requires local proteolysis of ECM proteins, 
amoeboid migration is driven by short-lived and relatively weak interactions with the 
substrate (Friedl, 2004). This lack of stable focal contacts and the use of protease- 
independent physical mechanisms to overcome matrix barriers by squeezing 
through narrow spaces (Wolf et al., 2003) allow the highly deformable leukocytes to 
move at high velocities. Migration of lymphocytes and neutrophils has been shown 
to be completely or partially independent of (31 integrin, both in vitro (Friedl et al., 
1998) and in vivo (Brakebusch et al., 2002; Werret al., 1998).
1.4 The innate immune response and inflammation
The recognition of pathogens by the innate immune system is dependent on Toll­
like receptors (TLRs) (Murphy et al., 2008). In mammals, 10 TLR genes are 
expressed, forming eight different receptors, which can be either heterodimers, 
homodimers or monomers. TLRs recognise diacyl lipopeptides, triacyl lipopeptides, 
flagellin, lipopolysaccharide (LPS), double and single stranded ribonucleic acid 
(dsRNA and ssRNA, respectively), guanine-rich oligonucleotides and unmethylated 
deoxyribonucleic acid (DNA). The initial stages of the innate immune response rely 
on mobilisation of existing leukocytes to the site of infection or damage. This is 
achieved through inflammation and subsequent extravasation of leukocytes from 
the blood to the tissue, termed transendothelial migration (TEM). Inflammation is a 
complex response and involves various cell types and numerous pro-inflammatory
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mediators. These pro-inflammatory mediators are produced upon tissue damage 
and infection and regulate the migration of leukocytes into the sites of inflammation. 
Pro-inflammatory cytokines include tumor necrosis factor-a (TNF-a), TNF-p, IL-1 
and IL-6 and are produced by a variety of activated cell types, including endothelial 
cells (ECs), platelets, leukocytes and fibroblasts (Huang et al., 2006b). Inflammation 
leads to the disruption of vascular integrity which can be potentially harmful and is 
known to be a contributing factor in the pathogenesis of a range of diseases, 
including atherosclerosis, cancer and neurodegenerative diseases (Lin and Karin, 
2007; Napoli and Palinski, 2005).
1.4.1 TNF-a induces an inflammatory response in ECs
TNF-a is predominantly produced by macrophages and monocytes, but ECs are 
also capable of TNF-a production (Kofler et al., 2005). TNF-a has several effects on 
the endothelium, including protein-synthesis-independent changes such as 
increases in monolayer permeability and cell motility, facilitating leukocyte 
extravasation, but also leading to vascular leakage and oedema formation (Friedl et 
al., 2002).
TNF-a exerts its effects via two cell surface receptors, TNFR1 (p50) and 
TNFR2 (p75) (MacEwan, 2002). TNF-a binding induces activation of nuclear factor- 
kB (NF-kB) and MAPKs, including ERK, p38 and c-Jun N-terminal kinase (JNK) 
among other responses (MacEwan, 2002; Paul et al., 1997).
1.4.2 NF-kB activation
At least 150 genes are regulated by the transcription factor NF-kB. It is composed of 
homo- and hetero-dimeric complexes of Rel family polypeptides, which include five 
related DNA binding family members: Rel-A (p65), Rel-B, c-Rel, NF-KB1/p50 and 
NF-xB2/p52 (Beinke and Ley, 2004). NF-kB activity is tightly regulated by the 
inhibitor of NF-kB (IkB) family, including kB-a, kB-p, kB-y, p100 and p105, which 
bind NF-kB in the cytosol and prevent it from activating target genes. Two distinct 
NF-kB activation pathways exist: the classical pathway and the alternative pathway 
(Fig. 1.6) (Karin and Greten, 2005). The classical pathway is triggered by pro- 
inflammatory cytokines, such as TNF-a, bacterial wall components, viruses and 
DNA-damaging agents and activates the IkB kinase (IKK) complex. This complex 
consists of three components, two catalytic subunits IKK-a and IKK-p, as well as a 
regulatory subunit IKK-y. The IKK complex phosphorylates IkB leading to its
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Figure 1.6: Classical and alternative pathway of NF-kB activation
A: In the classical pathway activation of cellular receptors by pro-inflammatory 
cytokines or other stimuli activates the IKK complex, which is composed of IKK-a, 
IKK-p and IKK-y. The IKK complex phosphorylates IkB, which is bound to and 
inhibits the NF-kB complex made up of p50 and Rel-A in the cytoplasm, leading to 
its proteasomal degradation. The p50/Rel-A dimer can enter the nucleus and up- 
regulate target gene transcription. In the alternative pathway, cellular receptors are 
activated by TNF family members leading to IKK-a-dependent phosphorylation of 
p100 (a p52 precursor) and its proteasomal degradation to p52. Dimers of p52 and 
Rel-B can enter the nucleus and activate downstream targets. B: NF-kB target 
genes include genes involved in inflammation, innate immunity and survival. From 
(Karin and Greten, 2005)
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polyubiquitination and subsequent proteasomal degradation. The liberated NF-kB 
dimers, which are mostly p50-Rel-A dimers, are translocated to the nucleus where 
they mediate transcription of target genes. The alternative pathway is triggered by 
certain TNF-family members and leads to an IKK-a-dependent phosphorylation of 
p100, resulting in its proteasomal degradation to p52 and translocation of p52-Rel-B 
dimers to the nucleus, where target genes are activated.
TNF-a-mediated adhesion molecule expression plays a central role in the 
inflammatory response. TNF-a-mediated NF-kB activation leads to transcriptional 
upregulation of E-selectin, P-selectin, intercellular adhesion molecule-1 (ICAM-1), 
vascular adhesion molecule-1 (VCAM-1), mucosal addressin adhesion molecule-1 
(MadCAM-1) and others (De Martin et al., 2000; Zeiffer et al., 2004). The distinct 
roles of the two TNF receptors in this process are controversial. Studies using 
receptor-specific antibodies and TNF-a mutants have shown that TNFR1 (p55) and 
not TNFR2 (p75) is important in mediating the TNF-a response (Paleolog et al., 
1994; Zhou et al., 2007), while mouse studies have shown that TNFR2 (p75) is 
critical for ICAM-1 upregulation at mRNA and protein level and P-selectin at the 
mRNA level (Chandrasekharan et al., 2007; Lucas et al., 1997). TNFR1 (p55)- 
mediated adhesion molecule upregulation is entirely NF-KB-dependent and no 
cross-talk with the MAPK pathway occurs (Zhou et al., 2007).
1.4.3 Leukocyte adhesion cascade and transendothelial migration
Leukocyte adhesion and TEM are active and tightly regulated mechanisms that 
involve many molecules on the endothelial and the leukocyte surface as well as 
cytoskeletal rearrangements and signalling events. The leukocyte adhesion 
cascade can be divided into distinct steps: tethering and rolling, arrest and firm 
adhesion, locomotion, and diapedesis or transmigration (Fig. 1.7) (Ley et al., 2007).
1.4.3.1 Leukocyte rolling
The initial steps of adhesion are mediated by L-selectin on leukocytes and/or E- and 
P-selectin on ECs, causing the leukocyte to be captured from the fast flowing 
bloodstream and to roll slowly along the endothelial surface (Hogg and Landis, 
1993). L-selectin, which is expressed by most leukocytes, interacts with sialylated 
ligands on the endothelial surface (McEver, 2002). L-selectin is localised to 
microvilli, which is mediated by its binding to moesin, a member of the ezrin-radixin- 
moesin (ERM) family (Ivetic et al., 2004). P-selectin glycoprotein ligand 1 (PSGL1)
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Figure 1.7: The leukocyte adhesion cascade and transendothelial migration
The leukocyte adhesion cascade is a multi-step process, involving a multitude of 
molecules on the endothelium as well as the leukocytes. The steps are: 1) Tethering 
and rolling, which involves P-selectin and E-selectin on the endothelial cells, as well 
as L-selectin and selectin ligands PSGL1, CD44 and ESL1 on the leukocytes. 
Rolling can also be mediated by integrins, where VLA-4 binds to VCAM-1 and LFA- 
1 binds to ICAM-1. 2) Leukocyte arrest and firm adhesion is mediated by 
chemokine-induced activation of integrins, including Mac-1, LFA-1, VLA-4, binding 
to ICAM-1 and VCAM-1. 3) Locomotion is, depending on the cell type, mediated by 
Mac-1 or LFA-1 binding to ICAM-1 and VCAM-1, respectively. 4) Transmigration is 
mediated by LFA-1 binding to ICAM-1, and additionally by PECAM-1, CD99 and 
JAMs during paracellular TEM. Dark blue font: leukocyte receptors; light blue font: 
endothelial receptors. Adapted from figure provided by Dr R.J. Cain.
is a ligand for all three selectins and is anchored to the actin cytoskeleton by ezrin 
and/or moesin (Ivetic et al., 2004; McEver, 2002). Binding of PSGL1 to L-selectin 
mediates leukocyte-leukocyte interaction, thereby allowing leukocytes without 
ligands for E- or P-selectin to reach sites of inflammation (Eriksson et al., 2001). 
Other selectin ligands include glycosylated CD44 and E-selectin ligand 1 (ESL1), 
which are both ligands for E-selectin (Hidalgo et al., 2007). Selectins have been 
shown to display catch bonds behaviour, where increasing force first prolongs and 
then shortens the lifetime of selectin binding (Marshall et al., 2003). This 
phenomenon allows deceleration of the leukocytes and increases proximity between 
leukocytes and the endothelium, a prerequisite for chemokine-induced signalling 
and firm adhesion.
Leukocyte rolling can also be mediated by integrins and their ligands: very 
late antigen-4 (VLA-4; a4(31)-mediated rolling on VCAM-1 has been seen for several 
leukocytes (Chan et al., 2001; Singbartl et al., 2001), while leukocyte function- 
associated antigen-1 (LFA-1; CD11a/CD18 or aL(32)-mediated rolling by binding to
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ICAM-1 has been observed in neutrophils (Chesnutt et al., 2006). The latter requires 
partial LFA-1 activation induced by E-selectin binding.
1.4.3.2 Leukocyte arrest and firm adhesion
The close proximity between rolling leukocytes and the endothelium allows 
modulation of the adhesiveness by chemokines presented on the apical surface of 
the ECs (Campbell et al., 1998). These chemokines can be produced by the 
endothelium in response to pro-inflammatory stimuli and are transported to the 
apical surface (Mordelet et al., 2007). Additionally, thrombin-activated platelets 
deposit CC-chemokine ligand 5 (CCL5; previously known as RANTES) as well as 
CXC-chemokine ligand 4 (CXCL4) and CXCL5 on the surface of inflamed 
vasculature (Huo et al., 2003; von Hundelshausen et al., 2001). Endothelium-bound 
chemokines and chemokine receptors on the leukocytes are localised to microvilli to 
facilitate their interaction. The chemokines presented on the ECs differ depending 
on the site of vasculature allowing recruitment of specific leukocyte subsets, for 
example to sites of inflammation or secondary lympoid organs (Muller and Lipp,
2003).
Chemokines exert their effect by binding to GPCRs, thereby dissociating Ga 
and G(3y subunits of the heterotrimeric G proteins (Viola and Luster, 2008). 
Chemokine receptors can signal through different Ga families, activating distinct 
signalling pathways. During TEM, exposure to chemokines induces arrest of rolling 
leukocytes (Huo et al., 2003; von Hundelshausen et al., 2001). The activation of 
chemokine receptors in endothelium-bound leukocytes has multiple effects, 
including direct or indirect stimulation of members of the Rho GTPase family and 
activation of leukocyte integrins (Wittchen et al., 2005).
1.4.3.2.1 Integrins
Integrins are heterodimers containing non-covalently linked a and (3 chains (Takada 
et al., 2007). Each subunit has a large extracellular domain, a single 
transmembrane domain and a short cytoplasmic domain. In mammals, combination 
of 18 a and 8 (3 subunits forms 24 integrins, which bind to various substrates, 
mediating cell-cell and cell-ECM contacts. The N-terminal portions of the a and (3 
subunit form a globular head containing the ligand-binding region. Nine of the 
a subunits contain a domain of about 200 amino acids, which is termed the inserted 
or I domain and is the major or exclusive ligand-binding site in these integrins 
(Takada et al., 1997). Ligand binding requires divalent cations, and integrins have
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several putative cation binding sites. Non-al integrin binding is mediated by specific 
regions of the N-terminal portions of both a and (3 subunits.
For leukocyte TEM, (32-containing integrins are most important, particularly 
LFA-1 and myeloid-specific integrin Mac-1 (CD11b/CD18 or aM(32), but a4 
containing integrins also play a role, including VLA-4 and a4(37 (Barreiro et al.,
2007). The ligands mediating cell-cell contacts belong mainly to the immunoglobulin 
superfamily, LFA-1 binds to members of the ICAM family (Hayflick et al., 1998), but 
also junctional adhesion molecule-A (JAM-A) (Ostermann et al., 2002). Mac-1 binds 
to ICAM-1, JAM-C and the endothelial receptor for advanced glycation end products 
(RAGE) (Chavakis et al., 2003; Lamagna et al., 2005), while VLA-4 interacts with 
VCAM-1 and JAM-B (Cunningham et al., 2002; Elices et al., 1990).
1.4.3.2.2 Integrin activation
During TEM, integrin adhesiveness is modulated by chemokines acting through 
leukocyte GPCRs. Integrin activation has long been thought to occur due to 
integration of successive GPCR signals encountered by rolling leukocytes until a 
threshold is reached. Shamri et al. have shown, though, that endothelium-bound 
chemokines induce instantaneous extension of LFA-1 in the absence of ligand 
(Shamri et al., 2005). The immediate binding of the ligand ICAM-1 then induces the 
fully active high-affinity conformation. GPCR-induced integrin activation is referred 
to as ‘inside-out signalling’, in contrast to signalling downstream of ligand binding, 
which is referred to as ‘outside-in signalling’.
How GPCRs exert their effects on integrin activation is not fully understood, 
but two members of the Ras GTPase family, RhoA and Rap1 have been implicated 
in this process (Bos, 2005) (Fig. 1.8). Rap1 has been shown to activate integrins in 
a RapL-dependent manner, where RapL is recruited by Rap1 to associate with and 
activate LFA-1 (Katagiri et al., 2003). The importance of RapL in integrin activation 
has been confirmed by the RapL knock-out phenotype, in which leukocytes show 
decreased binding to ICAM-1 (Katagiri et al., 2004). The role of RhoA in integrin 
activation is likely to be downstream of Rap1, since loss of RhoA function has been 
shown to prevent integrin activation induced by Rac1 and RaplA in vivo (Vielkind et 
al., 2005). Additionally, RhoA is also involved in LFA-1 extension triggered by 
SDF-1 (Pasvolsky et al., 2008). Rap1 has also been shown to activate integrins by a
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Figure 1.8: Integrin activation downstream of GPCRs
Integrin activation downstream of GPCRs involves the activation of the GTPase 
Rap1, which leads to RapL localisation to LFA-1, thereby inducing activation. 
Additionally, the Rap1 effector RIAM induces localisation of Talin to integrins, 
thereby mediating integrin activation by wedging in between the two cytoplasmic 
tails. RhoA is also likely to play a role in integrin activation and has been shown to 
be downstream of Rap1. Integrin activation downstream of GPCRs is also induced 
via PLC-generated lnsP3 and DAG generation, leading to increased intracellular 
Ca2+ levels.
profilin- and vasodilator-stimulated phosphoprotein (VASP)-binding protein termed 
Rap-interacting adapter molecule (RIAM) (Lafuente et al., 2004), which recruits talin 
to the vicinity of integrins, thereby inducing integrin activation (Han et al., 2006). 
Talin inserts between the a- and (3-cytoplasmic tails of integrins, thereby increasing 
adhesion (Kim et al., 2003; Tadokoro et al., 2003). Integrin activation downstream of 
GPCRs has also been shown to be dependent on activation of phopholipase C 
(PLC), 1,4,5-trisphophate receptors, Ca2+ influx and activation of calmodulin (CaM) 
(Hyduk et al., 2007).
The overall strength of adhesion is referred to as ‘avidity’ and is defined by 
the intrinsic affinity of the receptor-ligand bond and the number of bonds, the 
‘valency’ (Carman and Springer, 2003). The valency is defined by the density and 
distribution of the receptors on the cellular surface, as well as the ability to move
39
1 Introduction
into areas of adhesion. Integrin-mediated adhesion can be influenced by modulation 
of any or all of these parameters. Ligand-induced integrin clustering, a way of 
increasing valency, induces allosteric conformational changes, which probably 
contribute to outside-in signalling by recruiting protein tyrosine kinases (PTKs) 
required for signalling (Chatzizacharias et al., 2008; Xiao et al., 1996). The 
conformational changes of the cytoplasmic tail of LFA-1 in response to ICAM-1 
binding might play a role in the rapid arrest of leukocytes under flow (Kim et al., 
2003; Shamri et al., 2005), but are probably not required during inside-out signalling 
events. The proline-rich tyrosine kinase 2 (Pyk2) has been shown to mediate not 
only chemokine-induced but also integrin-mediated Rac1 activity by associating with 
the GEF Vav (Gismondi et al., 2003). However, efficient migration requires Rac1 
activation to be spatially and temporally restricted to the leading edge (Rose et al.,
2007). This is achieved via a signalling pathway involving a4[31 integrin-mediated 
R ad inhibition, where paxillin reversibly binds to the a4 cytoplasmic domain (Liu et 
al., 1999). This interaction is regulated by the phosphorylation of the a4 cytoplasmic 
domain at Ser988 by PKA, which leads to release of paxillin. When bound to a4, 
paxillin binds to other signalling molecules including the adenosine diphosphate 
(ADP)-ribosylation factor (Arf)-GAP, G protein-couples receptor kinase-interactor-1 
(GIT1) (Nishiya et al., 2005). GIT inhibits Rad by inhibiting the activation of another 
small GTPase, Arf6 (Vitale et al., 2000). The interaction between a4 integrin and 
paxillin is therefore an important regulator of the spatial and temporal activation of 
R ad during cell migration. Selective paxillin phosphorylation in the leading edge is 
likely to be achieved by PKA localisation and activation at the leading edge 
(Goldfinger et al., 2003).
Integrin-mediated firm adhesion, elicited by chemokine-mediated inside-out 
signalling, and leukocyte activation initiate the next step of TEM, migration on the 
endothelium (locomotion).
1.4.3.3 Locomotion
Only recently, Schenkel et al. have identified the importance of locomotion, a 
process in which leukocytes move from sites of firm adhesion to the nearest junction 
to transmigrate (Schenkel et al., 2004). This step is dependent on LFA-1 and Mac-1 
on the leukocyte surface, since blocking with specific antibodies prevents directed 
movement to the junctions and TEM. Similar results have been found with Mac-1''' 
mice, where locomotion of neutrophils was reduced (Phillipson et al., 2006). In LFA- 
Y1' mice, however, neutrophils did not exhibit a locomotion defect, but adhesion was 
significantly reduced. These data suggest that LFA-1 and Mac-1 have different
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functions in TEM in vivo, where LFA-1 is important for adhesion and Mac-1 in 
locomotion. However, further studies should clarify if this effect is neutrophil-specific 
or is valid for other leukocytes too.
1.4.3.4 Transmigration
Diapedesis or transmigration refers to the process whereby leukocytes traverse the 
endothelium and can be rapid, involving different sets of molecules depending on 
the transmigrating cell. Leukocytes have been shown to transmigrate using two 
distinct pathways, either by penetrating endothelial junctions, using a ‘paracellular 
route’, or by transmigrating directly through ECs in a process termed ‘transcellular’ 
TEM.
1.4.3.4.1 Endothelial cell-cell junctions
During paracellular TEM leukocytes have to transmigrate through endothelial cell­
cell junctions to reach the underlying tissue. Endothelial cell-cell junctions have 
specialised regions that are comparable to adherens junctions (AJs) and tight 
junctions (TJs) in epithelia (Dejana, 2004). TJs and AJs are formed by different 
molecules, but have common features, such as the formation of homophilic 
interactions. TJ-associated transmembrane proteins include JAMs, endothelial 
selective adhesion molecule (ESAM), claudins and occludin, while AJ-associated 
proteins include VE-cadherin (Fig. 1.9). Junctional adhesion proteins are anchored 
to the actin cytoskeleton by binding to various adapter molecules, which often have 
additional signalling functions (Matter and Baida, 2003; Wheelock and Johnson,
2003). Some of these adaptor molecules function as scaffolding proteins, by binding 
several effector proteins and enabling their reciprocal interaction. Examples of such 
scaffolding proteins are the TJ components zona occludens-1 (ZO-1), ZO-2 and 
ZO-3, which can associate with many transmembrane proteins, including claudins, 
occludin or JAMs, with cytoskeletal binding proteins such as cortactin, cingulin, 
a-catenin, and indirectly with vinculin and (3-catenin (Matter and Baida, 2003). VE- 
cadherin, like most other cadherins, binds catenins; (3- and y-catenin (plakoglobin) 
connect VE-cadherin with a-catenin, which binds to actin filaments (Vestweber,
2008), but possibly not when bound to (3-catenin (Drees et al., 2005). The nectin- 
afadin system plays an important role in both junction types. Nectin is a member of 
the immunoglobulin family and is linked to actin via afadin (or AF6) and ponsin 
(Takahashi et al., 1999). Outside specialised junctional structures, ECs express
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Figure 1.9: Organisation of endothelial cell-cell junctions
Endothelial junctions are made up of transmembrane adhesion proteins and their 
intracellular binding partners. TJs are formed by Claudins, Occludin, JAMs and 
ESAM, while adherens junctions AJs are composed of VE-cadherin. Nectin is part 
of both junction types. PECAM-1 is also present in the junctions, but outside of 
specialised junctional structures. Many intracellular binding partners mediate direct 
or indirect association to actin filaments, e.g. ZO-1/2, a-catenin, (3-catenin, a-actinin, 
plakoglobin, vinculin, cingulin and Ca2+/calmodulin-dependent serine protein kinase 
(CASK), afadin, ponsin, while others, such as vascular endothelial protein tyrosine 
phosphatase (VE-PTP), modulate cadherin and catenin phosphorylation, thereby 
regulating vascular permeability. Adapted from (Dejana, 2004)
additional adhesion molecules capable of forming homophilic interactions, which 
include CD99 and platelet EC adhesion molecule-1 (PECAM-1 or CD31) (Dejana,
2004). PECAM-1 belongs to the immunoglobulin superfamily and is not confined to 
any type of junctions.
1.4.3.4.2 Paracellular TEM
During paracellular TEM adherens junctions have to be transiently opened to allow 
passage of leukocytes. Binding of leukocytes to the endothelium has been shown to 
induce signalling events in the ECs, leading to remodelling of the actin cytoskeleton 
and loosening of the junctions (Millan and Ridley, 2004). This event is accompanied 
by formation of stress fibres, via RhoA/ROCK and Ca2+-dependent phosphorylation 
of MLC by MLCK, leading to increased contractility (Hixenbaugh et al., 1997; Huang 
et al., 1993; Wojciak-Stothard et al., 1999). Binding of leukocytes to ICAM-1 and
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VCAM-1 on the EC activates this pathway (Adamson et al., 1999; Thompson et al., 
2002; Wojciak-Stothard et al., 1999), possibly via the involvement of ERM proteins 
(Barreiro et al., 2002; Bretscher et al., 2002). Disruption of adherens junctions also 
occurs through VCAM-1-clustering and downstream Rac1 activation, leading to 
subsequent reactive oxygen species (ROS) production (Cook-Mills, 2002; van Buul 
and Hordijk, 2004). This process is dependent on VCAM-1-induced Ca2+ influx 
(Cook-Mills et al., 2004).
During diapedesis VE-cadherin is transiently removed from the junctions in 
order to allow leukocytes to pass (Shaw et al., 2001; Su et al., 2002), while 
endothelial junctional proteins that are also expressed on leukocytes (e.g. PECAM-1 
and JAM-A) actually facilitate TEM (Muller, 2003). PECAM-1 has been shown to 
localise to a membrane network just below the plasma membrane at the cell 
borders, which is connected to the junctional surface (Mamdouh et al., 2003). These 
structures have been referred to as ‘subjunctional reticulum’, ‘reticular junctions’ or 
‘lateral border recycling compartment’ (LBCR) (Mamdouh et al., 2003; Mamdouh et 
al., 2008). When leukocytes transmigrate, PECAM-1 in the endothelium recycles 
from these structures and concentrates around the migrating leukocyte. This 
process, which is dependent on kinesin family molecular motors and requires 
normally functioning endothelial microtubules, is a requirement for TEM, since 
disruption of microtubules and inhibition of kinesin motor domain blocked diapedesis 
(Mamdouh et al., 2008). VE-cadherin and CD99 have also been shown to localise to 
this compartment (Mamdouh et al., 2003).
As well as PECAM-1, ICAM-1, ICAM-2, JAM-A, JAM-B, JAM-C, ESAM and 
CD99 contribute to leukocyte TEM (Muller, 2003; Vestweber, 2002). These 
molecules are involved in binding to leukocyte integrins (ICAM-1 and -2 bind 
LFA-1), mediate homophilic interactions between leukocyte and endothelium 
(PECAM-1 and CD99), or do both (JAMs).
Following leukocyte extravasation endothelial junctions are rapidly resealed 
to prevent vascular leakage (Shaw et al., 2001; Su et al., 2002). VE-cadherin 
appears to be pushed aside during TEM and returns to the junctions within 5 min.
1.4.3.4.3 Transcellular TEM
Leukocytes have long been thought to transmigrate through endothelial cell-cell 
junctions only. However, in vivo EM studies have shown that leukocytes can also 
follow a transcellular route by transmigrating directly through ECs (Feng et al.,
1998). Transmigrating cells form channels through the EC by fusion of vesicles 
resembling vesiculo-vacuolar organelles (WOs) with the plasma membrane. More
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recent studies have shown that TEM via the transcellular route also occurs in vitro, 
although only a minority of cells uses this pathway and the rate is dependent on 
endothelial as well as leukocyte cell type (Carman and Springer, 2004; Millan et al.,
2006). W O s have not been observed in vitro. Instead, clustering of ICAM-1 has 
been shown to trigger signalling events leading to translocation of ICAM-1 and 
caveolae in F-actin-enriched areas, and it is postulated that caveolae fuse to form a 
channel through which leukocytes can transmigrate (Millan et al., 2006). Carman et 
al. have demonstrated the importance of invasive podosomes, actin-dependent 
protrusive structures at the basal surface of leukocytes, during transcellular TEM 
(Carman et al., 2007). Lymphocytes use these protrusions to probe the EC surface 
and form the transcellular pore. The formation of podosomes is dependent on Src 
kinase and the actin regulatory protein WASP, while the formation of the 
transcellular pore is dependent on membrane fusion.
Adherent leukocytes have been shown to induce the formation of 
‘transmigratory cups’ or docking structures in ECs (Barreiro et al., 2002; Carman 
and Springer, 2004). These structures play a role in the firm adhesion of leukocytes 
and are composed of microvillus-like projections from the ECs that surround 
transmigrating leukocytes. The projections are rich in ICAM-1 and VCAM-1, and 
VCAM-1 interacts directly with activated moesin and ezrin (Barreiro et al., 2002). 
Cytoskeletal components such as a-actinin, vinculin and VASP are also present, 
and phosphoinositides and the Rho/ROCK pathway participate in the activation of 
ERM proteins. The VCAM-1-rich vertical projections lead to a redistribution of 
leukocyte integrins and disruption of these structures leads to inhibition of TEM 
(Carman and Springer, 2004). However, the importance of these structures in TEM 
is still controversial.
In Mac17' mice, neutrophils predominantly transmigrate using the 
transcellular route, which takes 20 -30 minutes longer than the paracellular route in 
wild-type (wt) mice (Phillipson et al., 2006). Interestingly, M a d 7' mice did not 
display higher vascular permeability than wt mice. In both wt and M a d 7' mice, 
transmigrating neutrophils were enveloped by a dome-like structure (Phillipson et 
al., 2008). This structure could be an extension of the ‘transmigratory cup’ or 
docking structure and seems to prevent vascular leakage during TEM.
1.5 Reactive oxygen species
ROS is a collective term that describes chemical species that are formed upon 
incomplete reduction of oxygen (0 2). ROS include radicals and non-radical species 
such as superoxide anion (0 2), hydrogen peroxide (H20 2) and the hydroxyl radical
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(OH’) among others (Table 1.1). In cellular systems, ROS can be converted into 
‘secondary’ ROS, e.g. by the Fenton reaction (Fe2+ + H20 2 -> Fe3+ + OH* + OH ), or 
harmless molecules, such as water. ROS, in particular OH*, can react with all 
biological macromolecules, including lipids, proteins, DNA and carbohydrates. Free 
radicals react with other molecules in order to gain a stable electron configuration; 
their reaction with cellular macromolecules starts a chain reaction that propagates 
until two radicals meet to form a covalent bond. In cells, these chain reactions can 
have devastating effects, leading to damage of macromolecules. Other ROS induce 
oxidation of their targets, which can lead to addition of groups (e.g. glutathione 
groups (S-glutathionylation) (Hayes and McLellan, 1999)), cross-linking or 
fragmentation of proteins (Halleen et al., 1999) and modifications of nucleotide 
bases, single-strand breaks or cross-linking of DNA (Bertram and Hass, 2008). 
Despite their damaging properties, ROS, in particular H20 2, have been shown to 
have signalling properties and to be involved in mediating a variety of cellular 
processes (Droge, 2002; Veal et al., 2007). One of the first reports of ROS 
signalling properties was the activation of guanylate cyclase by H20 2 (Mittal and 
Murad, 1977). The signalling properties of ROS were first met with scepticism since 
signalling require a high level of specificity, whereas ROS were thought to react 
unspecifically due to their reactive nature. Specificity in signalling is achieved 
through non-covalent binding of two (or more) molecules through complementary 
structures. ROS on the other hand, mediate signalling by chemically reacting with 
specific atoms of the target molecule, thereby inducing covalent protein 
modifications (Nathan, 2003). ROS signalling therefore occurs at the atomic and not 
the macromolecular level. This mechanism is similar to signalling mediated by nitric 
oxide (NO) and reactive nitrogen species (RNS) (see Chapter 1.6).
The imbalance of pro-oxidants (high) and antioxidants (low) has been 
defined as oxidative stress (Jones, 2006) and has been implicated as being 
important in aging (Finkel and Holbrook, 2000) and the pathogenesis of several 
major diseases, including cardiovascular and pulmonary diseases, diabetes, 
neurogenerative diseases and cancer (Droge, 2002).
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Radicals Non-radicals
Superoxide o2- Hydrogen peroxide H20 2
Hydroxyl OH* Hypochloric acid HOCI
Nitric oxide NO’ Peroxynitrite ONOO'
Thyl RS* Singlet oxygen '1o2
Peroxyl r o 2* Ozone 03
Lipid peroxyl Lipid-OO* Lipid peroxide Lipid-OOH
Table 1.1: Radical and non-radical ROS
1.5.1 Sources of ROS
In a cellular system, ROS production can occur as a by-product of metabolism or be 
induced by exogenous or endogenous stimuli (Fig. 1.10) (Finkel and Holbrook, 
2000).
1.5.1.1 Exogenous stimuli of ROS production
Exogenous stimuli of ROS production include ultraviolet (UV) light, ionising 
radiation, chemotherapeutics and environmental pollution/toxins. Diverse 
chemotherapeutic agents have been shown to increase oxidative stress by inducing 
ROS production thereby inducing cell death (Mansat-de Mas et al., 1999; 
Schumacker, 2006). Air pollution with ultrafine and nano-particles can lead to 
increased oxidative stress (Stone et al., 2007). Additionally, alcohol has not only 
been shown to be directly involved in the production of ROS, but additionally 
reduces antioxidant activity (Das and Vasudevan, 2007). Cigarette smoke 
contributes to oxidative stress by directly or indirectly (via upregulation of cytokines) 
increasing ROS production (El-Zayadi, 2006; Perlstein and Lee, 2006). 
Environmental conditions and personal life-style choices can therefore affect 
oxidative stress levels and personal health.
1.5.1.2 ROS as a by-product of metabolism
In eukaryotes, low levels of ROS are constantly produced as a by-product of 
metabolism (Finkel and Holbrook, 2000). The majority is produced in mitochondria, 
where the production occurs mainly at two points in the electron transport chain, at 
complex I (NADH dehydrogenase) and more importantly at complex III (ubiquinone-
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Figure 1.10: Cellular generation of ROS
Cellular ROS production mainly occurs at three sites: 1) ROS generation in the 
mitochondria at complexes I and III of the respiratory chain as a by-product of the 
metabolism. 2) Regulated production of 0 2' via the NADPH oxidase complex, which 
assembles at the plasma membrane and is composed of the two membrane 
components gp91phox and p22phox and the cytoplasmic components p40phox, p67phox, 
p47ph°x ancj Rac  ^ t(ie cgse the phagocytic NADPH oxidase). 3) 0 2' production 
also occurs via 5-lipoxygenase (5-lox) during the conversion of arachidonic acid 
(AA) to hyroperoxyeicosatetraenoaic acid (HPETE), an intermediate in the 
conversion to leukotriene. Different isoforms of SOD convert 0 2' to H20 2. Adapted 
from (Chiarugi and Fiaschi, 2007)
cytochrome c reductase) (Echtay, 2007). ROS production at complex III can occur 
when the semiquinone anion species is formed as an intermediate during coenzyme 
Q regeneration. The semiquinone anion species can transfer electrons to molecular 
oxygen, leading to the generation of superoxide anion (0 2 + e' -> 0 2'), which can 
rapidly be transformed into other ROS. Additionally, electrons can leak away at 
every step of the electron transport chain and reduce oxygen to the superoxide 
anion. The generation of mitochondrial ROS is therefore dependent on the 
metabolic rate and it is not surprising that organisms with a high metabolic rate have 
greater production of ROS and a shorter life span (Finkel and Holbrook, 2000).
In vitro experiments with isolated mitochondria have shown that 1 -  2% of 
oxygen molecules are used to produce ROS under conditions with high oxygen 
concentrations (Boveris and Chance, 1973). The in vivo rate will undoubtedly be 
much smaller. Cellular mechanisms to reduce mitochondrial ROS production
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include a process known as metabolic uncoupling (Skulachev, 1996), where oxygen 
consumption is uncoupled from ATP generation and heat is produced. This process 
is mediated by the family of uncoupling proteins (UCP-1, -2 and -3) (Echtay, 2007).
1.5.1.3 Regulated cellular ROS production
Regulated ROS production has long been thought to be confined to phagocytic 
immune cells which produce ROS to promote killing of phagocytosed 
microorganisms by means of NADPH oxidase (Quinn et al., 2006). However, 
members of the Nox family of NADPH oxidases have now been found in a variety of 
cells and tissues (Geiszt and Leto, 2004).
1.5.1.3.1 The Nox family of NADPH oxidases
The phagocytic oxidase (phox), which has been studied extensively, consists of a 
membrane-bound flavocytochrome b558, several molecular cytosolic regulators 
(p47phox, p67phox, p40phox) and Rac1 or Rac2 (Geiszt and Leto, 2004). The 
cytochrome is a complex of two proteins, a flavin- and heme-binding glycoprotein 
(gp91phox or Nox-2) and a smaller subunit (p22phox). In resting cells the NADPH 
oxidase complex is unassembled and only assembles at the membrane upon 
stimulation. The activity of NADPH oxidase can be induced by microbial products 
such as bacterial lipopolysaccharide or N-formylated peptides such as fMetLeuPhe 
(fMLP) (DeLeo et al., 1998; Karlsson et al., 1995). NADPH oxidase in other cell 
types, e.g. ECs, has been shown to be activated in response to various agonists, 
including angiotensin II (ang II), TNF-a, and vascular endothelial growth factor 
(VEGF) (Alom-Ruiz et al., 2008). Other, non-physiological stimuli include phorbol 
12-myristate 13-acetate (PMA), which is commonly used in biomedical research as 
a tumour promoter (Jagnandan et al., 2007; Liu and Heckman, 1998).
The Nox family of oxidases consists of seven members, which have different 
expression patterns (Geiszt and Leto, 2004). Nox-1 is highly expressed in colon and 
at lower levels in the uterus, prostate and vascular smooth muscle cells (Suh et al.,
1999). Nox-1 knock-out mice are healthy, reproduce normally and do not exhibit a 
spontaneous phenotype, but have a moderately decreased blood pressure (Gavazzi 
et al., 2006). However, they show an almost complete loss of the sustained blood 
pressure response when treated with ang II, while the initial response is conserved. 
This suggests a role of Nox-1 in blood pressure regulation and vascular ang II 
response. Overexpression of Nox-1 in NIH-3T3 cells leads to increased cell 
proliferation and tumour formation when injected into mice. These data fit with 
previous findings linking enhanced ROS generation to enhanced growth triggered
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by growth factor stimulation or tumourigenesis (Sundaresan et al., 1995; Szatrowski 
and Nathan, 1991). Nox-1 over-expressing cells also show increased VEGF 
expression, indicating a role of ROS in angiogenesis in these tumours (Arbiser et 
al., 2002). Nox-2 or gp91phox is highly expressed in phagocytic cells, but also the 
endothelium (Alom-Ruiz et al., 2008; Geiszt and Leto, 2004). Mice deficient in Nox-2 
have been used as a model for chronic granulomatous disease (CGD) (Pollock et 
al., 1995). CGD is a rare genetic childhood disease in which phagocytes do not 
produce ROS, leading to severe recurring infections with bacteria and fungi (Seger,
2008). In addition, patients display aberrant inflammatory response and tissue 
granuloma formation. The X-linked form of human CGD is caused by mutations in 
gp91phox (60% of cases), while the autosomal recessive forms are caused by 
mutations in p47phox (30% of cases), p67phox (5% of cases) and p22phox (5% of 
cases). Nox-2 knock-out mice show an increased susceptibility to infections with 
Staphylococcus aureus and Aspergillus fumigatus, two CGD-typical infections 
(Pollock et al., 1995). Mice deficient in p47phox have also been used as a model for 
CGD: p47phox /' mice produce no superoxide and kill staphylococci ineffectively, they 
develop lethal infections and granulomatous inflammation similar to those 
encountered in humans (Jackson et al., 1995).
Nox-3 is predominantly expressed in fetal tissue, including kidney, liver, lung 
and spleen (Cheng et al., 2001; Kikuchi et al., 2000). Nox-4 is highly expressed in 
the kidney, and has been shown to induce cellular senescence when overexpressed 
in NIH-3T3 cells (Geiszt et al., 2000; Shiose et al., 2001). Nox-4 expression has 
also been shown for HUVECs (van buul 2005). Nox-5 is more distantly related and 
can be detected in spermatozoa and the spleen (Banfi et al., 2001). The dual 
oxidases Duoxl and Duox2 contain an N-terminal extracellular peroxidase-like 
domain and a gp91phox-like oxidase domain (Dupuy et al., 1999; Edens et al., 2001). 
These oxidases are thought to serve as a source of H20 2 supporting anti-microbial 
activity during mucosal surface host defense (Geiszt et al., 2003).
1.5.1.3.2 5-lipoxygenase
ROS production in the cell can also occur via lipoxygenases (Chiarugi and Fiaschi, 
2007). The enzyme 5-lipoxygenase (5-Lox) is involved in production of leukotrienes 
from arachidonic acid in response to several GFs and cytokines (Radmark et al., 
2007). During the conversion of arachidonic acid to leukotrienes, 0 2' is produced 
during one of the intermediate steps and can be converted to other ROS (Zuo et al.,
2004).
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1.5.2 ROS induces various biological responses
In their function as signalling mediators, ROS have been shown to induce a variety 
of biological responses (Droge, 2002; Veal et al., 2007). These include activation of 
the cellular antioxidant defence system and induction of redox-signalling pathways 
leading to regulation of various redox-regulated processes, including cell 
proliferation, differentiation, migration and apoptosis.
1.5.2.1 Cellular antioxidant defence system
Since ROS can have damaging effects on cells it is vital to have a cellular defence 
system able to deal with increasing ROS levels. In unicellular organisms the ROS- 
induced damage can be lethal, and one important response to increasing ROS level 
is therefore the upregulation of antioxidants (Lushchak, 2006; Scandalios, 2005). 
Similarly, antioxidants are also upregulated in certain cell types of multicellular 
organisms in response to ROS (An and Blackwell, 2003; Sablina et al., 2005). The 
concentration of ROS required to induce a response can vary significantly between 
cell types, e.g. concentration differences of up to 20-fold have been shown to be 
required to induce H20 2-mediated apoptosis in mammalian cells (Choi et al., 2006; 
Sablina et al., 2005). Moreover, different ROS levels have been shown to induce 
distinct, sometimes opposing responses. For example, mild oxidative stress leads to 
p53-induced upregulation of several genes with antioxidant properties, while high 
levels of ROS have pro-oxidant effects (Sablina et al., 2005).
The cellular antioxidant defence system comprises non-enzymatic 
antioxidants such as carotenoids, vitamins C and E and enzymes with antioxidant 
activities (Borek, 2004; Droge, 2002). The major antioxidant enzymes involved in 
the catalytic breakdown of ROS are superoxide dismutase (SOD), catalase, 
glutathione peroxidase (Gpx) and thioredoxin (Trx) peroxidases (peroxiredoxins, 
Prx) (Fig. 1.11). SOD is the only mammalian enzyme that converts 0 2' to H20 2 
(Kinnula and Crapo, 2004). Three different isoforms are expressed in mammalian 
cells, copper-zinc SOD (CuZnSOD), manganese SOD (MnSOD) and extracellular 
SOD (ECSOD). CuZnSOD is mainly localised in the cytosol, but also to a lesser 
extent in organelles, and protects against cytosolic produced 0 2'. MnSOD is 
produced as a precursor in the cytosol and is then transported to mitochondria, 
where is plays an important role in mediating oxidative resistance. ECSOD is 
synthesised in the cytosol and is secreted into the extracellular space, where it 
binds to ECM components via its four heparin-binding domains. H20 2 can be
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catalase
Prx
Figure 1.11: Enzymatic antioxidant defence mechanisms
Intracellular ROS can be rapidly converted into secondary ROS or harmless 
substances such as H20  and 0 2 by several enzymes with antioxidative properties. 
SOD converts 0 2' into H20 2 which can be further broken down by three parallel 
mechanisms: the enzyme catalase or the GSH and thioredoxin system involving 
Gpx and Prx.
catalytically broken down to H20  by three parallel processes: via catalase, the 
glutathione (GSH) system involving Gpx, or the thioredoxin system involving Prx 
(Veal et al., 2007). Catalase is a highly efficient enzyme that is widely expressed in 
peroxisomes, but can also be found in the cytosol and mitochondria, and uses its 
heme prosthetic group to convert H20 2 to H20  (van den Bosch et al., 1992). The 
GSH and thioredoxin system are similar in their functionality: the catalytic reduction 
of H20 2 involves the oxidation of Gpx or Prx and their recovery via reduced GSH or 
Trx, respectively (Fig. 1.12).
However, since ROS have been shown to have important signalling 
functions, it is important for the cells to allow enough ROS to induce signalling, but 
prevent damage due to high levels by inducing an antioxidant response.
1.5.2.2 ROS-sensitive targets in signalling cascades
ROS have been shown to be involved in several signalling cascades, including 
increasing protein phosphorylation, activating MAPKs, inducing intracellular Ca2+ 
and activation of transcription factors.
1.5.2.2.1 Inhibition of protein tyrosine phosphatases
Several protein tyrosine phosphatases (PTPs) have been shown to be regulated by 
ROS. Redox-sensitive PTPs include cysteine-based phosphatases (CBPs), which 
hydrolyse phospho-ester bonds via a cysteine-based mechanism (Salmeen and 
Barford, 2005). The environment in their catalytic site allows the thiol (or sulphydryl) 
group of a cysteine (Cys-SH) to be deprotonated (Cys-S ) at physiological pH, which 
makes it susceptible to reactions with mild oxidizing reagents such as H20 2 to form
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Figure 1.12: The catalytic removal of H20 2 by the GSH and thioredoxin 
systems
The catalytic reduction of H20 2 to H20  mediated by the GSH and thioredoxin 
systems involves the oxidation of thiol groups on selenocysteine (SeH) or cysteine 
(SH) residues in Gpx or cysteine residues in Prx to Gpx-SeOH, Gpx-SOH and Prx- 
SOH, respectively. The recycling of the oxidised peroxidase enzymes involves the 
oxidation of reduced GSH or thioredoxin (Trx) to their oxidised counterparts, while 
the recycling of GSH and Trx are dependent on NADPH+H+ and glutathione 
reductase or thioredoxin reductase, respectively. NADPH+H* is provided by the 
pentose phosphate pathway, hence coupling the antioxidant defence to cellular 
metabolism. The typical 2-Cys Prx contains two conserved cysteine residues, which 
are both involved in the reduction of H20 2 to H20. The cysteine residue is oxidised 
to sulphenic acid (SOH), which can either form a disulphide bridge with the cysteine 
of a partner protein, preventing further oxidation, or, since the disulphide formation 
is a slow process, the sulphenic acid is further oxidised to form sulphinic acid 
(SOOH), which can be reduced by either sulphiredoxin or sestrin enzymes. From 
(Veal et al., 2007)
a sulphenic acid intermediate (Cys-SOH). This modification renders the cysteine 
residue unable to act as a nucleophile, and the phosphatase looses its enzymatic 
activity. CBPs include PTPs, dual-specificity PTPs (dephosphorylate serine and 
threonine, as well as tyrosine), Cdc25 phosphatases and low-molecular-weight 
phosphatases (LMW-PTPs).
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1.5.2.2.2 Activation of protein kinases
Protein kinases are often regulated via phosphorylation and binding of regulatory 
proteins. However, protein serine-threonine kinases and protein tyrosine kinases 
(PTKs) also appear to be under redox control (Rhee et al., 2000). Protein 
phosphorylation, induced by ROS-mediated phosphatase inhibition is therefore 
additionally increased by activation of protein kinases. The mechanism of activation 
involves cysteine oxidation, as has been shown for the receptor tyrosine kinase 
(RTK) c-Ret (Kato et al., 2000) and the non-receptor tyrosine kinase c-Abl 
(Leonberg and Chai, 2007). Certain serine/threonine kinase protein kinase C (PKC) 
isoforms, which are typically activated by the lipid second messenger diacylgylcerol 
(DAG) (Yang and Kazanietz, 2003), can be activated by H20 2 in a phospholipid- 
independent process that involves tyrosine phosphorylation of the catalytic domain 
(Gopalakrishna and Anderson, 1989; Konishi et al., 1997).
1.5.2.2.3 Activation of MAPK cascade and apoptosis
H20 2 induces sustained activation of all three major MAPK pathways (i.e. ERK1/2, 
JNK and p38 MAPK) in HeLa cells and caradiomyocytes (Purdom and Chen, 2005; 
Wang et al., 1998). JNK is involved in programmed cell death by regulating a 
number of proteins involved in apoptosis, including Bcl-2 family proteins (i.e. Bcl-XL, 
Bax) (Shen and Liu, 2006). The pro-apoptotic signal from H20 2 is transmitted via 
TNF-R1 and recruitment of TRADD and TRAF2 (Pantano et al., 2003). Activation of 
apoptosis signali-regulating kinase 1 (or apoptosis-stimulated kinase 1 (ASK1)) after 
TNF-a-induced NADPH oxidase activation (Liu et al., 2000; Saitoh et al., 1998) 
seems to be one major mechanism by which ROS stimuli regulate JNK (Matsukawa 
et al., 2004; Shen and Liu, 2006). ASK1, a MAPKKK, binds to the reduced form of 
Trx. ROS induced oxidation of Trx leads to its dissociation from ASK1 allowing 
interaction with TNF receptor associated factor-2 (TRAF2) and activation of 
downstream targets, including JNK and p38.
1.5.2.2.4 Induction of intracellular Ca2+ and activation of transcription factors
Changes in intracellular Ca2+ level play a role in a variety of cellular processes, 
including transcription, cell contraction and migration (Ermak and Davies, 2002; 
Touyz, 2005). Cytosolic Ca2+ level can be increased by ROS either through 
mobilisation of intracellular Ca2+ stores or the influx of extracellular Ca2+ (Yan et al.,
2006). The increase in Ca2+ contributes to the activation of PKC-y, observed under 
conditions of oxidative stress (Wang et al., 2001) and the transcriptional induction of 
AP-1 (Wu, 2006). AP-1 is typically composed of c-Fos and c-Jun proteins and has
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been implicated in differentiation processes. In T lymphocytes AP-1 regulates 
expression of IL-2 and other immunological relevant genes (Altman and Villalba, 
2003). c-Fos and c-Jun mRNA are increased with a variety of ROS and other 
inducers of oxidative stress (Droge, 2002). The transcription factor NF-kB is 
involved in inflammatory reactions (see Chapter 1.4.1.1), growth control and 
apoptosis (Karin and Greten, 2005). ROS-mediated NF-kB activation has been 
shown in several cell types, including epithelial cells (de Oliveira-Marques et al., 
2007), monocytes (Lu and Wahl, 2005) and smooth muscle cells (Robbesyn et al., 
2003).
1.5.2.2.5 H20 2 as endothelium-derived hyperpolarising factor
Endothelial cells control the tone of the underlying vascular smooth muscle cells 
(VSMC) by releasing active vasodilators and vasoconstrictors (Furchgott and 
Vanhoutte, 1989). Prostacyclin (PGI2), a cyclooxygenase-dependent metabolite of 
arachidonic acid, and NO were identified as the major endothelium-derived 
vasodilators (Dusting et al., 1977; Palmer etal., 1987). However, other endothelium- 
dependent, but PGI2- and NO-independent agonist-induced relaxation has 
suggested the existence of additional mechanisms/factors (Feletou and Vanhoutte, 
1988; Komori et al., 1988). The endothelium-dependent relaxation occurs 
simultaneously with VSMC hyperpolarisation and the mediator(s) responsible have 
been termed endothelium-derived hyperpolarising factor(s) (EDHF) (Taylor and 
Weston, 1988). Two general pathways explaining EDH have been proposed 
(Sandow, 2004): 1) mediated by diffusible factors; 2) mediated by direct contact 
between cells, e.g. via gap junctions (Hill et al., 2002). Several endothelial-derived 
substances have been proposed as diffusible EDHF, e.g. epoxyeicosatrienoic acid, 
lipoxygenase metabolites, carbon monoxide and H20 2 (Feletou and Vanhoutte,
2007). H20 2 has been suggested due to the evidence that EC-derived H20 2 can 
hyperpolarise and relax pig VSMC (Beny and von der Weid, 1991). Catalase has 
been shown to abolish EDHF-mediated hyperpolarisation and relaxation in 
mesenteric arteries from mice (Matoba et al., 2000) and coronary arteries from 
human (Matoba et al., 2002) supporting this hypothesis. However, other studies 
have failed to confirm the existence of a catalase-sensitive pathway in small 
mesenteric arteries from the same strain of mice (Ellis et al., 2003). Meanwhile, 
H20 2 might function as an endothelium-derived vasodilator, since recent work has 
shown that eNOS-derived H20 2 can act as a vasodilator in pressurised cerebral 
arteries from mice and shares similar dilatory pathways as NO (Drouin et al., 2007).
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1.5.3 ROS in the immune system
ROS have long been known to play an important role in host defence, where ROS 
kill invading pathogens, but additionally, ROS plays an important role as a signalling 
mediator in inflammation, in particular in TEM.
1.5.3.1 Oxidative burst
The ability of phagocytic leukocytes to produce ROS is a vital component of host 
defence. Activated macrophages and neutrophils can produce large amounts of 0 2‘ 
via the NADPH oxidase (Quinn et al., 2006). The rapid production and release of 
antimicrobial ROS by leukocytes is referred to as ‘respiratory or oxidative burst’ 
(Murphy et al., 2008). Invading mircoorganisms are phagocytosed and killed by 
releasing antimicrobial proteins from specific granules into the phagosome 
(Hampton et al., 1998), while NADPH oxidase on the membrane releases ROS into 
the phagosome. In phagocytes, the combined activity of NADPH oxidase and 
myeloperoxidase also leads to the production of secondary ROS, including 
hypochlorous acid (HCIO), one of the strongest physiological oxidants and a 
powerful antimicrobial agent (Hampton et al., 1998). However, release of ROS into 
the phagosome induces a rise in the pH and has been shown to be important for 
pathogen killing (Segal et al., 1981).
1.5.3.2 ROS in transendothelial migration
ROS have been suggested to play important roles at different stages of TEM, 
including EC activation, leukocyte adhesion, regulation of endothelial permeability 
and leukocyte diapedesis. However, so far only the role of ROS in ECs has been 
investigated.
Many of the key signal transduction molecules involved in cytokine-induced 
endothelial activation such as various MAPKs and transcription factors AP-1 and 
NF-kB are known to be redox-sensitive (see Chapter 1.5.2.2.4). TNF-a and other 
pro-inflammatory cytokines induce upregulation of adhesion molecules, including 
ICAM-1 and VCAM-1, through an NF-xB-dependent redox-sensitive mechanism, 
which can be inhibited by antioxidants or NADPH oxidase inhibitors (Postea et al., 
2006; True et al., 2000). TNF-a-mediated upregulation of E- and P-selectin have 
also been shown to be mediated via NADPH oxidase-produced ROS (Chen et al., 
2003; Takano et al., 2002). ECs express Nox2 and Nox4 oxidase isoforms and 
TNF-a stimulation results in assembly of these complexes and ROS production 
(Alom-Ruiz et al., 2008). Adhesion of leukocytes to the endothelium is not only 
influenced by the ROS-mediated expression of adhesion molecules, but can also be
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directly influenced by ROS-induced modifications of the leukocyte surface ligands 
(Eguchi et al., 2005). Treatment of the human promyelocyte leukaemia cell line 
HL60 with ROS reduces E-selectin-mediated adhesion to the endothelium due to 
reduction of cell surface levels of sialyl LewisX. This mechanism allows a very fast 
regulation of adhesion, independent of transcripitional downregulation or 
internalisation of adhesion receptors.
Treatment of ECs with ROS has been shown to induce phosphorylation of 
PECAM-1 and increase HL60 cell TEM, which can be inhibited by antioxidants 
(Rattan et al., 1997). ROS have also been shown to be important in mediating 
VCAM-1 signalling following leukocyte binding (Deem and Cook-Mills, 2004; 
Keshavan et al., 2005). Engagement of VCAM-1 by leukocytes rapidly activates 
NADPH oxidase in ECs and subsequent ROS production is necessary for activation 
of matrix-metalloproteases (MMPs). Exogenous addition of ROS rapidly activates 
MMPs, whereas inhibition of NADPH oxidase or scavengers of ROS prevent MMP 
activation and block leukocyte TEM. Activated MMPs degrade ECM components, 
cell surface receptors in cell-cell junctions and tight junction proteins (Verma and 
Hansch, 2007).
ROS have also been shown to be important in the regulation of endothelial 
permeability, altering the blood-brain barrier (BBB) integrity, inducing cytoskeletal 
rearrangements and redistribution and disappearance of TJ proteins claudin-5 and 
occludin (Schreibelt et al., 2007). These events can be prevented by specific 
inhibitors for RhoA and PI3K, indicating their involvement in ROS signalling. Van 
Buul et al. have suggested a role of the redox-sensitive tyrosine kinase Pyk2 in 
regulating endothelial cell-cell adhesion (van Buul et al., 2005). Loss of VE-cadherin 
from the junctions is dependent on Rac1-induced ROS production, leading to 
activation and recruitment of Pyk2 to the junctions, where (3-catenin is 
phosphorylated leading to loss of VE-cadherin.
How leukocyte signalling and subsequent adhesion and TEM are influenced 
by ROS is subject of the present study.
1.6 Nitric oxide
The development of many cardiovascular disorders including hypertension, 
atherosclerosis, heart failure and stroke has been shown to be a result of excess 
production of ROS, decreased NO bioavailability due to ROS-mediated oxidative 
modification and decreased antioxidant capacity of the vasculature (Paravicini and 
Touyz, 2008).
56
1 Introduction
In addition to its well known function in regulating vascular tone, NO has 
been shown to exert multiple modulating effects on inflammation (Guzik et al., 
2003). NO is a hyper-reactive radical that is generated in the tissue by the action of 
NO synthases (NOS) (Alderton et al., 2001). NOS enzymes are usually referred to 
as dimeric, although in their active form, they are composed of two NOS monomers 
associated with two molecules of calmodulin (CaM). They contain relatively tightly- 
bound cofactors (6R)-5,6,7,8-tetrahydrobiopterin (BH4), flavin adenine dinucleotide 
(FAD), flavin mononucleotide (FMN) and iron protoporphyrin IX (heme), and 
probably catalyse a reaction of L-arginine, NADPH and 0 2 to give NO, citrulline and 
NADP, although the exact mechanism is not clear (Fig. 1.13). NO is synthesised in 
a large number of tissues, playing a role in a variety of physiological processes. In 
mammalian cells, there are three NOS isoforms: neuronal NOS (nNOS, NOS-1), 
which is predominantly expressed in neurons, inducible NOS (iNOS, NOS-2), which 
is inducible in a wide range of tissues and cells, and endothelial NOS (eNOS, 
NOS-3), which is mainly expressed in the vasculature (Alderton et al., 2001).
The high reactivity of NO makes a tight temporal and spatial regulation 
indispensable. Spatial regulation is achieved by membrane anchorage through lipid 
modifications (myristoylation and palmytoylation) and by specific protein-protein 
interactions (Oess et al., 2006). NO production via NOS and availability in cellular 
compartments can be regulated by transcriptional and post-transcriptional regulation 
(Alderton et al., 2001). NOS activity can be regulated by the availability of Ca2+: the 
dependency on Ca2+ is different for the isoforms though; while nNOS and eNOS 
require high Ca2+ concentrations, iNOS forms an active complex with CaM even at 
low Ca2+ levels. nNOS and eNOS have also been shown to be regulated by 
phosphorylation; in the case of eNOS via an Akt-dependent pathway (Dimmeler et 
al., 1999; Fulton et al., 1999), and iNOS by Src-mediated phosphorylation (Hausel 
et al., 2006).
NO is normally produced constitutively by eNOS in the endothelium, is 
responsible for maintaining low vascular tone and preventing leukocytes and 
platelets from adhering to the vascular wall (Ignarro, 2002; Sun et al., 2006). Low 
levels of NO, produced by the constitutive NOS, interact with guanylate cyclase, 
which leads to increased cGMP level and subsequent activation of PKGs (Hofmann 
et al., 2000). PKGI and PKGII mediate various processes, including vasorelaxation, 
increase in vascular permeability as well as anti-proliferative, anti-platelet and 
antioxidant effects (Hofmann et al., 2000).
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Figure 1.13: NO production by NOS
Active NOS is composed of two NOS subunits, bound to two CaM molecules. 
NADPH donates electrons (e ) to the reductase domain of NOS, which are then 
transferred to the oxygenase domain via FAD and FMN redox carriers. In the 
oxygenase domain electrons interact with the heme ion and BH4 to catalyse the 
reaction of L-arginine with 0 2 to generate citrulline and NO. Adapted from (Alderton 
et al., 2001)
In the inflammatory response NO, which is produced by iNOS in 
macrophages and other cells, has been shown to play multiple roles (Guzik et al., 
2003). At high concentrations, NO is an important toxic defence molecule that kills 
microorganisms. Under inflammatory conditions, NO is usually produced together 
with 0 2\  leading to formation of peroxynitrite (ONOO ) (Guzik et al., 2002), which 
has been shown to be involved in S-nitrosylation of proteins, e.g. NF-kB (Park et al.,
2005). S-nitrosylation is the covalent attachement of NO to the thiol group of a 
cysteine (to form an S-nitrosothiol, SNO) and has emerged as an important 
regulatory mechanism for a range of proteins (Hess et al., 2005). S-nitrosylation has 
been shown for a number of metabolic enzymes, oxidoreductases, proteases, 
protein kinases and phosphatases, as well as respiratory proteins, receptor/ion 
channels and transporters, cytoskeletal and structural components, transcription 
factors, regulatory elements (including G proteins) and others (Hess et al., 2005). In 
addition to regulating protein function, S-nitrosylation can promote or inhibit the 
formation of disulphide bonds within or between proteins.
NO is therefore an important signalling molecule that is involved in a range 
of processes, including TEM where endothelial NO has been shown to inhibit 
neutrophil and T cell extravasation (Oka et al., 2005; Sun et al., 2006).
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1.7 Role of ecto-enzymes in leukocyte transendothelial migration
In addition to the classical adhesion molecules (Fig. 1.14), a number of additional 
molecules have been suggested to be involved in different steps of the leukocyte 
adhesion cascade. Among these are several enzymes, which are expressed on the 
surface of leukocytes and ECs with their catalytic site in the extracellular space, and 
are termed ecto-enzymes (Salmi and Jalkanen, 2005).
1.8 Ecto-enzymes
Ecto-enzymes are a large and diverse class of proteins, which mediate a variety of 
functions, e.g. proteolytic maturation of chemokines or purine signalling (Goding,
2000). The strongest evidence for involvement of ecto-enzymes in the leukocyte 
adhesion cascade is available for nucleotidases and related proteins (CD39, CD73 
and Autotaxin (CD203)) (Fig. 1.14) (Salmi and Jalkanen, 2005).
Ecto-enzymes are usually large glycoproteins that belong to different groups 
of membrane protein types (Goding, 2000): 1) type II integral membrane proteins 
with a short N-terminal cytoplasmic domain, single transmembrane domain and a 
large extracellular C-terminal catalytic domain (e.g. CD26, CD38); 2) type I integral 
membrane proteins with N-terminal cleavable signal sequence, large extracellular 
N-terminal catalytic domain, a single transmembrane domain and short C-terminal 
cytoplasmic domains; 3) proteins with two transmembrane domains (CD39); 
4) proteins with a glycosylphosphatidyl inositol (GPI)-anchor (e.g. CD73) 
(Zimmermann, 1992). Ecto-enzymes are involved in the leukocyte adhesion 
cascade by modulating the purinergic signalling cascade, thereby inducing or 
terminating inflammatory stimuli. Additionally, many ecto-enzymes have enzyme- 
independent functions that are involved in the leukocyte adhesion cascade.
1.8.1 Ecto-enzymes as modulators of purinergic signalling
Adenosine triphosphate (ATP) and other nucleotides are powerful 
extracellular signalling molecules (Yegutkin, 2008). Nucleotide release occurs under 
several conditions: cell lysis due to organ injury, traumatic shock or certain 
inflammatory conditions (Bours et al., 2006). Under non-pathological conditions, 
nucleotide release occurs from various tissues including the epithelium (Burnstock,
2007), endothelium (Bodin and Burnstock, 2001), fibroblasts (Gerasimovskaya et 
al., 2002), neutrophils (Eltzschig et al., 2006), monocytes/macrophages (Wong et 
al., 2006) and other hematopoietic cells (Bours et al., 2006). These cells have been
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Figure 1.14: Role of ecto-enzymes in the leukocyte adhesion cascade
The different steps of the leukocyte adhesion cascade are mediated by a large 
number of molecules on the endothelium as well as the leukocyte surface. The 
molecules in green boxes are well characterised participants in the leukocyte TEM 
cascade. The molecules in the centre panel display the best characterised ecto- 
enzymes involved in the process, while the relevance of the involvement of the 
molecules in the lowest panel needs further confirmation. Adapted from (Salmi and 
Jalkanen, 2005).
shown to release ATP in response to a variety of stimuli, including shear stress, 
hypotonic swelling, hypoxia, stretching, hydrostatic pressure, bradykinin, serotonin 
and other Ca2+-mobilising agonists. ATP and ADP exerted their effects via two 
major receptor subfamilies, P2X and P2Y (Ralevic and Burnstock, 1998). 
Engagement of these receptors has many pro-thrombotic and pro-inflammatory 
effects, including cytokine secretion and dendritic cell (DC) activation (Di Virgilio et 
al., 2001; Idzko et al., 2002). In neutrophils and monocytes, ATP has been shown to 
stimulate adhesion to the endothelium, which is achieved by upregulation of Mac-1 
but also E-selectin upregulation on the endothelium (Bours et al., 2006).
1.8.1.1 CD39 and CD73
In the endothelial-leukocyte microenvironment, the ecto-nucleotidases CD39 and 
ecto-5’-nucleotidase (CD73) act in concert to degrade extracellular nucleotides,
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thereby terminating pro-inflammatory stimuli. Extracellular ATP is dephosphorylated 
by CD39, a nucleoside triphosphate diphosphohydrolase, in a sequential hydrolysis 
from ATP to ADP and AMP (Dombrowski et al., 1998). CD39 is expressed on many 
leukocytes, including B and T cells, monocytes and Langerhans cells, but also on 
the endothelium. CD39 deficient mice (CD39'7') have been shown to have severe 
platelet dysfunction with prolonged bleeding times and impaired platelet aggregation 
in response to ADP, thrombin and collagen, despite the fact that they have normal 
ATP and ADP plasma levels (Enjyoji et al., 1999). This platelet dysfunction is 
reversible and associated with a receptor P2Y1 desensitisation. Migration of CD39'/' 
monocytes or macrophages through ECs towards ATP or CCL2 is impaired in vivo 
(Goepfert et al., 2001). Additionally, CD39_/' mice show exacerbated skin 
inflammation in response to irritant chemicals (Mizumoto et al., 2002), 
demonstrating the importance of extracellular nucleotide degradation in attenuating 
inflammation.
In the nucleotide breakdown cascade (Fig. 1.15), AMP is further hydrolysed 
by CD73, a GPI-anchored protein that is expressed abundantly on ECs and on a 
subset of leukocytes (Airas et al., 1993; Thomson et al., 1990). So far, seven human 
5’-nucleotidases have been identified, five in the cytoplasm (gene symbols NT5C, 
NT5C1A, NT5C1B, NT5C2, NT5C3), one in the mitochondrial matrix (gene symbol 
NT5M) and one extracellular isoform (gene symbol NT5E) (Bianchi and Spychala,
2003). NT5E, NT5C and NT5M form dimers, NT5C1A and NT5C2 form tetramers, 
while NT5C3 is a monomer. The protein structure for NT5C1B has not been 
characterised yet. The term ‘CD73’ will be used throughout to refer to the 
extracellular protein (NT5E) only. The intracellular enzymes have broader substrate 
specificity, hydrolysing 5’-ribonucleoside monophosphates, 5’- (deoxy) nucleoside 
monophosphates (NMPs) and 2’- and 3’-NMPs, whereas CD73 hydrolyses only 
5’-AMP efficiently (Hunsucker et al., 2005; Zimmermann, 1992). CD73 has a 
molecular mass of 70 kDa and consists of two (glyco)protein subunits, which are 
tethered by non-covalent binding (Martinez-Martinez et al., 2000). The N-terminal 
domain binds two catalytic divalent metal ions and the C-terminal domain contains 
the substrate specificity pocket, while the substrate binds at the interface of the two 
domains (Strater, 2006). The enzymatic activity of CD73 produces adenosine, which 
has anti-inflammatory properties and exerts its effects via the G-protein-coupled P1 
purinergic receptors A1f A2A, A 2b and A3 (Yegutkin, 2008). A2A and A 2b activate 
adenylate cyclase, thereby increasing intracellular cAMP levels, while A, and A3 
inhibit cAMP production (Shryock and Belardinelli, 1997). In ECs, stimulation of A 2b
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Figure 1.15: Nucleotide breakdown cascade in the leukocyte-endothelial 
microenvironment
The pro-inflammatory mediators ATP and ADP are broken down to AMP by the 
endothelial diphosphohyrolase CD39. AMP is then further hydrolysed to adenosine 
(ado) by the GPI-anchored nucleotidase CD73 on the endothelial surface. 
Endothelium-bound lymphocytes inhibit CD73 via an unknown mechanism. 
Adenosine, an anti-inflammatory mediator, is degraded to inosine by adenine 
deaminase (ADA), which is bound to CD26 on the lymphocyte surface. From (Salmi 
and Jalkanen, 2005).
receptors increases endothelial barrier function by decreasing actomyosin 
contractility of the cytoskeleton and strengthening the intercellular junctions 
(Comerford et al., 2002; Srinivas et al., 2004). Adenosine has also been shown to 
inhibit neutrophil adhesion to the endothelium via neutrophil A2 receptors (Cronstein,
1994). This effect is mediated by preventing upregulation of (32 integrins and 
shedding of L-selectin from the neutrophil surface, necessary for successful binding 
(Thiel et al., 1996). The concerted activity of CD39 and CD73 therefore not only 
terminates pro-inflammatory stimuli of ATP/ADP, but also acts as an anti­
inflammatory signal, leading to increased endothelial barrier function and decreased 
leukocyte binding.
1.8.1.2 Adenosine deaminase and autotaxin
Binding of lymphocytes to the endothelium has been shown to inhibit endothelial 
CD73, likely by selectively masking the catalytic site (Henttinen et al., 2003). This
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mechanism is thought to be important to decrease vascular barrier function in order 
to facilitate TEM. Residual adenosine is rapidly degraded by lymphocyte-bound 
adenosine deaminase (ADA) (Yegutkin, 2008). ADA hydrolyses the irreversible 
deamination of adenosine and 2’-deoxyadenosine to inosine and 2’-deoxyinosine 
respectively and is widely expressed (Spychala, 2000). On the surface of 
lymphocytes, ADA is often associated with CD26 (Gorrell et al., 2001; Martin et al.,
1995). CD26 belongs to the group of ecto-peptidases and cleaves N-terminal 
dipeptides from polypeptides with either proline or alanine residues in the 
penultimate position (De Meester et al., 1999). CD26 has a range of substrates, 
including several chemokines, e.g. CCL5, CCL11, CXCL9, CXCL10, CXCL11, 
CXCL12 (De Meester et al., 1999; Lambeir et al., 2001). The effects of chemokine 
processing have been shown to be cell type- and chemokine-dependent, and 
include downregulation, termination and even potentiation of the inflammatory 
response (De Meester et al., 1999). CD26 is therefore an important modulator of 
chemokine-mediated inflammatory reactions.
The degradation of ATP to ADP, AMP and adenosine, thus the termination 
of pro-inflammatory signals, can also be accomplished by the action of nucleotide 
pyrophosphatases and nucleotide phosphodiesterases, one of which is autotaxin 
(ATX, CD206, NNP2) (Goding et al., 2003). ATX also has lysophospholipase D 
activity, which generates lysophosphatidic acid (LPA) from lysophosphatidylcholine 
and hydrolyses sphingosylphosphorylcholine to produce sphingosine 1-phosphate 
(S1P) (Clair et al., 2003; Tokumura et al., 2002; Umezu-Goto et al., 2002). LPA and 
S1P induce a variety of responses in many cell types by activating a family of five 
GPCRs and they are chemoattractants for certain types of leukocytes (Mills and 
Moolenaar, 2003; Rosen and Goetzl, 2005). However, there are other biosynthetic 
pathways producing LPA and S1P and autotaxin is not found in lymphoid tissue 
(Goding et al., 2003). The exact role and importance of autotaxin during 
inflammation therefore requires further investigation.
The interplay between ATP-consuming and ATP-regenerating pathways is 
what determines the inflammatory status. The nucleotide breakdown is 
counterbalanced by the re-synthesis of high-energy phosphoryls through backward 
phosphotransfer reactions (Yegutkin et al., 2002). Ecto-enzymes responsible for 
these reactions include adenylate kinase (AK), NDP kinase and ATP synthase 
(Yegutkin, 2008). The latter has only recently been found to be expressed on the 
outer plasma membrane in addition to its known localisation in mitochondria (Moser 
et al., 2001).
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Taken together, in the endothelial-leukocyte microenvironment pro- 
inflammatory stimuli in the form of ATP/ADP are rapidly terminated mainly by 
combined activity of CD39 and CD73. The resulting adenosine mediates anti­
inflammatory effects and can be further degraded to inosine by lymphocyte-bound 
ADA.
1.8.2 Non-enzymatic functions of ecto-enzymes
Ecto-enzymes are important modulators of the purinergic signalling cascade, 
thereby acting as regulators of pro- and anti-inflammatory signals. Additionally, 
many ecto-enzymes have enzyme-independent functions, which can be regulated at 
transcriptional, translational and post-translational levels. For example CD26 
increases migration in many cell types by binding to ECM proteins (such as 
fibronectin and collagen) and soluble molecules (such as type II plasminogen and 
adenosine) and by binding other proteins, such as ADA, at the cell surface 
(Boonacker and Van Noorden, 2003; Gonzalez-Gronow et al., 2005; Kameoka et 
al., 1993). Engagement of leukocyte CD73 promotes leukocyte binding to the 
endothelium by LFA-1 clustering via a yet unknown ligand (Airas et al., 1995; Airas 
et al., 2000; Airas et al., 1993).
1.8.3 CD73 as a modulator of inflammation
CD73'/_ mice have been used to demonstrate a role for CD73 in tubuloglomerular 
feedback and renal function (Castrop et al., 2004; Huang et al., 2006a), lung 
protection (Eckle et al., 2007a; Volmer et al., 2006), cardioprotection during 
myocardial ischemia (Eckle et al., 2007b) and vasoprotection (Koszalka et al., 2004; 
Thompson et al., 2004; Zernecke et al., 2006). CD73'/_ mice are viable and do not 
show significant differences in systolic blood pressure or cardiac output (Koszalka et 
al., 2004). Zernecke et al. reported increased neointimal plaque formation in CD73'/_ 
mice and increased monocyte adhesion due to upregulation of VCAM-1 on the 
endothelium (Zernecke et al., 2006). Additionally, CD73'/" mice display significantly 
increased vascular leakage after subjection to hypoxia (8% 0 2) (Thompson et al.,
2004). In the cremaster model of ischaemia-reperfusion, leukocyte attachment to 
the endothelium is significantly increased in CD73'' mice (Koszalka et al., 2004).
Hypoxia, e.g. as a result of ischaemia, is known to result in tissue 
accumulation of polymorphonuclear cells (PMNs) (Eltzschig et al., 2004). However, 
hypoxia is also associated with increased intravascular adenosine levels, due to 
upregulation of CD73, which can be reversed by reoxygenation (Li et al., 2006). It is 
thought that adenosine production via CD39/CD73 is upregulated on the
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endothelium during hypoxia as an anti-inflammatory response to dampen damaging 
effects (Eltzschig et al., 2004). CD73 expression and activity has also been shown 
to be induced by IFN-a in HUVECs (Niemela et al., 2004) and by IFN-(3 in mice, 
thereby improving the vascular barrier function after intestinal ischemia-reperfusion 
injury (Kiss et al., 2007). IFN-a levels are usually low, but are increased in 
inflammatory conditions. Since adenosine is highly anti-inflammatory, CD73- 
mediated production of adenosine presents a way to reduce detrimental effects of 
inflammatory conditions in the endothelial microenvironment. An additional 
regulatory mechanism has been shown to involve the transcriptional induction of 
CD73 by its enzymatic product (Narravula et al., 2000). Adenosine acts via A2B 
receptor and elevated cAMP level to induce CD73 mRNA, surface expression and 
function. On the other hand TNF-a reduces CD73 surface levels (Kalsi et al., 2002). 
Since no changes in mRNA level could be detected, TNF-a is thought to activate Pl- 
PLC, leading to cleavage of the GPI-anchor, which results in loss of CD73 from the 
surface.
These findings demonstrate the importance of CD73-derived adenosine in 
the maintenance of vascular barrier function and anti-inflammatory conditions.
1.8.4 Ecto-enzymes as therapeutic targets
Ecto-enzymes are attractive therapeutic targets to influence leukocyte trafficking, 
since their activity can be modulated by monoclonal antibodies or specific inhibitors. 
Their extracellular location means that enzyme inhibitors do not need to be cell 
membrane permeable and can therefore be administered orally. Some ecto- 
enzymes have already been targeted in early clinical trials; VAP-1 can be blocked 
by administration of the mouse monoclonal antibody Vepalimomab in patients with 
nickel-induced allergic contact dermatitis lesions, which resulted in decreased 
inflammation (Vainio et al., 2005). Other ecto-enzymes need to be stimulated in 
order to reduce inflammation. Increased adenosine production might be achieved by 
providing additional substrate in form of ADP, to increase the anti-inflammatory 
signal. CD73 is upregulated in vivo specifically on the vasculature of urinary bladder 
cancer patients when treated with IFN-a (Niemela et al., 2004). This upregulation 
can not be observed in lymphocytes present in the tumour or in CD73-positive 
malignant cells. However, CD73-positive leukaemia cells are thought to have a 
better chance of survival, when patients are treated with anti-metabolites that block 
de novo synthesis of purines (Pieters and Veerman, 1988). The use of CD73 
inhibitors in combination with anti-metabolites could therefore be used in therapies,
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especially since CD73 inhibitors have been shown to reverse multi-drug resistance 
to doxorubicin in a T lymphoma cell line (Ujhazy et al., 1994).
Many solid tumours are characterised by hypoxia due to insufficient blood 
supply (Harris, 2002; Vaupel et al., 2001). Hypoxia-induced upregulation of 
adenosine production (Eltzschig et al., 2004) in the tumour can stimulate cell 
proliferation (Braganhol et al., 2007) and is therefore associated with poor 
prognosis. Additionally, the accumulation of adenosine in the tumour and 
subsequent diffusion into the extracellular space leads to increased adenosine 
levels in the tumour microenvironment (Eltzschig et al., 2004; Ohta et al., 2006). 
Tumour-released adenosine protects the cancerous tissue by inhibiting anti-tumour 
T cells in the close environment (Ohta et al., 2006). T cell inhibition occurs through 
occupation of the adenosine receptor A2A and genetic deletion of A2AR in mice 
resulted in rejection of established immunogenic tumours by T cells (Ohta et al.,
2006). A2AR-deficient mice also developed autoimmunity, which has to be taken 
into consideration when developing an A2AR-antagonist-based cancer therapy. 
Prevention of tumour-induced adenosine production could therefore be a possible 
approach to increase tumour rejection by T cells and to prevent pro-proliferative 
signals, which could be achieved by downregulating CD39 and CD73 activity with 
specific inhibitors or by RNAi.
Taken together, ecto-enzymes such as CD39 and CD73 offer several 
prospects for therapeutic modification of potentially harmful purinergic signalling 
during inflammation as well as the pathogenesis of cancer.
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1.9 Aims of this project
Transendothelial migration has been extensively studied, but the signalling 
pathways involved in mediating leukocyte extravasation are not yet fully understood. 
The regulation of TEM involves not only endogenously generated signals, but can 
also be influenced by exogenous factors. This study aims to investigate novel 
aspects of leukocyte TEM, in particular the influence of oxidative stress. Oxidative 
stress can affect a range of diseases, and can be increased by several exogenous 
factors. The role of ROS, as an inducer of oxidative stress, on leukocyte TEM will be 
investigated with respect to morphological changes induced in leukocytes and 
signalling pathways involved. While chapters three and four investigate the role of 
ROS in TEM, chapter five is concerned with the role of the ecto-enzyme CD73 in 
TEM. A range of ecto-enzymes have been proposed as new ‘players’ in the process 
of leukocyte TEM, but detailed investigations have not been carried out yet. In this 
study, the role of endothelial CD73 will be investigated in leukocyte adhesion and 
TEM, and in maintaining the endothelium in a non-inflammatory state.
In this study I aim to further the understanding of mechanisms involved in 
leukocyte TEM by investigating poorly understood aspects of this process.
67
2 Materials and Methods
2
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2.1 Materials
Chemicals for solutions were purchased from Sigma-Aldrich unless otherwise 
stated.
2.1.1 Reagents and kits
[2-3H]Adenosine 5'-monophosphate, ammonium salt 
adenosine
adenosine-5'-monophosphate disodiumsalt
3-amino-1,2,4-triazole (AT)
4-amino-5-methylamino-2',7'-difluorofluorescein 
diacetate
angiotensin II
Annexin V-FLUOS staining kit 
BioMax MS Film
BioMax TRANSSCREEN LE Intensifying Screen 
calcium ionophore A23187 
carboxy-H2DCFDA 
carboxy-H2DFFDA 
CellTracker Green CMFDA (5- 
chloromethylfluorescein diacetate) 
complete Mini EDTA-free (Pl-mix)
CXCL12/SDF-1a human recombinant
2\7'-dicholorofluorescin diacetate
GE Healthcare
www.gehealthcare.com
Sigma-Aldrich
www.sigmaaldrich.com
Fluka
www.sigmaaldrich.com
Calbiochem
www.merckbiosciences.co.uk
Molecular Probes
www.invitrogen.com
Sigma-Aldrich
Roche
www.roche.com
Kodak
www.sigmaaldrich.com
Kodak
Sigma-Aldrich 
Molecular Probes 
Molecular Probes 
Molecular Probes
Roche
R & D systems
www.mdsystems.com
Sigma-Aldrich
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Dynabeads® Protein A 
Dynabeads® Protein G
Dynal MCP®-S, magnetic particle concentrator 
EBM-2 bullet kits
ECL Reagent
fetal bovine serum (FBS)
fibronectin from human plasma 
filipin III from Streptomyces filipinensis 
FITC-dextran, Mr 42 000 
fluorescent mounting medium
GDP 100x
GTPyS 100x
human sera type AB
hydrogen peroxide 3% in H20  (H20 2)
ICAM-1 human recombinant 
interleukin-2, human 
isopropyl (3-D-1 -thiogalactopyranoside 
MagneGST™ glutathione particles
MCP-1/CCL2 human recombinant
MG132
N-acetyl-L-cysteine 
n-formyl-MET-LEU-PHE 
n-octyl glucoside 
NuPAGE® 4 -12% Bis-Tris Gel 
NuPAGE® LDS sample buffer (4x)
NuPAGE® MES SDS running buffer (20x) 
NuPAGE® transfer buffer (20x) 
nw-nitro-L-arginine methyl ester (L-NAME) 
Oligofectamine™
OPI media supplement
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Dynal
www.invitrogen.com
Dynal
Dynal
Lonza
www.lonza.com 
GE Healthcare 
biosera
www.biosera.com
Sigma-Aldrich
Sigma-Aldrich
Sigma-Aldrich
Dako Cytomation
www.dako.com
Upstate
www.millipore.com
Upstate
Lonza
Sigma-Aldrich 
R & D systems 
Roche
Sigma-Aldrich
Promega
www.promega.com
Peprotech
www.peprotech.com
Calbiochem
Sigma-Aldrich
Sigma-Aldrich
Sigma-Aldrich
Invitrogen
Invitrogen
Invitrogen
Invitrogen
Sigma-Aldrich
Invitrogen
Sigma-Aldrich
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Opti-MEM +GlutaMax™-l
PBS (phosphate buffered saline)
(-) CaCI2 (-) MgCI2 
PBS (+) CaCI2 (+) MgCI2
penicillin/streptomycin (10 000 U/ml/10 000 pg/ml) 
phorbol-12-myristate-13-acetate
phosphatidylinositol-specific phospholipase C 
phytohaemagglutinin (PHA)
Precision PlusProtein™ standards 
Rac/cdc42 assay reagent (PAK1 PBD, agarose) 
Re-Blot Plus
rhotekin-RBD protein GST beads
RMPI 1640, (+) L-glutamine
silica gel 60 ADAMANT™ on TLC plates
s-nitroso-N-acetylpenicillamine (SNAP)
Super RX medical X-ray film
TNF-alpha/TNFSF1A
Transwell™ Permeable Supports, 0.4 pm pore size, 
12 mm
Transwell™ Permeable Supports, 5 pm pore size,
6.5 mm 
trypsin/EDTA 0.05%
VCAM-1 human recombinant 
VEGF 165 human recombinant
Gibco
www.invitrogen.com
Gibco
Gibco
Gibco
Cell Signaling
www.cellsignal.com
Molecular Probes
Roche
Bio-Rad
Upstate
Chemicon
www.millipore.com
Cytoskeleton
www.cytoskeleton.com
Gibco
Sigma-Aldrich
Sigma-Aldrich
Fuji
www.fujimed.com 
R & D systems 
Costar
www.colepalmer.com
Costar
Gibco
R & D systems 
R & D systems
2.1.2 Buffers and solutions
Fluorescence- PBS (-) CaCI2 (-) MgCI2
activated cell sorting BSA 0.2%
(FACS) buffer N3Na 0.1%
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Glutaraldehyde
fixative
Glutaraldehyde 
wash solution
HEPES buffer
Homogenising
buffer
Integrin activation 
buffer
Lysis buffer 
Magne-GST buffer
MES buffer
Na2HP04 x 2H20
NaH2P04
pH 7.35 then add
glutaraldehyde
Na2HP04 x 2H20  
NaH2P04 
pH 7.35 then add 
sucrose
HEPES 
NaCI 
glucose 
pH 7.4
Tris, pH 7.4
MgCI2
NaCI
HEPES buffer
MgCI2
EGTA
Triton X-100 
SDS
Tris, pH 7.5
NaCI
EDTA
Na2HP04 
KH2P04 
NaCI 
KCI 
pH 7.2
MES 
pH 5.5
73.1 mM 
21.8 mM
2.5%
51.2 mM
15.2 mM
250 mM
20 mM 
140 mM 
2 mg/ml
25 mM add fresh
5 mM Na3V 04 1 mM
150 mM Pl-mix
5 mM
1 mM
1%
0 .1%
20 mM add fresh
150 mM Na3V 04 1 mM
10 mM Pl-mix
4.2 mM
2 mM 
140 mM 
10 mM
25 mM
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Mg2+ lysis buffer (5x) HEPES, pH 7.5 125 mM add fresh
NaCI 750 mM NaF 25 mM
NP-40 substitute 5% Na3V 04 1 mM
MgCI2 50 mM Aprotinin 10 pg/rr
EDTA 5 mM Leupeptin 10 pg/m
PMSF 100 pM
Glycerol 10%
Osmium tetroxide NaH2P04 1.68%
fixative NaOH 0.38%
glucose 0.54%
pH 7.3 then add
0 s 0 4 1%
Rho lysis buffer (2x) Tris, pH 7.4 100 mM add fresh
EDTA 4 mM NaF 2 mM
NaCI 1 M Na3V 04 0.4 mM
MgCI2 20 mM PMSF 2 mM
SDS 0.2% DTT 2 mM
Triton X-100 2% Aprotinin 1 pg/ml
Glycerol 20% Leupeptin 1 pg/ml
Na-deoxycholate 1%
p-mercaptoethanol 1%
RIPA buffer Tris pH 7.5 20 mM
NaCI 150 mM
EDTA 1 mM
NP-40 1% add fresh
Na-deoxycholate 0.5% Na3V 0 4 1 mM
SDS 0.1% Pl-mix
STE buffer Tris, pH 8 10 mM
NaCI 150 mM
EDTA 1 mM
TBS (10x) Tris 200 mM
NaCI 1.5 M
pH 7.4
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TST buffer Tris, pH 7.4 25 mM
NaCI 150 mM
Triton X-100 0.2%
2.1.3 Antibodies and oligonucleotides
Table 2.1: Primary antibodies
Antigen Species Dilution Supplier
(3-actin mouse western blotting 
(WB) 1/1000
Sigma-Aldrich
active (31 integrin 
(12G10)
mouse FACS 1/100 Chemicon
active (32 Integrin 
(mAb 24)
mouse FACS 1/100 Generous gift from 
Dr N. Hogg
a-catenin rabbit immunofluores­
cence (IF) 1/100
Sigma-Aldrich
a-tubulin-FITC mouse IF 1/200 Sigma-Aldrich
(3-catenin mouse IF 1/100 BD Biosciences 
www.bdbeurope.com
(3-catenin rabbit IF 1/100 Sigma-Aldrich
Cadherin 5 
(VE-cadherin)
mouse IF 1/100 BD Biosciences
Catalase rabbit WB 1/200 Calbiochem
Caveolin-1 rabbit IF 1/100 Santa Cruz 
www.scbt.com
CD11a/aL integrin 
(LFA-1)
mouse IF 1/100 BD Biosciences
CD11b/aM integrin mouse IF 1/100 Serotec
www.serotech.com
CD11c/ax integrin mouse IF 1/100 Serotec
CD18 / (32 Integrin mouse FACS 1/100 BD Biosciences
CD29 / (31 Integrin mouse FACS 1/100 Serotec
CD44 mouse FACS undiluted Generous gift from 
Dr I. Dransfield
CD59 (MEM43) mouse IF 1/100 Generous gift from Dr Horejsi
CD59 (MEM43/5) mouse WB 1/1000 Generous gift from Dr Horejsi
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CD73 (4G4) mouse IF, FACS 1/2000 Generous gift from 
Dr S. Jalkanen
CD73 (H-300) rabbit WB 1/500 Santa Cruz
Cdc42 rabbit WB 1/1000 Cell Signaling
c-Myc rabbit IP 2 ug Santa Cruz
ERK1 rabbit WB 1/1000 Santa Cruz
E-selectin mouse FACS 1/100 Santa Cruz
GAPDH mouse WB 1/5000 Chemicon
ICAM-1 mouse WB 1/500 
FACS 1/1000
R&D Systems
lgG1 negative (neg) 
control
mouse FACS 1/100 Serotech
lgG2a neg control mouse FACS 1/100 Serotech
IkB-o rabbit WB 1/200 Santa Cruz
iNOS/NOS type II mouse WB 1/500 BD Biosciences
JAM-A rabbit IF 1/100 Zymed
www.invitrogen.com
MnSOD rabbit WB 1/1000 Stressgen
www.nventacorp.com
PECAM-1 mouse WB 1/500 Santa Cruz
P-selectin mouse FACS 1/100 BD Biosciences
p-tyrosine 
(clone 4g10)
mouse WB 1/1000 Upstate
Rac1 mouse WB 1/1000 Upstate
RhoA mouse WB 1/100 Santa Cruz
RhoE mouse FACS undiluted generated in mice against 
recombinant full-length RhoE
(Riento et al., 2003)
RhoGDI rabbit WB 1/1000 
IP 2 pg
Santa Cruz
VCAM-1 mouse FACS 1/500 BD Biosciences
ZO-1 rabbit IF 1/100 Zymed
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Table 2.2: Secondary antibodies
Antigen Species Conjugate Dilution Supplier
mouse IgG sheep HRP 1/10 000 GE Healthcare
rabbit IgG goat HRP 1/10 000 Dako Cytomation
mouse IgG 
(H+L)
goat AlexaFluor®
488
1/200 Molecular Probes
mouse IgG 
(H+L)
goat AlexaFluor®
594
1/200 Molecular Probes
rabbit IgG 
(H+L)
goat AlexaFluor®
488
1/200 Molecular Probes
rabbit IgG 
(H+L)
goat AlexaFluor®
594
1/200 Molecular Probes
phalloidin TRITC 1/400 Sigma-Aldrich
phalloidin FITC 1/400 Sigma-Aldrich
phalloidin Cy5 1/200 Molecular Probes
Table 2.3: Oligonucleotides
Gene Sense Sequence Concen­
tration
Supplier
siControl onTARGET plus 
# 1
sequence not 
known
25 -  50 
nM
Dharmacon
www.dharmacon.com
NT5E
(CD73)
siGENOME 
duplex 1
GAACCUGGCUG
CUGUAUUGUU
25 -  50 
nM
Dharmacon
NT5E
(CD73)
siGENOME 
duplex 2
GGAAGUCACUG
CCAUGGAAUU
25 -  50 
nM
Dharmacon
NT5E
(CD73)
siGENOME 
duplex 3
UGAAAUCACUG
CAUUACAAUU
25 -  50 
nM
Dharmacon
NT5E
(CD73)
siGENOME 
duplex 4
GGACUUUAUUU
GCCAUAUAUU
25 -  50 
nM
Dharmacon
NT5E
(CD73)
Silencer™ pre­
designed siRNA
GGAAUUAGGGA
AAACAAUUtt
25 nM Ambion
www.ambion.com
NT5E
(CD73)
GeneSolution
#1
CAGGACTTTATT
TGCCATATA
25 nM Quiagen
www.quiagen.com
NT5E
(CD73)
GeneSolution
#2
CAGCAAGAGGC
TAGCACTGAA
25 nM Quiagen
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NT5E
(CD73)
GeneSolution
#4
TAGGGTAAATCC
TATTAGAAA
25 nM Quiagen
NT5E
(CD73)
GeneSolution
#5
CAACGTGGTTT C 
TACATATAT
25 nM Quiagen
2.2 Methods: cell biology
2.2.1 Mammalian cell culture
2.2.1.1 Endothelial cells
Pooled human umbilical vein endothelial cells (HUVECs) were cultured in EBM-2 
medium with growth factors (EGM-2) containing 2% FBS. All cell culture vessels 
were coated with 10 pg/ml fibronectin (FN) for 1 h at 37°C (Table 2.1). Cells were 
passaged by washing once in PBS and incubating with 3 ml trypsin/EDTA at 37°C 
until all cells detached. Trypsin/EDTA was inactivated by addition of 7 ml EGM-2 
and cells pelleted by centrifugation at 200 g. Unless otherwise indicated, cells were 
stimulated with 10 ng/ml TNF-a for 8 -  15 h. HUVECs were used until passage five.
Table 2.4: HUVEC usage in various experimental set-ups
Experiment Cell culture vessel Cell number Used after
Immunoblotting 6-well dish 400 000 24 h
FACS 6-well dish 400 000 24 h
RNAi 6-well dish 150 000 24 h
Immunofluorescence coverslips 13 mm 100 000 48 h
CD73 Activity Assay 24-well dish 100 000 48 h
Microscopy-based 
transmigration assay
24-well dish 100 000 48 h
Permeability Assay 12 mm Transwell™ filter 100 000 48 h
Transwell™ trans­ 6.5 mm Transwell™ filter 30 000 48 h
migration assay 50 000 24 h
Adhesion Assay 96-well dish 30 000 
50 000
48 h 
24 h
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2.2.1.2 T lymphoblasts (T cells)
T lymphoblasts were thawed and transferred to a cell culture flask containing RPMI- 
1640 medium supplemented with 10% human plasma, penicillin (100 U/ml), 
streptomycin (100 pg/ml) and 0.5% PHA. To induce proliferation, the medium was 
replaced after 48 h with RPMI-1640 medium containing 10% human plasma, 
penicillin (100 U/ml), streptomycin (100 pg/ml) and 10 U/ml IL-2. Cells were
passaged by pelleting at 120 g for 5 min and resuspended in fresh medium. Cells
were used between passage 4 and 10.
2.2.1.3 THP-1 cells
The human monocytic cell line THP-1 was cultured in RPMI-1640 medium 
supplemented with 2 mM (+) L-glutamine, 10% heat-inactivated FBS, penicillin 
(100 U/ml) and streptomycin (100 pg/ml). For passaging, cells were pelleted at 
200 g, resuspended in fresh medium at 2 - 5 x 105 cells/ml and transferred to a fresh 
cell culture flask. THP-1 cells were frozen down at a density of 5 x 106 cells/ml in 
growth medium, containing 60% FBS and 10% DMSO.
2.2.1.4 CCRF-CEM cells
The T lymphoplastoid cell line CCRF-CEM was cultured in RPMI-1640 medium with 
2 mM (+) L-glutamine, 25 mM HEPES, 1 mM sodium pyruvate, 10% heat- 
inactivated FBS, penicillin (100 U/ml) and streptomycin (100 pg/ml). Cells were 
passaged by pelleting at 200 g and resuspending in fresh medium at 2 - 5 x 105
cells/ml before being transferred to a fresh cell culture flask.
2.2.1.5 MonoMac6 cells
The human monocytic cell line MonoMac6 (MM6) was cultured in RPMI-1640 
medium containing 2 mM (+) L-glutamine, 10% heat-inactivated FBS, 1x non- 
essential amino acids, 1 mM oxaloacetate, 0.45 mM pyruvate, 0.2 U/ml insulin, 
penicillin (100 U/ml) and streptomycin (100 pg/ml). For passaging, cells were 
pelleted at 200 g, resuspended in fresh medium and transferred to a fresh cell 
culture flask.
2.2.2 siRNA transfection of HUVECs
HUVECs (1.5 x 105) were plated onto FN-coated 6-wells in EGM-2 medium without 
antibiotics 24 h prior to transfection. For each transfection sample, 50 nM CD73 
(NT5E) or control siRNA were diluted into 175 pi Opti-MEM whilst 4 pi 
Oligofectamine was diluted in 15 pi Opti-MEM. To knock-down CD73 five different
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oligonucleotides were used separately. Dilutions were mixed and incubated for
5 - 1 0  min at RT. Diluted oligonucleotides and lipids were then combined, mixed 
and incubated for 20 min at RT. While the complexes were forming, the growth 
medium was removed from the cells and replaced with 800 pi Opti-MEM. The 
siRNA transfection mixture was added drop wise to the cells and incubated for 4 h, 
before growth medium containing 3 x the normal concentration of serum, but no 
antibiotics was added. After transfection for 24 h the medium was replaced with 
normal EGM-2 medium and cells subsequently split after 48 h into appropriate 
dishes. Cells were used for endpoint assays 72 h after transfection.
2.2.3 Transmigration assays
Transmigration of leukocytes across HUVECs was assessed either by time-lapse 
microscopy or a Transwell™-based assay.
2.2.3.1 Transwell™-based assay
HUVECs were grown to confluency on FN-coated Transwell™ filters (6.5 mm 
diameter, 5 pm pore size) and either stimulated with TNF-a prior to the experiment 
or left unstimulated. THP-1 or CCRF-CEM cells were treated with biochemical 
reagents or left untreated, pelleted and resuspended in fresh medium before 2 x 105 
cells were added per filter. Chemoattractants were added to the lower chamber 
(THP-1: 100 ng/ml monocyte chemotactic protein-1 (MCP-1); CCRF-CEM: 50 ng/ml 
SDF-1a) and cells were allowed to transmigrate for 2 h at 37°C and 5% C02. Cells 
from the lower chamber were counted using a CASY® cell counter (Scharfe System 
GmbH).
2.2.3.2 Time-lapse-microscopy-based assay
HUVECs were grown to confluency in FN-coated 24-well dishes and stimulated with 
TNF-a prior to experiments. THP-1 cells were either treated with biochemical 
reagents or left untreated and then pelleted and resuspended in fresh medium 
before addition of 1.5 x 105 cells per 24-well. Movies of cells were generated using 
Metamorph software and a Nikon Eclipse TE2000-E microscope with a Hamamatsu 
Orca-ER digital camera for 2 h at 37°C and 5% C 02 at 1 frame/min. The movies 
were analysed using ImageJ analysis software (http://rsb.info.nih.gov/ij/) and 
counting transmigrating cells manually. The results were normalised to the 
untreated cells.
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2.2.3.3 Migration analysis
Migration data were recorded on a Nikon TE2000-E time-lapse microscope using 
Methamorph software as a series of images, and Motion analysis software (Andor 
Technologies) was used to track the individual THP-1 cells migrating on the HUVEC 
surface. The movement of the cells was followed with a mouse pointer and x-y 
coordinates were recorded for each cell, at each frame. The resulting series of 
x and y coordinates was analysed using a Mathematica (Wolfram Research) 
notebook, written by Dr D. Zicha (Allen et al., 1998). This notebook uses a 
calibration of the pixel size of the images and the actual size of the images in pm. In 
this way, coordinates relating to image pixels were used to calculate the actual 
distance between points in the image. With reference to the time between each 
frame, the migration speed was calculated.
2.2.4 Adhesion assay
HUVECs were grown to confluency in FN-coated black 96-well dishes with clear 
bottom (Corning Inc.) and TNF-a-stimulated prior to experiments. THP-1 cells were 
stained with 1 pM CellTracker™ Green CMFDA for 30 min, washed once with PBS 
and subsequently treated with biochemical reagents or left untreated. 5 x 104 THP-1 
cells were added for 15 min to wells containing HUVECs or wells coated with 
ICAM-1 or VCAM-1 (5 pg/ml, 1 h at 37°C). The wells were washed twice with PBS 
and fluorescence measured in RPMI-1640 medium without phenol-red in a Fusion™ 
a-FP plate reader (Perkin Elmer) at 485 nm excitation wavelength and a 535/25 nm 
emission bandpass filter. To determine absolute cell numbers a standard curve was 
constructed.
2.2.5 Permeability assays
Untreated or siRNA-treated HUVECs were cultured to confluency on FN-coated 
Transwell™ filters (12 mm diameter, 0.4 pm pore size) and either stimulated with 
TNF-a or left unstimulated. siRNA-treated cells were used 72 h after transfection. 
THP-1 cells were incubated with or without H20 2for 30 min at 37°C and 1 x 106 cells 
added to the upper chamber. After a 25 min incubation 100 pg/ml FITC-dextran was 
applied to the upper chamber. Samples of the medium from the lower chamber 
were subsequently removed at 40 and 80 min time points and were measured in 
black clear-bottom 96-well plates using a Fusion™ a-FP plate reader (Perkin Elmer) 
at 485 nm excitation wavelength and a 535/25 nm emission bandpass filter. To 
maintain the volume in the lower chamber over the course of the experiment, an
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equivalent volume of fresh medium was added to the lower chamber after each 
removal. Each condition was performed in triplicate.
2.2.6 FACS analysis
FACS analysis was used to detect cell surface levels of adhesion proteins in 
leukocytes and ECs, to determine intracellular ROS and NO levels and the fraction 
of apoptotic/necrotic cells after H20 2 treatment. FACS analysis was carried out 
using a BD FACSCanto™ and BD FACSCalibur™ flow cytometer 
(www.bdeurope.com) at 488 nm excitation wavelength and a 530/30 nm emission 
bandpass filter for AlexaFluor®488 and AnnexinV-FITC, and 488 nm excitation 
wavelength and a 610/20 nm emission bandpass filter for propidium iodide (PI).
2.2.6.1 Immunolabelling
Control or siRNA-treated HUVECs were cultured in FN-coated 6-well dishes. 
HUVECs were detached by washing once with PBS, addition of 0.2 ml typsin/EDTA, 
incubation for 1 min and pelleting by centrifugation at 200 g for 5 min. Suspension 
cells such as THP-1, MM6 and CCRF-CEM cells were pelleted by centrifugation at 
200 g for 5 min.
Cells were washed once with FACS buffer and pelleted by centrifugation at 
200 g for 5 min. For staining of active (31 integrin, cells were fixed in 70% ethanol 
(30 min, 4°C) prior to labelling, since the antibody activates (31 integrin. Cells were 
then incubated with 10 pi of 2% BSA in FACS buffer on ice for 10 -  30 min to block 
unspecific binding. Primary antibodies, including negative isotype controls, were 
diluted in FACS buffer and 50 pi was added to the cells before incubation on ice for 
30 min. For detection of active integrins, positive (pos) and negative (neg) activation 
controls were additionally carried out. For (31 activity detection, cells were treated 
with 200 pM Mn2+ (pos) or 5 mM EDTA (neg) for 15 min prior to fixation, whereas for 
active (32 integrin activity antibody labelling was carried out in the presence of 
200 pM Mn2+ or 5 mM EDTA. To remove the antibody, 100 pi of FACS buffer was 
added and cells were pelleted at 200 g for 5 min. This step was then repeated. A 
1/200 dilution of AlexaFluor488 antibody was added (50 pi) and incubated on ice for 
20 min. To remove the antibody, 100 pi of FACS buffer was added and cells were 
pelleted at 200 g for 5 min. This step was then repeated. The cells were 
resuspended in 300 pi of FACS buffer and transferred into FACS tubes. Controls for 
this assay included unstained and IgG isotype negative control stained cells.
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2.2.6.2 ROS and NO detection
THP-1 cells were centrifuged at 200 g for 5 min and resuspended in fresh medium. 
For ROS detection, cells were treated with various concentrations of H20 2 for 
30 min. H20 2 was removed by centrifugation and cells were subsequently incubated 
with 10 pM DCF or H2DCFDA for 60 min. The reagent was removed by 
centrifugation and cells resuspended in 300 pi FACS buffer before transferring to 
FACS tubes.
For NO detection, cells were incubated with 10 pM DAF for 60 min. The 
reagent was removed by centrifugation and cells subsequently incubated with 
various concentrations of H20 2 for 30 min. Hydrogen peroxide was removed by 
centrifugation and cells were resuspended in 300 pi FACS buffer before transfering 
to FACS tubes.
As the dyes used are light sensitive, all experiments were carried out with as 
little exposure to light as possible.
2.2.6.3 Apoptosis/necrosis assay
THP-1 and CCRF-CEM cells were treated with various concentrations of H20 2 for 
30 min (THP-1: 0 - 1 0 0  mM; CCRF-CEM cells: 0 - 5  mM). H20 2 was removed by 
centrifugation at 200 g for 3 min. Cells were resuspended in fresh medium and 
allowed to recover (2 h, 37°C, 5% C 02). Control cells were either treated with 1 pM 
staurosporine for 2.5 h (positive control for apoptosis) or briefly heated to 70°C 
(positive control for necrosis).
For the assay, 8 x 105 cells were centrifuged at 200 g and resuspended in 
Annexin V buffer. Cells were stained with Annexin V (dilution 1/500) for 10 min on 
ice. Samples were transferred to FACS tubes in this buffer and 1 pM PI was added 
just before measuring.
2.2.7 Ca2+ detection assay
To detect a potential Ca2+ influx after H20 2 treatment, the Fluo-4 NW assay kit 
(Molecular Probes) was used. For the assay, 1.25 x 105 THP-1 cells were pelleted 
per condition, resuspended in 50 pi assay buffer and transferred to a 96-well plate. 
The cells were allowed to settle for 60 min (37°C and 5% C 02). The reagents were 
prepared according to the manufacturer’s instructions and 50 pi 2x loading dye was 
added to each well and incubated for 30 min (37°C and 5% C 02). THP-1 cells were 
then treated with H20 2 (0 -  5 mM) for 30 min and fluorescence measured using a 
Fusion™ a-FP plate reader (Perkin Elmer) at 485 nm excitation wavelength and a
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535/25 nm emission bandpass filter. As a positive control 10 pM Ca2+ ionophore 
A23187 was added to one of the untreated samples before measuring.
2.2.8 Immunofluorescence microscopy
For immunofluorescence labelling, HUVECs were grown to confluency on FN- 
coated coverslips and treated either with or without TNF-a. For THP-1 cell labelling, 
treated or untreated THP-1 cells were allowed to adhere to FN- or VCAM-1 -coated 
coverslips (5 pg/ml, 15 h, 4°C).
For monocultures, cells were washed once with PBS and fixed with 4% PFA 
in PBS (20 min, room temperature (RT)). For co-cultures, HUVECs were incubated 
with THP-1 cells for 25 min or with T cells for 10 min, before fixation with 4% PFA in 
PBS (20 min, RT). After fixation cells were permeabilised when appropriate with 
0.1% Triton X-100 in PBS (5 min, 4°C), washed three times with PBS, and 
incubated with 2% BSA in PBS (30 -  60 min). Coverslips were then sequentially 
incubated with various dilutions of the appropriate polyclonal or monoclonal 
antibodies, AlexaFluor488- or AlexaFluor568-conjugated anti-rabbit or anti-mouse 
IgG secondary antibodies and counterstained with TRITC- or Cy5-conjugated 
phalloidin to visualise F-actin. Coverslips were mounted onto slides using 
fluorescent mounting Medium, and visualised using a LSM 510 laser scaning 
confocal microscope (Zeiss).
For CD73 staining, HUVECs were washed with PBS and incubated 
sequentially with undiluted 4G4 hybridoma supernatant on ice for 30 min and an 
AlexaFluor488-conjugated anti-mouse antibody for 20 min on ice. Cells were fixed 
subsequently with 4% PFA in PBS (20 min, RT) and either further stained or 
mounted onto slides.
2.2.9 Protrusion assay
THP-1 cells were treated with 1 pM CellTracker™ Green CMFDA (30 min, 37°C). 
Excess dye was removed by centrifugation at 200 g before subsequent treatment 
with 0, 0.1, 0.5, 1, 2 and 5 mM of H20 2 (30 min, 37°C). Cells were centrifuged for 
3 min at 200 g to remove H20 2 and 3 x 106 cells were added to a TNF-a stimulated 
HUVEC monolayer, grown to confluency on FN-coated coverslips. After 25 min of 
incubation at 37°C, cells were washed with PBS and fixed with 4% PFA in PBS 
(20 min, RT). Co-cultures were either counterstained with TRITC- or Cy5- 
conjugated phalloidin to visualise F-actin or directly mounted onto glass slides. The 
number of cells with protrusions was determined by capturing images using a Zeiss 
Axiophot with a Q-lmaging Retiga SRV camera and counting cells manually.
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2.2.10 Transmission electron microscopy
In order to visualise the interaction between THP-1 cells and the HUVEC monolayer 
in the y-z plane in greater detail, HUVECs were grown to confluency on FN-coated 
coverslips, stimulated with TNF-a for 15 -18 h then 3 x 105 THP-1 cells were added 
per coverslip for 25 min. Co-cultures were washed twice with PBS and fixed with 
2.5% glutaraldehyde fixative at RT for 1 h. Coverslips were washed three times with 
glutaraldehyde wash solution.
The following procedures were carried out by Ken Brady at the Centre for 
Ultrastructural Imaging at King’s College London. In order to enhance the contrast in 
the resulting images, the cells were post-fixed in osmium tetroxide fixative ( 1 5 - 3 0  
min, RT). The samples were sequentially dehydrated at RT in 10% ethanol for 
10 min, 70% ethanol for 15 min and three times 100% ethanol for 15 min. TAAB 
premix medium resin was made up according to the manufacturer’s instructions and 
one drop applied to one glass slide per sample. The coverslips were placed onto the 
resin drop with the glass surface facing down and covered immediately with a few 
drops of resin which were allowed to penetrate the sample for 2 h at RT. BEEM® 
capsules in a rack were filled to the brim with resin and inverted onto the coverslip 
ensuring that resin did not get under the coverslip. The slides were placed into an 
embedding oven and allowed to polymerise for 24 h at 60°C. Cooled samples were 
placed onto a hot plate for 30 sec, glass slide facing down, the BEEM® capsules 
snapped off the coverslip. BEEM® capsules were sawn in half in order to obtain 
block faces of suitable size. The blocks were then cut on a Leica Ultra-cut machine 
(Leica, www.leica-microsystems.com) to semi-thin thickness (0.75 -  2 pm). These 
sections were stained with toluidine blue to select appropriate areas for 
transmission electron microscopy. Ultra-thin sections (100 -  120 nm) of the selected 
viewing area were cut on the Leica Ultra-cut machine and placed onto 200 mesh 
gilder grids with a support film of pioloform. The grids were stained with uranyl 
acetate and lead citrate to further enhance the contrast and viewed on a Hitachi 
H7600 transmission electron microscope (Hitachi, www.hht-eu.com).
2.2.11 Cholesterol-depletion of HUVECs
To deplete cholesterol from the plasma membrane, HUVECs grown on FN-coated 
coverslips or 24-well dishes were incubated with 4 mg/ml methyl-p-cyclodextrin 
(MpCD) (15 min, 37°C). Mf3CD was removed and cells were washed with PBS and 
used in various experiments.
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To visualise cholesterol by light microscopy, coverslips with either 
cholesterol-depleted or untreated HUVEC monolayers were incubated with 5 pg/ml 
filipin for 15 min at 37°C and subsequently mounted onto coverslips. The staining 
and mounting procedure was carried out in the dark as filipin is highly sensitive to 
light. The samples were visualised using a Zeiss Axiophot with a Q-lmaging Retiga 
SRV camera.
2.2.12 Phosphatidylinositol-specific phospholipase C (PI-PLC)-induced 
shedding of CD73
In order to shed CD73 from the cell surface, HUVECs were treated with 0.2 U/ml of 
PI-PLC (15 min, 37°C). PI-PLC was removed and cells were used in various 
experiments.
2.2.13 Antibody-mediated cross-linking of ICAM-1, VCAM-1 and CD73
HUVECs were grown to confluence in FN-coated 24-well dishes and stimulated with 
TNF-a for 15 -  18 h. Cells were washed once with EGM-2 and cross-linking was 
carried out for 30 min on ice using 50 pi IgG! negative control (1/100), ICAM-1 
(1/100), VCAM-1 (1/100), RhoE (undiluted) or CD73 (undiluted) antibodies or no 
antibody as a control. Monolayers were washed twice with PBS and either 
incubated for 20 min at 37°C with 50 pi FITC-conjugated anti-mouse antibody 
(1/100) or PBS only. Cells were washed twice with EGM-2 and used for 
determination of CD73 activity.
2.2.14 CD73 activity assay (radio-thin layer chromatography)
To measure CD73 enzymatic activity, treated or untreated HUVECs were grown in 
FN-coated 24-well dishes until confluency and either treated with or without TNF-a. 
For leukocyte binding experiments, THP-1 cells were treated with 0, 0.5, 1 and 
5 mM H20 2 for 30 min and 3 x 105 THP-1 cells were added per well for 25 min. For 
CD73 inhibition experiments, various concentrations of AMP-CP were added for 1 h. 
Cells were washed once with EGM-2 before adding 250 pi EGM-2, containing 
180 pM [2-3H] adenosine 5’-monophosphate (specific activity per well: 37 pBq) and 
20, 200 or 900 pM unlabelled adenosine 5’-monophosphate for 5 - 4 5  min at 37°C. 
Aliquots of the medium ( 6 - 8  pi) were applied to silica 60 gel thin layer 
chromatography (TLC) plates and were separated using isobutyl alcohol / isoamyl 
alcohol / 2-ethoxyethanol / ammonia / H20  (ratio 9:6:18:9:15) as a solvent. The TLC 
plates were developed by exposing to tritium-sensitive film (Kodak BioMax MS film)
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together with a BioMax TranscreenLE intensifying screen (Kodak) for 110 -  150 h 
at-80°C.
2.3 Methods: biochemistry
2.3.1 Western immunoblotting
Protein samples were prepared by lysing 3 -  5 x 106 cells/ml in lysis buffer for 
20 min at 4°C with rotation. Cell lysates were centrifuged at 18 500 g for 15 min to 
remove insoluble material. Cleared lysates were boiled for 5 min with 4x sample 
buffer either with or without 4 mM DTT and 20 pg of total protein was applied to 
NuPAGE 4 -  12% Bis-Tris gels. Proteins were separated using a constant voltage 
of 120 V, in NuPAGE MES running buffer. After electrophoresis proteins were 
transferred to Immobilon-P membranes for immunoblotting. Protein transfer was 
carried out for 90 min at constant voltage of 100 V in NuPAGE transfer buffer.
Immunoblotting was performed using various monoclonal and polyclonal 
antibodies (see Chapter 2.1.3). Membranes were sequentially blocked in Tris- 
buffered saline containing 0.03% Tween-20 (TBS-T) and either 5% (weight/volume) 
milk powder or 2% BSA for 1 h at RT, incubated with primary antibody either for 1 h 
at RT or for 15 -  18 h at 4°C, washed with TBS-T and incubated with secondary 
antibodies for 1 h at RT. Membranes were washed with TBS-T and 
immunodetection performed using an ECL detection kit according to the 
manufacturer’s instruction and Super RX medical X-ray film (Fuji).
Immunoblots were quantified by densitometry using VisionWorks®LS 
analysis software (UVP, www.uvp.com), subtracting the background from the 
reading and normalising to the loading control.
2.3.2 Proteasome inhibition
In order to inhibit proteasome-mediated degradation, THP-1 cells were treated for 
15 - 18 h with 10 pM of the proteasome inhibitor MG132. The inhibitor was removed 
by centrifugation at 200 g for 3 min and cells washed once with PBS before they 
were lysed in lysis buffer. Samples were separated by gel electrophoresis.
2.3.3 Co-immunoprecipitation
For antibody immobilisation, 15 pi of protein A+G Dynabeads® were washed three 
times with MES buffer, and incubated with 2 pg of RhoGDI or c-Myc antibody in 
70 pi MES buffer for 15 - 18 h at 4°C and washed with MES three times. To cross­
link the antibody to the beads, the beads were sequentially washed twice with 0.2 M
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triethanolamine (TEA), pH 8.2, resuspended in fresh 20 mM dimethyl pimelimidate x 
2HCI (DMP) in 0.2 M TEA and incubated for 30 min at RT with rotational mixing. 
The supernatant was discarded and the reaction stopped by adding 50 mM Tris, 
pH 7.5 for 15 min with rotational mixing. The beads were washed three times with 
0.1% Tween-20 in PBS.
Cell lysates were prepared by homogenising 5 x 106 treated or untreated 
THP-1 cells in homogenising buffer using a BioSpec Tissue-Tearor homogeniser 
(www.biospec.com) and centrifuged at 18 500 g for 30 min at 4°C. A small aliquot of 
the cleared homogenate was kept for western blotting (whole cell lysate; WCL); the 
remainder was incubated with the antibody cross-linked beads at RT for 2 h. To 
remove unbound protein, the beads were washed three times with homogenising 
buffer and proteins eluted by boiling the beads for 5 min with 2x sample buffer. 
Samples were separated by gel electrophoresis.
2.3.4 GST-Pull-downs
To detect GTPase activity in treated and untreated THP-1 cells, GST-fusion proteins 
of rhotekin, the p21-binding domain (PBD) of PAK and the Cdc42/Rac interactive 
binding (CRIB) domain of WASP were used for RhoA, Rac1 and Cdc42 pull-downs 
respectively.
2.3.4.1 GST-Pull-down for suspension THP-1 cells
2.3.4.1.1 Preparation of GST-proteins
E. coli transformed with plasmids encoding GST-fusion proteins were plated onto 
Luria broth (LB) agar containing 50 pg/ml ampicillin. One colony was used to 
inoculate 100 ml of LB medium containing 100 pg/ml ampicillin and grown for 
15 - 18 h at 37°C. The overnight culture was diluted 1/20 into fresh LB medium with 
ampicillin and grown at 37°C to an optical density of 0.7 (OD600). To induce protein 
expression, isopropyl (3-D-1-thiogalactopyranoside (IPTG) was added at a 
concentration of 0.5 mM for 2 h at 30°C. To collect the cells, the culture was 
centrifuged at 600 g for 20 min at 4°C and pellets were either stored at -40°C for 
future use or used the same day. Bacterial pellets derived from 50 ml of culture 
were resuspended in ice-cold STE buffer with 1 mM phenylmethylsulphonyl fluoride 
(PMSF), homogenised with a 19G needle and 100 pg/ml lysozyme added before 
incubation on ice for 15 min with gentle mixing. In order to further lyse the bacteria, 
5 mM dithiothreitol (DTT), 1% Tween-20 and 0.03% sodium dodecyl sulfate (SDS)
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were sequentially added. The lysate was then centrifuged at 18 500 g for 20 min at 
4°C.
In the meantime, 10 pi MagneGST beads per condition were washed three 
times with MagneGST buffer and resuspended in 100 pi MagneGST buffer 
containing 1% BSA to reduce non-specific binding. Bacterial lysate was added to 
the beads and incubated at 4°C for 1 h with rotation. The supernatant was removed 
and the beads washed three times with MagneGST buffer and resuspended in 
10 pi.
2.3.4.1.2 Pull-down assay
THP-1 cells were treated with 0, 0.1, 0.5, 1, 2 and 5 mM H20 2 (5 x 106 cells per 
condition) for 30 min, washed once with PBS and lysed with 1x Mg2+ buffer for 5 min 
on ice. Lysates were centrifuged for 5 min at 18 500 g and a small aliquot of each 
was kept for immunoblotting as WCL. The remaining lysate was either incubated 
with the prepared beads for 1 h at 4°C or subjected to GTPase activation or 
inactivation reactions (positive and negative controls).
To generate positive and negative controls, the pre-cleared lysate was 
incubated with 10 mM EDTA and either 100 pM GTPyS or 1 mM of GDP at 30°C for 
15 min. The reaction was stopped by adding 60 mM MgCI2 and the lysate added to 
the MagneGST beads for 1 h at 4°C.
After incubation, the supernatant was removed and beads were washed with 
MagneGST buffer 5 times. In order to elute the bound proteins, beads were 
incubated with 2x sample buffer with DTT for 5 min at RT. Beads were removed and 
supernatants and WCL in sample buffer were boiled for 5 min. The pull-down 
samples were separated in parallel with the WCL samples by gel electrophoresis.
2.3.4.2 GST-Pull-down for adherent THP-1 cells
To detect Rho GTPase activity in adherent THP-1 cells, 5 x 106 THP-1 cells per 
experimental condition were treated with 0, 0.1, 0.5, 1, 2 and 5 mM H20 2 for 30 min. 
Cells were pelleted, resuspended in 800 pi integrin activation buffer, divided in two 
parts and each centrifuged onto a FN-coated 6-well for 5 min at 170 g. Cells were 
then lysed by addition of an equal volume of 2x Rho lysis buffer and passed through 
a 19G needle several times. In order to remove cellular debris and insoluble 
material the lysate was centrifuged at 18 500 g at 4°C for 10 min. A small sample of 
the supernatant was kept for immunoblotting as WCL, while the rest was added to 
20 pi GST-Rhotekin-RBD beads (RhoA; Cytoskeleton) or 10 pi GST-PAK1-PBD 
conjugated agarose beads (Rac1 and Cdc42; Upstate) and incubated at 4°C for 1 h
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with rotation. The beads were washed three times with Rho lysis buffer and pelleted 
by centrifugation for 1 min at 2 500 g at 4°C. Protein was eluted by boiling in 
2x sample buffer. The pull-down samples were separated in parallel with the WCL 
samples by gel electrophoresis.
2.3.5 Raft fractionation by n-octylglucoside (OG)-selective solubility
Raft fractionations were carried out at 4°C, at all stages using only pre-chilled 
pipette tips. HUVECs were grown to confluency on FN-coated 6-well dishes, 
washed twice with ice-cold PBS and lysed with 100 pi of TST buffer. Cells were 
harvested by thorough scraping and incubated with occasional agitation for 20 min. 
The supernatant (soluble fraction, S) was separated from the pellet by centrifugation 
at 18 500 g for 3 min. The pellet was resuspended in 100 pi TST containing 60 mM 
OG and incubated on ice for 15 min followed by a 10 min incubation at 37°C. To 
separate the raft fraction from the pellet, the lysate was centrifuged again for 3 min 
at 18 500 g and supernatant (raft fraction, R) was separated. In order to solubilise 
the final pellet, 100 pi of TST was added. The three fractions were boiled with 
4x sample buffer and sonicated before loading equal volumes of each fraction onto 
a NuPAGE gel.
2.4 Statistical analysis
Statistical analysis was carried out where three or more independent experiments 
were available. In order to determine statistical significance, Student’s t-test and 
analysis of variants (ANOVA) with Bonferroni post-test was carried out using 
GraphPad Prism software (www.graphpad.com).
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3
Role of reactive oxygen species in leukocyte 
transendothelial migration
3.1 Introduction
The intra- and intercellular signalling pathways involved in regulating TEM have yet 
to be fully elucidated. Additionally, how external factors, including environmental 
pollution and life-style choices such as diet, alcohol consumption and smoking 
influences leukocyte TEM has not been investigated in detail. These exogenous 
factors have been shown to increase oxidative stress, a condition defined as an 
imbalance between ROS and antioxidants (Jones, 2006). Several studies have 
investigated the role of endothelium-derived ROS in TEM. ROS have been shown to 
be important in the endothelium during TNF-a-mediated upregulation of adhesion 
molecules (Alom-Ruiz et al., 2008), VCAM-1 signalling following leukocyte binding 
(Deem and Cook-Mills, 2004; Keshavan et al., 2005) and also in regulating 
endothelial monolayer permeability (Schreibelt et al., 2007; van Buul et al., 2005). 
However, very few studies have investigated the effects of ROS on leukocytes 
during TEM. Eguchi et al. have shown that treatment of HL60 cells with ROS 
reduces E-selectin-mediated adhesion to the endothelium by decreasing cell 
surface level of sialyl LewisX (Eguchi et al., 2005). Also, overexpression of UCP-2, 
a protein involved in metabolic uncoupling, in a monocytic cell line leads to 
decreased adhesion and TEM due to reduced intracellular ROS and (32 integrin 
levels (Ryu et al., 2004). In addition, an increasing number of studies have 
investigated the involvement of ROS in adhesion and the regulation of the actin 
cytoskeleton in experimental settings other than inflammation. Fraticelli et al. have 
demonstrated a ROS-induced upregulation of (32 and aM in PMNs (Fraticelli et al., 
1996), while ROS-induced rearrangements of the actin cytoskeleton have been 
observed in different cell types, including rat hepatocytes and ECs (Huot et al., 
1998; Perez et al., 2006). Actin itself undergoes direct oxidative modifications during 
integrin-mediated adhesion, promoting spreading and actin rearrangements (Fiaschi 
et al., 2006). Additionally, localised ROS production due to subcellular targeting of
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NADPH oxidase has been shown to be important in directional migration (Ushio- 
Fukai, 2006).
Since rearrangements of the actin cytoskeleton and actin-dependent processes, 
such as migration, play a crucial role in leukocyte extravasation, it was interesting to 
investigate if and how ROS affect leukocyte TEM. The aim of this chapter was 
therefore to set up an in vitro model for leukocyte TEM and to investigate the 
transmigration behaviour of ROS-treated leukocytes.
3.2 In vitro transendothelial migration assays
3.2.1 Characterisation of leukocytes
Leukocytes express different patterns of cell surface proteins, including adhesion 
molecules such as integrins. Integrins constitute a family of over 20 heterodimers 
whose ligand-binding activity can be rapidly regulated by conformational changes, 
clustering, and redistribution from surface and intracellular pools (Carman and 
Springer, 2003; Dustin et al., 2004). The most relevant integrins for leukocyte 
adhesion to the endothelium are a4(37 integrin and (31 and (32 containing integrins, 
including ICAM-1-binding LFA-1 (aL(32), MAC-1 (aM(32) and VCAM-1-binding VLA-4 
(a4(31) (Barreiro et al., 2007). FACS analysis was used in order to characterise a 
number of different leukocyte lines to be used in in vitro TEM assays. The human 
monocytic leukaemia cell lines THP-1 and MM6 and the T lymphoblastoid cell line 
CCRF-CEM were chosen, as they have been well characterised in TEM models 
(Cabrero et al., 2006; Ryu et al., 2004; Weber et al., 1998). Cells with different 
properties were chosen in order to provide a range of responses in the system.
In order to characterise the leukocytes, FACS analysis was carried out in 
which cells were stained for: CD44 (phagocytic glycoprotein 1, Pgp-1), which binds 
to hyaluronic acid (HA) in the ECM; integrins such as (31 (CD29), (32 (CD18), CD11a 
(aL, a subunit of LFA-1), CD11b (aM, a subunit of Mac-1) and CD11c (aX). 
Representative FACS traces show, that (31 integrin levels were high and uniform for 
THP-1 and CCRF-CEM cells, whereas MM6 cells showed two distinct populations, 
one with high, and the other with levels at negative control intensity (Fig. 3.1A). The 
(32 integrin was highly expressed on THP-1 and CCRF-CEM cells, but only a portion 
of MM6 cells showed staining above negative control levels (Fig. 3.1B). CD44 was 
highly expressed in all three cell lines, but MM6 cells additionally showed a second
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Figure 3.1: Characterisation of leukocyte surface marker expression by flow 
cytometry
FACS analysis was carried out on untreated THP-1, CCRF-CEM and MM6 cells. 
Cells were labelled with antibodies against (31 and (32 integrin, CD44, CD11a (aL), 
CD11b (aM) and CD11c (aX) and FITC-conjugated secondary antibodies. Mouse 
IgG was used as negative control. A - G: Representative FACS traces for individual 
antibodies and cell lines. H: Graphical display of all experiments. Fold increase is 
calculated over each respective IgG control. Bars represent SEM. n = 3.
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population with lower CD44 levels (Fig. 3.1C). CD11a was highly expressed in all 
three cell lines, whereas CD11b and CD11c integrins were expressed at low levels 
in THP-1 and CCRF-CEM cells, but could not be detected in MM6 cells (Fig. 3.1 D -  
F). The results from all experiments were normalised to the IgG negative control of 
the appropriate cell line (Fig. 3.1G) and displayed in a histogram (Fig. 3.1H). THP-1 
and MM6 cells had comparable levels of CD44, (31 and (32 integrin. MM6 cells had 
relatively high levels of CD11a; CCRF-CEM cells had relatively low levels of (31 and 
(32 integrin.
3.2.2 Characterisation of ECs
HUVECs were grown to confluency and stimulated with TNF-a to induce 
upregulation of leukocyte adhesion molecules (Alom-Ruiz et al., 2008; De Martin et 
al., 2000). In order to determine the best TNF-a concentration, confluent HUVEC 
monolayers on coverslips were stimulated for 15 -  18 h with a range of TNF-a 
concentrations. Upregulation of ICAM-1, an adhesion molecule for integrins, and an 
increase in stress fibres (arrows) were observed with increasing TNF-a 
concentrations (Fig. 3.2). The cell morphology changed from a ‘cobblestone-like’ 
appearance for untreated cells to an elongated and aligned phenotype in TNF-a- 
stimulated cells. An intermediate concentration of 10 ng/ml TNF-a was chosen for 
future experiments as this concentration was sufficient to induce maximal ICAM-1 
upregulation.
3.2.3 Time-lapse microscopy analysis of TEM
In order to study transendothelial migration as well as other aspects of cell 
behaviour, a time-lapse-microscopy (TLM)-based assay was set up. The 
microscopy based assay allows not only the determination of the transmigration 
rate, but also analysis of cell morphology and behaviour after various treatments. 
Movies of transmigrating THP-1 cells were recorded over 2 h and the transmigration 
rate was calculated from the movies and amounted to 16.3 ± 2% and 15.8 ± 2.3% 
(of input) for untreated THP-1 and CCRF-CEM cells respectively (see Fig. 3.14). 
Phase-contrast images from these movies show that cells did not exhibit a clear 
polarised phenotype with lamellipodium and uropod during their migration on the 
HUVEC surface and instead had a rounded morphology with dynamic protrusions at 
multiple sites of the migrating cell (Fig. 3.3A -  D). During the early phase of TEM, 
cells extended these protrusions to invade the junctions between neighbouring ECs. 
In transmigrating cells, these exploratory protrusions evolved into a lamella (Fig. 
3.3B, C, arrow) and squeezed into the monolayer gap, finally followed by the
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Figure 3.2: TNF-a response in HUVECs
HUVECs were grown to confluency on coverslips and stimulated for 15 -  18 h with 
0, 1, 10, 50 or 100 ng/ml TNF-a. Monolayers were fixed and stained for ICAM-1 and 
F-actin. Arrows indicate stress fibres. Bar = 50 pm.
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Figure 3.3: Leukocyte transendothelial migration
THP-1 cells were added to a TNF-a-activated (10 ng/ml, 15 - 18 h) HUVEC 
monolayer. A -  D: Transmigration was monitored using time-lapse microscopy and 
phase contrast images from the movies at the indicated timepoints (min) are shown. 
Phase-dark areas (arrows) of THP-1 cells are underneath the HUVEC monolayer. 
Bar = 20 pm. E -  J: Cells were fixed after 25 min, embedded and ultra-thin sections 
(100 -  120 nm) in the y-z plane were cut by Ken Brady (Centre for Ultrastructural 
Imaging, KCL). The sections were post-stained to enhance the contrast and viewed 
in a Hitachi H7600 transmission electron microscope. Bars = 2 pm.
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cell body (Fig. 3.3D). Most transmigrating THP-1 cells underwent reverse TEM (i.e. 
reappeared on the HUVEC surface) after 5 - 1 0  min. This is a phenomenon that 
has been observed in vivo as well, but not at this high rate, which is likely to be due 
to the lack of underlying matrix (i.e. ECM) in this system into which the cells could 
migrate. THP-1 cells were exclusively observed to use a paracellular route for TEM. 
This could be due to their relatively large size; THP-1 cells have a diameter of 
~ 15 pm (determined with CASY® cell counter, Scharfe Systems), whereas T cells, 
which are known to be able to use a transcellular route (Millan et al., 2006), have a 
diameter of only ~ 6 pm.
To further investigate the cell morphology during the transmigration process, 
electron microscopy (EM) was carried out on THP-1 cells undergoing 
transmigration. The EM images of transmigrating THP-1 cells in the z-y plane 
confirm the observations made from the TLM movies: THP-1 cells are not spread, 
but exhibit a rather rounded morphology during the whole transmigration process 
(Fig. 3.3E - J). The diameter of THP-1 cells is large in comparison to the flat ECs 
( 1 - 3  pm). THP-1 cells exhibited only small lamellipodia while crawling on the 
endothelium (Fig. 3.3F) and protrusions could be seen probing junctions and ECs 
(Fig. 3.3G -  I). Even during diapedesis, THP-1 cells were not spread (Fig. 3.3J) as 
high magnification images of transmigrating THP-1 cells confirmed (Fig. 3.4A). The 
details of the transmigrating cell illustrate the close proximity of the endothelial and 
the leukocyte plasma membrane during paracellular TEM (Fig. 3.4 B -  D). The sites 
of interaction are not continuous, but rather ‘button-like’. These areas are likely sites 
of adhesion, which could be demonstrated by immunogold-labelling of cell-cell 
adhesion molecules.
3.2.4 Transwell™ assay of migration
The disadvantage of the TLM-based TEM is the relatively small number of cells that 
can be recorded (~ 100 THP-1 cells per field of view). In order to provide a more 
rapid quantification of cell TEM rate, a second TEM assay was set up, using 
Transwell™ cell culture inserts. These cell culture inserts provide a two chamber 
system, which is separated by a porous membrane. This membrane can be coated 
with cell substrates, such as VCAM-1, or used to grow HUVECs on. In order to 
induce efficient migration in the Transwell™-based assay a chemotactic gradient 
using CCL2 (MCP-1) was applied. To determine the most efficient concentration of 
MCP-1 for THP-1 migration, concentrations from 0 -  200 ng/ml were tested.
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Figure 3.4: EM details of a transmigrating THP-1 cell
THP-1 cells were added to a TNF-a-activated (10 ng/ml, 15 - 18 h) HUVEC 
monolayer. Cells were fixed after 25 min, embedded and ultra-thin sections (100 -  
120 nm) in the z-y plane were cut by Ken Brady (Centre for Ultrastructural Imaging, 
KCL). The sections were post-stained to enhance the contrast and viewed in a 
Hitachi H7600 transmission electron microscope. A: Overview of a transmigrating 
THP-1 cell. B -  D: Details of leukocyte-endothelial interaction sites. Arrows indicate 
areas of close contact between leukocyte and EC. Bar = 2 pm.
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Transwell™ filters were coated with VCAM-1 since adhesion of THP-1 cells was 
highest for this substrate (see Fig. 3.12), and THP-1 cells were added to the upper 
chamber and allowed to transmigrate for 2 h in response a range of MCP-1 
concentrations. Cells from the lower chamber were counted and the migration rate 
calculated (Fig 3.5). THP-1 cells displayed increased migration in response to 
MCP-1, with most effective migration at 100 ng/ml MCP-1. This concentration was 
used in future experiments. The migration rate was calculated by counting the cells 
from the lower chamber and amounted to 7.4 ± 1.9% and 20.4 ± 11.7% (of input) for 
untreated THP-1 and CCRF-CEM cells respectively (see Fig. 3.14). A similar 
response to MCP-1 with a peak at 100 ng/ml has been seen in a Transwell™-based 
TEM assay in the presence of HUVECs (R.J. Cain, unpublished data). Similarly, 
CCRF-CEM cells migrated in response to CXCL12 (SDF-1) in Transwells™, with a 
peak at 50 ng/ml without or 100 ng/ml with HUVECs (S.J. Heasman, unpublished 
data).
The TLM and Transwell™ assays provided complementary approaches for 
studying in vitro TEM.
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Figure 3.5: Determination of MCP-1 concentration for Transweil™-based 
migration assay
Untreated THP-1 cells were added to a VCAM-1-coated (5 pg/ml) Transwell™ filter. 
MCP-1 was added to the lower chamber at 0, 50, 100 and 200 ng/ml to provide a 
chemoattractant gradient across the filter. Cells from the lower chamber were 
counted after 2 h. Results were normalised to untreated control. Bars represent 
SEM. ★ p < 0.05 determined by Student’s t-test and Bonferroni post-test, n = 5.
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3.3 H2O2 application decreases leukocyte transendothelial migration
To determine the role of H20 2 in TEM, H20 2 treatment was chosen as a model for 
ROS exposure (see Chapter 1.5). THP-1, CCRF-CEM, and MM6 cells were treated 
independently from HUVECs with a range of H20 2 concentrations and H20 2 was 
removed by centrifuging and resuspending the cells in fresh medium. The treated 
leukocytes were used in the TLM- and Transwell™-based assays, except for MM6, 
which were only used in TLM-based assays. Phase-contrast images from time- 
lapse movies with treated or untreated THP-1, CCRF-CEM, or MM6 cells after 
5 and 120 min are shown in Figure 3.6. THP-1 cells did not show an obvious 
change in morphology with H20 2 treatment (Fig. 3.6A -  D), whereas CCRF-CEM 
cells appeared more rounded after H20 2 treatment (Fig. 3.6E -  H). The rounded 
morphology could indicate a defect in polarisation. The effect might only be 
detectable in CCRF-CEM cells, as THP-1 cells do not exhibit a clearly polarised 
phenotype which impedes the identification of a polarisation defect without 
analysing specific markers. The reason for this rounding remains to be determined, 
but could contribute significantly to the observed decrease in TEM.
The analysis of time-lapse movies revealed that no MM6 cells transmigrated 
during the 2 h of recording, neither in treated nor untreated conditions. The cells 
appeared to be rounded throughout the 2 h of recording (Fig. 3.6I - L), which could 
contribute to the lack of TEM. This finding is surprising as MM6 cells have been 
used for TEM experiments by other groups (Weber et al., 1998). The transmigration 
of MM6 cells was not pursued further.
Analysis of the THP-1 and CCRF-CEM cell movies showed a significant 
decrease in TEM from 0.5 mM H20 2 for both cell types (Fig. 3.7A, B). The 
transmigration rate was calculated as a percentage of untreated cells in all following 
experiments. TEM was inhibited by a maximum of 54.5 ± 14.7% (0.5 mM) in THP-1 
cells and 95.2 ± 2.6% (5 mM) in CCRF-CEM cells. THP-1 TEM was not inhibited at 
lower H20 2 concentrations ranging from 0 -  100 pM (Fig. 3.7C).
The TEM results were confirmed using the Transwell™-based assay (Fig. 
3.7D, E). However, THP-1 TEM was inhibited less efficiently, needing higher 
concentrations to reach a maximum inhibition of 61 ± 4.5% at 5 mM H20 2. CCRF- 
CEM TEM showed a very similar trend to the TLM-based assay, but lower 
concentrations (0.1 and 0.5 mM) were move effective at reducing TEM.
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Figure 3.6: Phase-contrast images of transmigrating H20 2-treated leukocytes
THP-1, CCRF-CEM and MM6 cells were treated with 0 and 1 mM H20 2 (30 min, 
37°C). H20 2 was removed by centrifugation and cells were allowed to transmigrate 
across TNF-a-activated (10 ng/ml, 15 - 18 h) HUVECs for 2 h and monitored by 
TLM. To promote CCRF-CEM cell TEM, HUVECs were additionally incubated with 
50 ng/ml CXCL12 (SDF-1) for 15 min, then SDF-containing medium was removed 
and CCRF-CEM cells were added. Phase-contrast images of THP-1, CCRF-CEM 
and MM6 cells, taken from movies (1 frame/min) started 10 min after leukocyte 
addition, are shown for untreated conditions after 5 (A, E, I) and 120 min (B, F, J) 
and cells treated with 1 mM H20 2 after 5 (C, G, K) and 120 min (D, H, L). Arrows 
indicate examples of transmigrated leukocytes. Bars = 50 pm.
To investigate whether the chemotactic response and the ability to deform 
the cell, e.g. by remodelling the actin cytoskeleton, in order to transmigrate through 
confined areas was compromised in H20 2-treated THP-1 cells, the Transwell™- 
based migration assay was carried out without HUVECs. The pore size of 5 pm is 
small enough to force the THP-1 cells (diameter 15 pm) to remodel the cytoskeleton 
and nucleus extensively in order to migrate through the pores. The results show a 
significant inhibition of migration at 1 and 5 mM H20 2, but only by a maximum of 
23.7 ± 6% (Fig. 3.7F), indicating that neither changes in chemotaxis nor the ability to 
deform the cells are able to explain the detected defect in TEM. The reduction in 
TEM seems to be specific for the interaction of leukocytes with the endothelium.
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3.4 Leukocytes are viable after H2O2 treatment at working 
concentrations
H20 2 has been shown to be an inducer of apoptosis in several cell types (Cook et 
al., 1999; Kazzaz et al., 1996; Lee et al., 2002). JNK has been shown to be 
activated in response to ROS, which is mediated via Src kinase and ASK-1 (Shen 
and Liu, 2006). JNK is an important mediator of apoptosis, and is required for 
mitochondrial cytochrome C release (Tsuruta et al., 2004). To determine if H20 2 
induced apoptosis in THP-1 and CCRF-CEM cells at working concentrations, an 
apoptosis assay was carried out. Apoptotic cells can be detected by Annexin V and 
PI staining. Annexin V binds to phosphatidylserine (PS), which usually is confined to 
the inner leaflet of the plasma membrane in viable cells (Koopman et al., 1994), but 
is translocated to the outer leaflet of the plasma membrane during apoptosis. PI 
staining of the DNA is used to distinguish between cells with intact and 
compromised membranes (Nicoletti et al., 1991).
H20 2-treated cells were allowed to recover for 2 h before being labelled with 
Annexin V and PI. Controls for apoptosis were staurosporine treatment (Nicotera et 
al., 1999) and briefly heated THP-1 cells for necrosis. In this assay, apoptosis is 
defined by positive Annexin V staining and lack of PI uptake, while necrosis is 
defined by positive Annexin V staining and uptake of PI (Fig. 3.8A). With these 
markers, it is not possible to distinguish between normal necrosis and secondary 
necrosis. Secondary necrotic cells are late apoptotic cells and can be distinguished 
by the presence of nuclear condensation and/or fragmentation along with PI uptake 
(Kelly et al., 2003).
The assay revealed no significant increase in apoptosis or necrosis for 
THP-1 cells at working concentrations of H20 2 (Fig. 3.8). THP-1 cells showed an 
increase in necrosis from 50 mM H20 2 upwards. CCRF-CEM cells were more 
susceptible to the damaging effects of H20 2, showing an increase in necrosis, with
22.4 ± 4.9% at 5 mM compared to 6.4 ± 0.3% at 0 mM H20 2. Results with 5 mM 
H20 2 on CCRF-CEM cells should therefore be treated with caution.
101
3 Results
1 cells
TLM
mM H2O2
C) THP-1 cells 
_  120-|
E) CCRF-CEM cells 
100 1
TLM
pM H2O2
Transwell
mM H2O2
B) CCRF-CEM cells 
100 TLM
mM H2O2 0 0.1 
D) THP-1 cells
3  1001 Transwell
mM H2O2 0 0.1 0.5 1
F) THP-1 cells, no HUVECs 
_  120 1 Transwell
« 60 "
m 20 “
mM H2O2
Figure 3.7: H20 2 decreases THP-1 and CCRF-CEM cell TEM
THP-1 and CCRF-CEM cells were treated with 0 - 100 |jM H20 2 or 0 - 5 mM H20 2 
(30 min, 37°C). H20 2 was removed by centrifugation and cells were added to 
HUVECs for 2 h. TEM rate was normalised to untreated samples. THP-1 (A, C) and 
CCRF-CEM (B) cell TEM across HUVECs was monitored by TLM and movies were 
analysed to calculate TEM rate, n = 7 (A); 5 (B); 3 (C). THP-1 (D) and CCRF-CEM 
(E) cell TEM across HUVECs was detected using a Transwell™-based system. 
Transmigrated cells from the lower chamber were counted after 2 h. n = 6 (D) or 
5 (E). Migration across a VCAM-1-coated Transwell™ filter (F) was determined by 
counting cells from the lower chamber after 2 h of transmigration, n = 5.
Results are normalised to untreated control. Bars represent SEM. ★★★ p < 0.001, 
★ ★ p < 0.01, ★ p < 0.05 determined by Student’s t-test and Bonferroni post-test, as 
compared to untreated control.
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3.5 TEM of T lymphoblasts and primary monocytes is not significantly
altered after H2O2 treatment
To investigate if primary leukocytes had the same response to H20 2 as leukaemic 
cell lines, T lymphoblasts and primary monocytes were subjected to H20 2 treatment 
and subsequent TLM-based TEM assays. The two cell types displayed different 
susceptibility to oxidative damage after H20 2 treatment as determined by Trypan 
blue staining. Trypan blue is a diazo dye that is excluded from cellular uptake in 
viable cells, but stains dead cells (Rodrigues et al., 2007). Different H20 2 
concentrations were chosen for the TEM assays. T cells were treated with 
concentrations ranging from 0 -  500 pM H20 2, which is lower than the range used 
for THP-1 cells, but overlaps with concentrations that reduce TEM in THP-1 cells. 
T cells died at concentrations higher than 500 pM. Control T cells transmigrated at a 
high rate of up to 48.3 ± 5.5% (compared to THP-1 cells at 16.3 ± 2%; see Fig. 4.8) 
and exhibited a highly polarised morphology with long tails (Fig. 3.9A, B). The 
analysis of the movies showed a trend towards a decrease in TEM for high 
concentrations, but these results were not statistically significant due to the high 
variability between assays (Fig. 3.9E).
Primary monocytes were even more susceptible to the toxic effects of H20 2 
and lower concentrations from 0 -  60 pM were therefore used. These 
concentrations have been shown to have no effect on THP-1 cells (Fig. 3.7C). 
Primary monocyte TEM rate for untreated cells was 11.1 ± 3%, similar to THP-1 
cells (see Fig. 4.8). The cell morphology was relatively rounded throughout the 2 h 
of recording (Fig. 3.9C, D). Again, a trend towards a decrease in TEM was 
detectable, but due to the high variability, changes were not statistically significant 
(Fig. 3.9F).
Together these data indicate a trend towards a reduction in TEM for primary 
leukocytes, although they are more susceptible to the toxic effects of H20 2 and 
show a higher variability in the transmigration rate than leukaemic cell lines.
103
3 Results
A) unlabelled B) apoptosis control C) necrosis control D) 0 mM H20 2
,510’
Q210
a
04Q3o
100%
o I0J i o' to’
to5
la*
1% (jts 21 %
M.'
2 5 % 5 3 %
3 % , w j ■to 96%
0.3% 0.7%
to3
^  5%
91 %
' f '
4 %
Annexin V
E) 0.5 mM H20 2 F) 1 mM H20 2
10*
2 mM H20 2
to5 1 %
^  9%
■*
85% 6%
to' to’ to 10* 18'  10'
■ 12  %
10* # 10* to4 10s
H) 5 mM H20 2
I) THP-1 cells
■  apoptosis
■  necrosis
50 -I
mMHjOj A N 0 0.1 0.5 1 2 5 10 25 50 100
J) CCRF-CEM cells 
1 0 0 ★ ★ ■  apoptosis
■  necrosis
S 3 0 -
9- 10
mM H2Q2 A
2%
w.
• ^  22 %
■ 1 ■.. \
70%---- r-1— V ,ft,%
10 10 10 10* 10 10
Figure 3.8: Working concentrations of H20 2 do not induce a significant 
increase in apoptosis or necrosis
Cells were treated with H20 2 concentrations from 0 - 1 0 0  mM or 0 -  5 mM (30 min, 
37°C) and allowed to recover for 2 h. Controls for apoptosis (A) were cells treated 
with staurosporine (1 pM, 2.5 h, 37°C) or cells briefly heated for necrosis (N). The 
apoptosis and necrosis rates were determined by Annexin V-binding and PI staining 
respectively, which were detected by FACS analysis. A -  H: Representative FACS
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dot plots from CCRF-CEM cells. Quadrant 3 (Q3) represents viable cells (AnnexinV 
and PI negative), quadrant 4 (Q4) represents apoptotic cells (AnnexinV positive and 
PI negative) and quadrant 2 (Q2) represents necrotic cells (AnnexinV and PI 
positive). I: Graphical display of all apoptosis/necrosis assays for THP-1 cells, n = 7. 
J: Graphical display of all apoptosis/necrosis assays for CCRF-CEM cells, n = 3. 
Bars represent SEM.** p < 0.01, ★ p < 0.05 determined by Student’s t-test and 
Bonferroni post-test, as compared to untreated control.
3.6 Adhesion to HUVECs is increased after H2O2 treatment
Adhesion to the endothelium is the first step of TEM and a necessity for subsequent 
steps of TEM. A defect in adhesion will therefore lead to a defect in transmigration. 
To dissect which steps of TEM are affected by H20 2, the adhesive properties of 
H20 2-treated leukocytes were first investigated. THP-1 and CCRF-CEM cells were 
incubated with 0 - 5  mM H20 2 and adhesion to VCAM-1 and ICAM-1 was measured 
in a plate-reader-based assay. THP-1 cells did not show a change in adhesion to 
VCAM-1 and ICAM-1 after H20 2 treatment (Fig. 3.10A). CCRF-CEM cells showed a 
trend for increased adhesion to both substrates for concentrations up to 2 mM with 
a maximum increase of 53.3 ± 35.2 % (0.5 mM H20 2 on ICAM-1), but due to the 
high variability between assays the results were not statistically significant. The 
lower adhesion at 5 mM can be explained by the detected increase in necrosis in 
CCRF-CEM cells at this concentration (Fig. 3.8). To be able to compare level of 
adhesion to the two substrates the data are also displayed as total number of cells 
binding (Fig. 3.10C). Both cell types bind to ICAM-1 and VCAM-1, but with a 
preference for VCAM-1.
To investigate whether adhesion to the endothelium was altered in H20 2- 
treated cells, the adhesion of H20 2-treated THP-1 and CCRF-CEM cells to a 
HUVEC monolayer was determined (Fig. 3.10D). The adhesion of THP-1 cells was 
significantly increased for 0.5 and 2 mM H20 2, by 24 ± 5.7% and 13.1 ± 2%, 
respectively. CCRF-CEM cells displayed a higher significant increase in adhesion, 
which was 48.3 ± 13% at 0.1 mM H20 2 (Fig. 3.10E). The decrease in adhesion at 
5 mM can be disregarded as being due to an increase in cell death (see Fig. 3.8J).
These data indicate that the interaction between leukocytes and HUVECs is 
influenced by H20 2, leading to an increase in adhesion.
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Figure 3.9: Effects o f H20 2 on TEM of T lymphoblasts and monocytes
T lymphoblasts and monocytes were treated with H20 2 (30 min, 37°C): 
T lymphoblasts: 0 -  500 pM; monocytes: 0 - 6 0  pM. H20 2 was removed by 
centrifugation and cells were added to a TNF-a-activated (10 ng/ml, 15 - 18 h) 
HUVEC monolayer for 2 h. TEM rate was determined by TLM. Phase-contrast 
images of untreated T lymphoblasts and monocytes after 5 (A, C) and 120 min (B, 
D) are taken from movies (1 frame/min) started 10 min after cell addition. Arrows 
indicate examples of transmigrated cells. Bar = 50 pm. E, F: Graphical illustration of 
results from all T lymphoblast and monocyte transmigration experiments. Results 
are normalised to untreated control. Bars represent SEM. n = 3.
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Figure 3.10: THP-1 and CCRF-CEM cell adhesion to HUVECs is increased by 
H20 2 treatment
THP-1 and CCRF-CEM cells were labelled with green CellTracker™ dye (1 pM, 30 
min, 37°C), cells were washed and treated with 0 - 5  mM H20 2 (30 min, 37°C). 
Cells were washed and allowed to adhere for 15 min to either VCAM-1- or ICAM-1 - 
coated 96-well plates or TNF-a-activated (10 ng/ml, 15 - 18 h) HUVECs. Unattached 
cells were washed off and fluorescence was measured using a Fusion™ a-FP plate 
reader. THP-1 (A) and CCRF-CEM (B) cell adhesion to VCAM-1- and ICAM-1- 
coated 96-well plates, n = 4. C: Total numbers of THP-1 and CCRF-CEM cells 
adhering to VCAM-1- and ICAM-1. n = 4. Error bars are omitted for clarity. D, E: 
THP-1 and CCRF-CEM cell adhesion to HUVECs. n = 3.
Results are normalised to respective untreated control. Bars represent SEM. 
★ ★ p < 0.01, ★ p < 0.05 determined by Student’s t-test and Bonferroni post-test, as 
compared to untreated control.
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3.7 Integrin level and activity are not significantly changed upon H2O2
treatment of THP-1 cells
Circulating leukocytes maintain their integrins in a largely inactive state in order to 
prevent binding at sites other than inflammation or injury. Integrin activation is 
triggered by chemokine-induced (‘inside-out’) and ligand-induced (‘outside-in’) 
conformational changes from low-affinity to high-affinity state (Alon and Dustin, 
2007).
To determine if alterations in integrin surface levels and activity play a role in 
the observed changes in adhesion, the cell surface levels of (31 and (32 integrin in 
H20 2-treated THP-1 cells were determined by FACS analysis. The analysis shows 
that cell surface levels did not change upon the treatment (Fig. 3.11 A). Antibodies 
that specifically recognize activated (31 and (32 integrins were used for FACS 
analysis; as positive (pos) and negative (neg) controls for integrin activation cells 
were treated with Mn2+ and EDTA respectively. Exposure to Mn2+ mimics the high 
affinity ligand-bound form, whereas EDTA chelates cations (mainly Mg2+) necessary 
for integrin activity (Dransfield et al., 1992). The results show some variation in (32 
activity, but these changes are not significant (Fig. 3.11B). The activity of (31 integrin 
was unchanged (Fig. 3.11C).
These data indicate that the observed TEM defect is unlikely to be due to a 
change in the cell surface level or activity of (31 and (32 integrins.
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Figure 3.11: Integrin levels and activity are unchanged upon H20 2 treatment of 
THP-1 cells
THP-1 cells were treated with 0 - 5  mM H20 2 (30 min, 37°C) and integrin levels 
were determined by FACS analysis using specific antibodies for total and active (31 
and (32 integrin. A: Total surface level of (31 and (32 integrin. n = 4. B, C: Positive 
(pos) and negative (neg) controls for active (32 (B) and (31 (C) integrin labelling were 
cells treated with 200 pM Mn2+ or 5 mM EDTA respectively. (31 integrin-labelled cells 
were fixed prior to staining with antibodies, n = 8 (B); 5 (C).
Results are normalised to respective untreated control. Bars represent SEM.
3.8 H20 2 treatm ent increases THP-1 cell m o tility  on HUVECs
To identify possible mechanisms involved in the TEM defect caused by H20 2, some 
of the time-lapse movies of THP-1 cells were analysed further. Fifteen THP-1 cells 
per condition and experiment were tracked on the surface of HUVECs and tracks 
were analysed using a Mathematica notebook written by D. Zicha (Allen et al., 
1998). The migration tracks are shown as vector plots with all tracks beginning at 
the origin (0,0) of a Cartesian coordinate system (Fig. 3.12). The coloured bars 
represent the time, starting at the left hand side.
The distance migrated and total displacement was determined from the 
migration tracks, and migration speed and persistence were calculated (Fig. 3.13). 
The distance migrated by H20 2-treated was significantly increased at 1 mM H20 2 
(441 ± 52 pm, 127 ± 10.4% of untreated), while the displacement was significantly
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increased at 2 mM H20 2 (96.1 ± 8.23 pm, 123 ± 8.8 % of untreated). The distance 
and displacement decreased for high concentrations to 378 ± 49.5 pm (117 ± 13.3% 
of untreated) and 79.2 ± 12.6 pm (98.8 ± 16.3% of untreated). The migration speed 
(Fig. 3.13C), which is calculated from the distance and time, ranges from 
1.38 ± 0.08 pm/min (0 mM H20 2) to a maximum of 1.87 ± 0.17 pm/min (0.5 mM 
H20 2; 136.7 ± 13% of untreated) and decreased for high levels to a minimum of 
1.63 ± 0.11 pm/min (2 mM; 119.3 ± 8.1% of untreated). The persistence was 
calculated as displacement divided by distance, the values lie therefore between 0 
and 1; 0 represents circular migration, whereas 1 represents migration in a straight 
line. The persistence for THP-1 cells migrating on a HUVEC monolayer did not 
change significantly with H20 2 treatment and lay between 0.22 ± 0.01 and 
0.28 ± 0.02, indicating that they turn regularly (Fig. 3.13D).
Together these data provide evidence that the observed TEM defect is not 
due to a general migration defect. On the contrary, the motility of H20 2-treated 
THP-1 cells was significantly increased, as was the distance migrated and the total 
displacement. The mechanisms involved in cell turning were not influenced by H20 2, 
as seen from the unchanged persistence.
It is worth noting that all adhesion and motility effects were highest for 
intermediate H20 2 concentrations unlike TEM itself which shows strongest effects 
for high H20 2 concentrations. This will be further discussed in Chapter 4.
3.9 Data spread for TEM and adhesion assays
To illustrate the actual percentage of leukocytes transmigrating or adhering to 
substrate and the endothelium, Box-and-Whisker plots were constructed for 
untreated THP-1 and CCRF-CEM cells. The Box-and-Whisker plot for THP-1 cells 
illustrates, that transmigration was more efficient in the TLM-based TEM assay, but 
with higher variability than the Transwell™-based system (Fig. 3.14A). All adhesion 
assays had high variability; the adhesion to VCAM-1 was highest, intermediate to 
HUVECs and lowest to ICAM-1. CCRF-CEM cells had comparable levels of TEM for 
TLM- and Transwell™-based TEM assays, but variability was higher for the 
Transwell™-based assay (Fig. 3.14B). Adhesion was low compared to THP-1 cells 
for substrates, as well as adhesion to HUVECs. Levels of adhesion were similar for 
VCAM-1 and HUVECs, whereas adhesion to ICAM-1 was low. The variability was 
lower for CCRF-CEM cells, compared to THP-1 cells.
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Figure 3.12: Analysis of THP-1 cell migration on HUVECs
THP-1 cells were treated with 0 - 5  mM H20 2 (30 min, 37°C), added to TNF-a-
activated (10 ng/ml, 15 -18 h) HUVECs and monitored using time-lapse microscopy 
(1 frame/min) for 2 h. 15 randomly chosen THP-1 cells per movie were tracked with 
Motion Analysis software (Andor Biotechnology) and tracks were analysed using a 
Mathematica notebook written by Dr D. Zicha. A -  F: Representative migration 
tracks for treated and untreated THP-1 cells are shown as vector plots with tracks 
beginning at the origin of a Cartesian coordinate system. The migration tracks are
colour coded to indicate the progression during the movie.
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Figure 3.13: H20 2 treatment increases THP-1 motility on HUVECs
Histograms with two y-axes are shown, the black bars represent ‘percentage of 
untreated’ (left axis), while the diamonds represent pm or pm/min (right axis). 
Distance migrated (length of track) and the total displacement (direct distance from 
start to endpoint) was determined from the migration tracks of H20 2-treated THP-1 
cells on TNF-a-activated (10 ng/ml, 15 -18 h) HUVECs (A, B). The migration speed 
(C) and the persistence (D) were calculated from these measurements. The 
persistence is defined as the displacement/distance; it is 0 for migration in a 
complete circle and 1 for migration in a straight line, n = 7 with 15 cells/experiment. 
Results are normalised to untreated control. Bars represent SEM. ★ p < 0.05 
determined by Student’s t-test and Bonferroni post-test, as compared to untreated 
control.
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Figure 3.14: Data spread for TEM and adhesion in THP-1 and CCRF-CEM cells
The box-and-whisker plots illustrate the data range for untreated THP-1 (A) and 
CCRF-CEM cells (B) in TEM and adhesion experiments as percentage of input. The 
horizontal bar indicates the median, the box indicates the upper and lower quartile, 
and the vertical bars the largest and smallest observation, n £ 4.
3.10 THP-1 cell morphology on substrate is not altered
To understand the effect of H20 2 on leukocytes, the morphology of treated THP-1 
cells was assessed. To this end, THP-1 cells were incubated with varying H20 2 
concentrations, allowed to adhere to VCAM-1 coated coverslips and stained for 
F-actin and tubulin (Fig. 3.15). Most THP-1 cells did not exhibit a very polarised 
phenotype with a clear lamellipodium and uropod. This morphology seems to be 
typical for THP-1 cells, as it was also observed in the time-lapse movies of 
untreated THP-1 cells. The immunofluorescence images did not reveal a clear 
trend, although differences in the actin cytoskeleton and microtubule network could 
be observed. All samples had cells with actin accumulations at multiple sites around 
the cell, which are likely to be the dynamic protrusions that were observed in the 
time-lapse movies. Samples treated with 1 -  2 mM H20 2 seemed to have ruffles 
around the cells, which were less frequent in other samples. The microtubule 
network appeared to be denser and less organised in the cells treated with 5 mM
h2o 2.
This data indicates that the overall actin organisation is not influenced by 
H20 2, whereas the microtubule network is.
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3.11 H2O2 treatment might lead to a decrease in THP-1 cellular 
protrusions
During TEM leukocytes extend cellular protrusions to probe the endothelium for 
suitable sites of diapedesis (see Fig. 3.3). These exploratory protrusions can be 
retracted or developed into lamellae which allow the cells to transmigrate. These 
protrusions are therefore important structures and impairment of their development 
could lead to a decrease in TEM. During the process of protrusion extension and 
lamella development, LFA-1 plays a prominent role. Therefore, H20 2-treated and 
CellTracker-stained THP-1 cells were allowed to transmigrate across a HUVEC 
monolayer, before the cells were fixed and stained for LFA-1 and F-actin. The 
immunofluorescence images show LFA-1 localisation in the cell protrusions 
underneath the HUVECs as well as in the cell body above the endothelium (Fig. 
3.16). White arrows indicate areas of ring-like LFA-1 clusters at the leukocyte- 
endothelial interface. More of these accumulations could be detected with 
increasing H20 2 concentration. The LFA-1 staining as well as the CellTracker™ dye 
labelling possibly suggests a decrease in the number of cells with protrusions (red 
arrowheads) with increasing H20 2 concentration. Quantification of the number of 
cells with protrusions should be carried out to confirm these preliminary 
observations.
This potential decrease in cellular protrusions could to play a crucial role in 
the decrease of leukocyte TEM after H20 2 treatment.
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Figure 3.15: The actin cytoskeleton is not altered by H20 2
THP-1 cells were treated with 0 - 5  mM H20 2 (30 min, 37°C). H20 2 was removed 
and cells were allowed to adhere to VCAM-1-coated coverslips. After 60 min, cells 
were fixed and stained for F-actin and tubulin. Bar = 20 pm.
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Figure 3.16: LFA-1 staining of H20 2-treated THP-1 cells on HUVECs
THP-1 cells were labelled with green CellTracker™ dye (1 pM, 30 min, 37°C), 
treated with 0 - 5  mM H20 2 (30 min, 37°C) and added to TNF-a-activated (10 ng/ml, 
15 - 18 h) HUVECs for 25 min before cells were fixed and stained for LFA-1 and 
F-actin. White arrows indicate LFA-1 accumulation, red arrowheads indicate cells 
with protrusions. Bar = 20 pm.
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3.12 HUVEC monolayer permeability is increased when H202-treated 
THP-1 cells are bound
Endothelial cell-cell junctions need to be disrupted when leukocytes transmigrate 
using the paracellular route. THP-1 cells exclusively use the paracellular pathway 
(see Chapter 3.2.3); endothelial junction remodelling therefore is a critical event 
during TEM. If the ability to induce reversible opening of adherens junctions in 
endothelial monolayers was impaired in H20 2-treated THP-1 cells, the resulting 
transmigration rate would be decreased. To test if bound H20 2-treated THP-1 cells 
are able to induce a reversible reorganisation of endothelial junctional structures, 
VE-cadherin and F-actin staining of transmigrating THP-1 cells was carried out. In a 
co-culture with untreated THP-1 cells, VE-cadherin was localised in reticular (red 
arrowheads) as well as non-reticular junctions (Fig. 3.17A). Reticular junctions have 
been described as PECAM-1-bearing membranes that can serve as a recycling 
compartment (Mamdouh et al., 2003). The arrows indicate sites of transmigration 
where VE-cadherin is reorganised. Non-quantitative analysis of the 
immunofluorescence images showed few gaps between ECs (white arrow heads) 
with untreated THP-1 cells. For H20 2 concentrations of 0.5 and 1 mM a decrease in 
the width of the junctions, hence fewer reticular junctions, might be observed 
(Fig. 3.17D, G). Concurrently, the number of gaps between cells at sites without 
transmigrating cells appears to be increased. For 5 mM H20 2 the portion of reticular 
junctions was possibly increased, but at sites of non-reticular junctions more gaps 
between ECs appeared to open (Fig. 3.17J). The F-actin staining also showed this 
potential increase in gaps for HUVEC monolayers with H20 2-treated THP-1 cells 
(Fig. 3.17B, E, H, K; white arrow heads). H20 2-treated THP-1 cells also seemed to 
induce an increase in the formation of actin stress fibres in HUVECs.
These data possibly suggest a differential influence of H20 2-treated and 
untreated THP-1 cells on endothelial junction remodelling after leukocyte binding. 
However, this potential regulation is usually thought to support TEM and is therefore 
controversial to the observed decrease in TEM. Further investigations, including the 
role of reticular junction in TEM, the quantification of number of gaps and proportion 
of reticular to non-reticular junctions, are needed to confirm these preliminary results 
an to draw conclusions about their impact on THP-1 cell TEM.
To further investigate the influence of H20 2-treated THP-1 cells on HUVEC 
remodelling after leukocyte binding, a permeability assay was carried out. This 
assay measures paracellular integrity by applying fluorescently labelled dextran to 
the upper chamber of Transwells™ coated with a HUVEC monolayer. Samples from
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Figure 3.17: Modulation of endothelial adherens junctions after adhesion of 
H20 2-treated THP-1 cells
THP-1 cells were treated with 0 - 5  mM H20 2 (30 min, 37°C) and allowed to 
transmigrate across TNF-a-activated (10 ng/ml, 15 - 18 h) HUVECs. Cells were 
fixed and stained for VE-cadherin and F-actin. White arrows indicate VE-cadherin 
reorganisation at sites of THP-1 transmigration; red arrow heads indicate reticular 
junctions; white arrow heads indicate intercellular gaps. Bar = 40 pm.
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the lower chamber were taken and measured for fluorescence after 40 and 80 min 
(Fig. 3.18). The assay was carried out with either H20 2-treated or untreated THP-1 
cells and HUVECs alone as a negative control. Untreated THP-1 cells were able to 
increase the permeability by 28.1 ± 23.2% (40 min). H20 2-treated THP-1 cells 
increased the permeability even further, by a maximum of 154 ± 40.8% (1 mM H20 2; 
40 min). The increase in endothelial permeability with THP-1 cells treated with 
1 mM H20 2 was statistically significant, when compared to untreated THP-1 cells 
(40 min).
Together these results demonstrate that H20 2-treated THP-1 cells are 
capable of inducing adherens junction remodelling. In fact they induce stronger actin 
remodelling then untreated THP-1 cells, as becomes apparent from the increased 
number of gaps between neighbouring ECs. This was confirmed by the permeability 
assay, which demonstrated a significant increase in permeability between untreated 
and H20 2-treated THP-1 cells bound to the endothelium. This indicates that the 
decrease in TEM is not due to an inability of H20 2-treated THP-1 cells to remodel 
the adherens junctions and the endothelial actin cytoskeleton.
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Figure 3.18: Endothelial permeability is significantly increased when H20 2- 
treated THP-1 cells are bound
THP-1 cells were treated with 0 - 5  mM H20 2 (30 min, 37°C) and then added to 
TNF-a-activated (10 ng/ml, 15 - 18 h) HUVECs grown on Transwell™ filters. To 
determine monolayer permeability, 100 pg/ml FITC-dextran was added to the upper 
chamber and samples of media from the lower chamber were measured for 
fluorescence using a Fusion™ a-FP plate reader after 40 and 80 min. HUVECs 
without THP-1 cells were used as a control and samples were normalised to this. 
Significance was determined against samples without THP-1 cells unless otherwise 
indicated.
Results are normalised to untreated control. Bars represent SEM. n = 5. ★ p < 0.05 
determined by Student’s t-test and Bonferroni post-test, as compared to '- THP-1’ 
sample. # p < 0.05 determined by two-way ANOVA and Bonferroni post-test.
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3.13 Discussion
In this chapter, the experimental conditions for two in vitro TEM assays were set-up 
and used to assess the effects of H20 2 on leukocyte TEM. Adhesion, motility and 
integrin surface levels and activity of H20 2-treated cells were determined in the 
appropriate assays. Additionally, the morphology of H20 2-stimulated leukocytes 
their influence on endothelial actin reorganisation and monolayer permeability were 
also investigated.
All leukocytes tested, except MM6 cells, showed a trend of decreased TEM 
with increasing H20 2 level, but only the results for the cell lines THP-1 and CCRF- 
CEM were statistically significant. Primary cells displayed a higher variability in TEM 
rates, which makes it much harder to reach statistical significance, unless sample 
size is high. MM6 cells were non-transmigratory under the experimental settings 
used, although they have been reported to transmigrate by other groups (Weber et 
al., 1998), which may reflect experimental differences or differences in the cell line 
itself, which can occur with increasing length of culture. ROS have been shown to 
have multiple targets and effects (Droge, 2002). H20 2 could inhibit leukocyte TEM 
by direct modification of cell surface proteins or by inducing/inhibiting signalling 
pathways important for TEM, such as the regulation of actin dynamics (see 
Chapter 4). In future experiments it would be useful to perform a time course for the 
effects of H20 2 on TEM, to determine the time point where the maximum response 
can be reached. However, when performing this time course it has to be taken into 
account, that short-term (up to 2 h) and long-term treatment can have very different 
effects. While the effects of short-term treatment are more likely to involve early 
responses such as direct oxidative modification of molecules, e.g. inhibition of 
phosphatases and subsequent increase in phosphorylation, the effects of long-term 
treatment are more likely to involve changes in expression level as well as oxidative 
modifications. Since this study was more interested in short-term effects a time point 
of 30 min was chosen, that was sufficiently long to allow the development of those 
early responses. An additional limitation to the approach taken is to look at one time 
point of TEM only. For future experiments it could be interesting to look at longer 
time points to see if the H20 2-treated THP-1 cells eventually transmigrate and only 
display a delay or if the decrease in TEM is irrevocable.
Different leukocytes displayed varying susceptibility to the oxidative damage 
caused by H20 2. The leukaemia cell lines THP-1 and CCRF-CEM showed low 
susceptibility, whereas the primary cells were damaged at lower H20 2 
concentrations. It remains to be determined if these discrepancies are due to cell
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type differences or arise from the fact that the less sensitive cells are leukaemia cell 
lines. Cancer cells have been shown to have increased ROS production, but also 
display upregulation of antioxidant enzymes such as Catalase, MnSOD and 
CuZnSOD (Chowdhury et al., 2007; Kattan et al., 2008; Trachootham et al., 2006). 
Cancer cells, including the leukaemia cell lines tested here, might therefore be 
better prepared to deal with exogenous H20 2 than non-cancerous cells.
Previous studies have shown that in THP-1 cells, overexpression of UCP2, a 
protein belonging to the mitochondrial anion carrier family, reduces the steady state 
level of intracellular ROS (Ryu et al., 2004). Overexpression reduced (32 integrin- 
mediated firm adhesion and TEM across human aortic endothelial cells (HAEC). 
These TEM results are inconsistent with the H20 2-dependent decrease in leukocyte 
TEM observed in the present study. These apparent differences could be due to 
differences in the EC type, but more importantly, overexpression of UCP2 might 
induce changes in addition to the reported changes in ROS level that influence 
adhesion and TEM. If a decrease in intracellular ROS indeed decreases adhesion 
and TEM (Ryu et al., 2004), it would be predicted that the application of H20 2 would 
lead to increased adhesion and TEM. The former is true for H20 2-treated THP-1 as 
well as CCRF-CEM cells; but the latter was reduced. This could be due to the 
interdependency of adhesion and diapedesis. While adhesion is independent of 
TEM, diapedesis depends on successful adhesion. It is therefore inevitable that 
defects in adhesion will ultimately lead to a diapedesis defect. The reverse 
conclusion that H20 2 should lead to an increase in adhesion and a decrease in 
diapedesis is therefore not necessarily tenable.
The findings from Ryu et al. (2004) are mainly interpreted as being 
dependent on the decrease in (32 integrin levels caused by the reduced intracellular 
ROS level. It has been shown for PMNs that ROS lead to an upregulation of CD18 
((32 integrin) and CD11b within 15 min (Fraticelli et al., 1996). The upregulation is 
accompanied by shedding of L-selectin from the surface and 0.1 mM H20 2 is 
sufficient to exert the effects. This is contrary to findings of the present study, where 
(32 and (31 integrin surface levels were unchanged after H20 2 treatment. Since the 
upregulation of surface integrins reported by Fraticelli et al. occurs within 15 min it is 
probable that increased delivery of integrin-containing vesicles is responsible for this 
effect, rather than upregulation of gene expression. FACS analysis in the present 
study has shown that in THP-1 cells, (31 and (32 integrin levels are high compared to 
CCRF-CEM. This could indicate that a high proportion of the total pool of integrin 
molecules is located at the plasma membrane and therefore H2Q2-induced delivery
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of vesicles would not lead to an increase in integrin level. The reported upregulation 
of integrin gene expression (Ryu et al., 2004) has not been detected by the FACS 
analysis at the timepoints tested here. It would therefore be interesting to look at the 
integrin levels at later time points, e.g. 6 h after H20 2 treatment.
In control cells, (31 and (32 integrins were mainly inactive. The activity of (32 
integrin showed some variability with H20 2 treatment, while (31 activity remained 
unchanged. Other integrins would need to be investigated to determine changes in 
surface levels and activation, since small changes in multiple integrins could lead to 
the observed changes in adhesion. Activation of VLA-4 has been shown to be 
directly dependent on redox modification of the a4 subunit (Liu et al., 2008). Ligand 
binding of VLA-4 induces exposure of a thiol group and subsequent 
S-glutathionylation in the presence of H20 2 and GSH, which plays a role in integrin 
activation.
Interestingly, only adhesion to the endothelium was increased, whereas no 
change could be observed for adhesion to VCAM-1 or ICAM-1. These data indicate 
that the endothelium provides particular conditions that can be utilised by H20 2- 
treated cells to strengthen their adhesion, which are not present on substrate. 
These could include clustering of ICAM-1 and VCAM-1 on the endothelial surface 
and/or chemokine presentation. How H20 2-treated leukocytes increase their 
adhesion remains to be determined, but chemokine signalling leading to integrin 
activation could play a role. The activation status of leukocyte integrins could thus 
be changed in H20 2-treated cells only when bound to the endothelium, but not in 
suspension as was tested in this study.
The signalling events involved in mediating leukocyte adhesion have been 
extensively studied. The H20 2-mediated increase in adhesion could be dependent 
on the activation of the FAK family member Pyk2, which has been shown to be 
activated by ROS (Frank et al., 2000). The signalling involved in the H20 2-mediated 
TEM defect in THP-1 cells will be discussed in Chapter 4.
To determine if the TEM defect in H20 2-treated THP-1 and CCRF-CEM cells 
was due to the compromised ability to deform the cell, e.g. by remodelling the actin 
cytoskeleton, a Transwell™-based TEM assay without HUVECs was carried out. 
The results demonstrate that the ability of cells to deform in order to transmigrate 
through confined spaces was not compromised. In addition, the actin cytoskeleton 
of H20 2-treated THP-1 cells on VCAM-1 did not appear to be changed. However, 
further investigations, including quantifications of actin structures are needed to 
draw firm conclusions about any changes to the actin cytoskeleton. Findings by
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others have suggested a role of ROS in a variety of actin-based mechanisms in 
various cell types. For example Perez et al. proposed a role for ROS in the induction 
of actin-cytoskeletal rearrangements and tight-junction impairment in rat 
hepatocytes in a PKC-mediated and Ca2+-dependent mechanism (Perez et al., 
2006). It is worth mentioning that hepatocytes are slow moving cells, whereas 
leukocytes are fast moving, which might require a different regulation of the actin 
cytoskeleton. In ECs, H20 2 induces formation of focal adhesion complexes and a 
major reorganisation of the actin cytoskeleton, causing the disappearance of 
membrane ruffles with disruption of cortical actin filaments and formation of a dense 
transcytoplasmatic stress fibre network (Huot et al., 1998). Since THP-1 cells are 
not very spread, displaying only cortical F-actin and do not form obvious ruffles actin 
changes are more difficult to detect. Investigating the distribution of actin-regulating 
proteins in H20 2-treated THP-1 cells could allow us to analyse further whether H20 2 
regulates the actin cytoskeleton in THP-1 cells.
Although no obvious difference in the actin cytoskeleton was detectable in 
cells adherent to ICAM-1 and VCAM-1, the increased motility of THP-1 cells on 
endothelium at intermediate H20 2 concentrations suggests H20 2-induced changes 
in actin dynamics. The role of H20 2 in regulating actin cytoskeletal dynamics and 
cellular motility has been the subject of many studies. ROS can affect the activity of 
signalling pathways by direct modification of regulatory proteins via disulphide bond 
formation, nitrosylation, carbonylation or glutathionylation (England and Cotter, 
2005). Actin can also undergo direct redox regulation by glutathionylation of Cys374 
during integrin-mediated cell adhesion in NIH-3T3 fibroblasts (Fiaschi et al., 2006). 
The impairment of this redox modification leads to the inability of cells to spread and 
organise the cytoskeleton in response to ECM and the inhibition of the disassembly 
of the actomyosin complex. These findings suggest that this redox modification is a 
key step in the dynamic contraction of the actin cytoskeleton during cell spreading. 
Moldovan et al. showed that migrating ECs produce ROS, which contribute to the 
actin cytoskeletal reorganisation required for migration (Moldovan et al., 2000). 
Their results suggest that ROS induce the uncovering of new barbed ends, thereby 
increasing the actin polymerisation rate. The positive regulation of cell motility 
observed in the present study is therefore in accordance with findings from other 
groups, although the exact mechanisms involved in THP-1 cells remain to be 
determined.
Cell migration also involves reorganisation of the microtubule network 
(Watanabe et al., 2005). During leukocyte TEM the relatively rigid microtubules are
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retracted into the uropod to increase the deformability of the cells and to facilitate 
their migration through confined spaces (Ratner et al., 1997). Preliminary and non- 
quantitative data suggest that microtubules are altered in H20 2-treated THP-1 cells 
on VCAM-1. Not much is known about the effects of ROS on the microtubule 
network and most studies have been carried out in porcine brain. There, tubulin has 
been shown to be oxidised by peroxynitrite, leading to a dose-dependent inhibition 
of microtubule polymerisation (Landino et al., 2002). Cysteine oxidation of Tau and 
microtubule-associated protein-2 (MAP-2), two neuron-specific MAPs, has been 
reported in response to peroxynitrite and H20 2 (Landino et al., 2004). This cysteine 
oxidation prevents the assembly of microtubules in porcine brain extracts. These 
results are contrary to findings in the present study, where there appear to be more 
microtubules after H20 2 treatment. The differences could be attributed to the 
different cells types used, as it is known that the effects of ROS can depend on the 
cell type (Droge, 2002). Rho GTPases have been implicated in the regulation of 
microtubule dynamics during cell migration (Watanabe et al., 2005). If and how Rho 
GTPases are affected by H20 2 treatment in THP-1 cells will be determined in the 
next chapter. Quantification of the immunofluorescence images should reveal if 
H20 2 induces a change in the microtubule network. How the observed changes in 
microtubule network integrate into the H20 2-induced TEM defect remains to be 
determined.
It appears that H20 2 has multiple effects on THP-1 cells, regulating cell 
motility, adhesion and TEM. The interdependency of these events and the sensitive 
regulatory mechanisms make TEM a highly adaptable process, but also renders it 
susceptible to environmental influences such as exogenous H20 2.
It is noticeable that changes in adhesion and migration speed follow the 
same pattern, both display a peak at intermediate H20 2 concentration followed by a 
decrease to approximate control levels at high H20 2 concentrations. The 
interdependency of migration speed and adhesion strength has been well studied. 
DiMilla et al. proposed a mathematical model which predicted that migration speed 
would exhibit a biphasic response to increasing adhesion strength (DiMilla et al., 
1991). This model has since been experimentally confirmed by modulating ECM 
ligand density, integrin expression levels or integrin-ECM affinity (DiMilla et al., 
1993; Huttenlocher et al., 1996; Palecek et al., 1997). The increased migration 
speed observed in the present study could therefore be a result of the increased 
adhesion to the endothelium, optimising the conditions for a higher migration 
velocity.
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The increased cell motility at intermediate H20 2 concentrations did not affect 
the migration persistence, i.e. the turning frequency of the cells, leading to greater 
displacement from the migration origin. The unchanged persistence indicates that 
the regulatory mechanisms involved in cellular turning are not affected by H20 2 
treatment. The increased migration speed might contribute to the TEM defect, by 
preventing the probing of the endothelium for suitable sites of diapedesis. This 
process might be less efficient when cells migrate faster, leading to a decrease in 
TEM. The leukocytes probably have to slow down or arrest to extend the 
exploratory protrusions which are necessary for TEM. However, migration was only 
significantly increased at intermediate H20 2 concentrations, while TEM was 
significantly decreased at concentrations £ 0.1 mM, indicating that other regulatory 
mechanisms are playing a role.
The importance of cellular protrusions for TEM was further investigated. 
Preliminary and non-quantitative date suggests a dose-dependent decrease in 
cellular protrusion in H20 2-treated leukocytes when bound to HUVECs. Migrating 
THP-1 cells do not normally exhibit typical lamellipodia or filopodia, which 
complicates the characterisation of cellular protrusions. Cellular protrusions are 
essential for cell motility and are particular important during TEM where filopodia 
have an exploratory function (Barreiro et al., 2007). During transcellular TEM, 
podosomes play an important role in forming the transcellular pore (Carman et al., 
2007; Millan et al., 2006). The potential decrease in protrusions could play a crucial 
role in the H20 2-mediated TEM defect. Additionally, it might also contribute to the 
increase in migration speed. Although cellular protrusions, in particular the 
lamellipodium, are essential structures for migration, extensive protrusive activity 
might decrease migration velocity. This could be particularly true for exploratory 
protrusions that probe the endothelium for suitable sites of TEM. The potential 
decrease in protrusion formation will be further investigated in the next Chapter 4.
Preliminary and non-quantitative data suggest that binding of H20 2-treated 
THP-1 cells leads to alterations in the junctions of HUVECs. Reticular junctions 
appeared to increase with binding of H20 2-treated THP-1 cells. Reticular junctions, 
also termed the ‘subjunctional reticulum’, have been described as PECAM-1- 
bearing membranes that can serve as a recycling compartment (Mamdouh et al., 
2003). Other junctional proteins such as VE-cadherin and CD99 also localise to 
these structures. The role of these structures is unclear, but they have been 
suggested to play a role in endothelial barrier function (Millan et al. unpublished). 
This potential increase in reticular structures in HUVECs with H20 2-treated THP-1
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cells bound could therefore increase the endothelial barrier function and decrease 
TEM. However, preliminary and non-quantitative data suggest that HUVECs with 
H20 2-treated THP-1 cells also display more intercellular gaps. This could indicate 
that two different, H20 2-induced, mechanisms are acting on the HUVECs, one to 
induce the formation of reticular structures and another to induce retraction of the 
ECs, leading to intercellular gaps. The exact mechanism of how these two 
responses are induced remains to be determined.
ROS are known to induce a variety of biological responses (Droge, 2002; 
Veal et al., 2007). However, the responses are not only dependent on the type of 
ROS, but also the concentration. There are various examples, where differences in 
concentration can lead to different and sometimes opposing effects: while H20 2 
concentrations of up to 0.4 mM increase protein degradation, 1 mM H20 2 inhibits 
this process (Grune et al., 1997). Small amounts of damage, e.g. one or two 
oxidised amino acids, increase the proteolytic susceptibility, while damage further 
than an optimal degree (which is different for each protein) will lead to a decrease in 
protein degradation. Also, Sablina et al. have shown that while mild oxidative stress 
leads to p53-induced upregulation of several genes with antioxidant properties (e.g. 
SESN1 and SESN2, both encoding sestrins, and GPX1, encoding glutathione 
peroxidase 1), high levels of ROS induce upregulation of genes with pro-oxidant 
effects (e.g. TP53I3, encoding a quinine oxidoreductase homologue, or BBC3, 
encoding PUMA) (Sablina et al., 2005). In the latter study, H20 2 concentrations of 
up to 0.4 mM are considered mild oxidative stress, while 1 mM H20 2 is considered a 
high level. In cells, low micromolar concentrations (up to 10 pM) of ROS have been 
measured under physiological conditions (Deem and Cook-Mills, 2004; Nathan and 
Root, 1977). The exposure of cells to high micromolar and particularly millimolar 
concentrations of H20 2 are therefore unlikely to be physiological, but can prove 
useful to provoke a response. However, high H20 2 concentrations ( 1 - 5  mM) in this 
study might give rise to not only multiple, but also potentially opposite effects. 
Examples would be the potential induction of more gaps in the endothelial 
monolayer, while TEM is decreased.
H20 2-treated THP-1 cells bound to HUVECs not only seemed to induce 
more junctional gaps but also a higher increase in permeability than untreated THP- 
1 cells. Leukocyte binding has been shown to induce stress fibre formation in ECs 
(Millan and Ridley, 2004), and is often accompanied by an increase in endothelial 
permeability (Wedmore and Williams, 1981). The leukocyte-induced stress fibre 
formation is induced via a RhoA/ROCK and Ca2+-dependent MLCK-induced
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phosphorylation of MLC, and is important for leukocyte TEM (Adamson et al., 1999; 
Hixenbaugh et al., 1997; Huang et al., 1993; Wojciak-Stothard et al., 1999); (Millan 
et al., 2006). This pathway is activated by binding of leukocytes to ICAM-1 and 
VCAM-1 on the endothelial surface (Adamson et al., 1999; Thompson et al., 2002; 
Wojciak-Stothard et al., 1999), possibly via the involvement of ERM proteins 
(Barreiro et al., 2002; Bretscher et al., 2002). Clustering of VCAM-1 has also been 
shown to induce disruption of adherens junctions through Rac1 activation and 
subsequent ROS generation (Cook-Mills, 2002; van Buul and Hordijk, 2004), which 
has been reported to be necessary for TEM (Matheny et al., 2000; van Buul et al., 
2002). The concerted activation of RhoA and Rac1 in response to leukocyte 
engagement of ICAM-1 and VCAM-1, leading to actomyosin contractility and 
disruption of endothelial junctions, is therefore thought to facilitate leukocyte TEM. 
These events also seem to occur, and are probably even more pronounced, after 
binding of H20 2-treated THP-1 cells, but do not enhance THP-1 TEM. This 
emphasises the strength of the effects of H20 2 on THP-1 cells. The potential 
increase in stress fibres and intercellular gaps in the endothelium might arise due to 
the increased adhesion and migration on the endothelial surface, leading to 
increased ICAM-1 and VCAM-1 interactions and subsequent RhoA and Rad 
activation in the endothelium. Inadvertent carryover of small amount of H20 2 could 
also lead to the increase in stress fibres and intercellular gaps, as ROS have been 
shown to induce cytoskeletal rearrangements in ECs (Matheny et al., 2000).
Future experiments that lie outside of the time-frame of this study should use 
alternative approaches to investigate the role of ROS in leukocyte TEM. In 
particular, other ways to deliver and increase ROS in cells should be explored. 
These approaches could include the use of different ROS species and ROS delivery 
systems, e.g. the xanthine oxidase/hypoxanthine system. Xanthine oxidase uses 
hypoxanthine as substrate to produce 0 2', which subsequently becomes converted 
to H20 2 and OH' and ’OH (Sato et al., 2008). Additionally, H20 2 could be 
administered together with glucose oxidase. This approach allows the establishment 
of a steady-state level of H20 2, since glucose oxidase compensates for the H20 2 
loss by oxidising 0 2 to H20 2 (Antunes et al., 2001). Intracellular ROS could also be 
increased by knocking-down UCP2 using siRNA. Also, the transmigration behaviour 
of cells that have inhibited intracellular ROS production, e.g. the use of THP-1 cells 
transfected with siRNA against components of the NADPH oxidase (e.g. gp91phox or 
p47phox), or leukocytes from mice deficient in one these components, in response to 
H20 2 treatment could be studied. Other approaches to inhibit production or
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decrease levels of intracellular ROS are the overexpression of UCP2 or ROS- 
converting enzymes, such as Catalase. The effectiveness of these measures to 
increase/reduce ROS should be determined by using dyes that specifically measure 
intracellular ROS (see Chapter 4.6). The use of these alternative approaches should 
not only allow the confirmation of previous results with H20 2, but also elucidate 
more general aspects of how ROS regulates TEM or distinguish between specific 
roles of different ROS.
The results from this chapter show that H20 2 negatively regulates TEM in different 
cell types, which is probably due to effects on multiple stages of the TEM process, 
including adhesion, migration and protrusion formation. To further elucidate the 
mechanisms involved in H20 2-mediated decrease in TEM, the underlying signalling 
pathways will be assessed in the next chapter.
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4
Redox-signalling in leukocyte transendothelial 
migration
4.1 Introduction
The results from the previous chapter have shown that treating leukocytes with 
H20 2 inhibited TEM. H20 2 has been shown to induce a range of signalling 
processes (see Chapter 1.5.2.2), which could play a role in the observed TEM 
defect, including protein phosphorylation, activation of MAPK pathways, changes in 
intracellular Ca2+ levels and activation of transcription factors with subsequent 
transcriptional upregulation of target genes (Droge, 2002). Due to the length of the 
H20 2-treatment (30 min) and the immediacy with which the effects can be seen, it is 
likely that early signalling responses, involving non-transcriptional modifications, 
play an important role in mediating the TEM defect. These could include changes in 
protein phosphorylation, which is known to play a role in a wide range of signalling 
pathways. ROS have been shown to modify protein phosphorylation in two ways: by 
activating protein kinases, and by inhibiting protein phosphatases (Rhee et al.,
2000). One example of a ROS-regulated process involving inhibition of protein 
phosphatases is the Rac1-induced downregulation of RhoA: Rac1 induces ROS 
production via NADPH oxidase, which increases phosphorylation of p190RhoGAP 
by inhibiting the LMW-PTP, thereby reducing RhoA activity (Nimnual et al., 2003). 
Rho GTPases have additionally been shown to be ROS-regulated via direct 
oxidation of cysteine residues (Heo and Campbell, 2005).
Since ROS have been shown to play a role in the development of a variety 
of diseases, several clinical studies have been carried out involving the 
administration of antioxidants or ROS scavengers (Mandel et al., 2004; Slemmer et 
al., 2008). One commonly used antioxidant in clinical studies and basic research is 
the synthetic cysteine and GSH precursor NAC. NAC has been shown to increase 
intracellular GSH level and prevent ROS induced signalling (Hashimoto et al.,
2001). It was therefore interesting to investigate the effects of antioxidants, 
specifically NAC, under the experimental conditions set up in Chapter 3.
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A common feature of many vascular diseases is not only the contribution of 
ROS, but also RNS to vascular injury. Signalling pathways involving NADPH 
oxidase-derived ROS and NOS-derived RNS, in particular NO, have been shown to 
be linked in several processes, and ROS may participate in NF-xB-dependent 
upregulation of iNOS (Ginnan et al., 2008; Mendes et al., 2003). NO may play a role 
in TEM by modulating adhesion molecule expression level. Under basal conditions 
both nNOS- and eNOS-deficient mice exhibit significantly increased P-selectin 
expression levels, leukocyte rolling and adhesion, whereas iNOS-deficient mice do 
not (Lefer et al., 1999). NO constitutively produced by nNOS and eNOS therefore 
seems to inhibit P-selectin expression. In addition, neutrophil and T cell TEM has 
been shown to be negatively regulated by NO. Neutrophil TEM is at least partly 
inhibited by activating soluble guanylate cyclase (sGC) (Oka et al., 2005), while 
T cell adhesion and migration is reduced due to downregulation of MMP-9 
production and (31 integrin expression (Sun et al., 2006).
The aim of this chapter was to investigate the role of NO and H20 2-mediated 
signalling events in the observed TEM defect. In particular the involvement and 
regulation of Rho GTPases in H20 2-treated leukocytes was of interest, since Rho 
GTPases are key players in the regulation of TEM.
4.2 H202-induced secretion of anti-inflammatory mediators is not 
responsible for reduced TEM
Inflammatory mediators such as TNF-a and IL-1(3 alter endothelial morphology 
through changes in the actin cytoskeleton and the junctional composition, which 
leads to decreased barrier function, necessary for efficient TEM. Anti-inflammatory 
mediators, which increase endothelial barrier function, include nucleotides such as 
ATP, AMP or adenosine (Yegutkin, 2008), which can be secreted from a range of 
cells, including leukocytes.
To investigate if H20 2-induced secretion of anti-inflammatory mediators was 
responsible for the observed changes in TEM and adhesion, conditioned medium 
from H20 2-treated THP-1 cells was used in Transwell™-based TEM and adhesion 
assays. Neither TEM nor adhesion of untreated THP-1 cells were significantly 
changed by the presence of conditioned media over the duration of the assay 
(Fig. 4.1 A, B), in fact TEM was actually significantly increased at 5 mM H20 2.
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These results suggest that H20 2 did not induce secretion of anti­
inflammatory mediators. In fact, conditioned medium from THP-1 cells treated with
5 mM H20 2 induced an increase in TEM, indicating that the conditions for TEM are 
favourable, but defects in the H20 2-treated leukocytes are dominant in preventing 
TEM.
4.3 H2O2 has long-term effects on TEM and adhesion to HUVECs
To investigate the characteristics of the H20 2-induced TEM defect, long-term effects 
of transient H20 2 treatment on leukocyte TEM and adhesion were investigated. 
THP-1 cells were incubated for 30 min with H20 2 and then allowed to recover for 0,
6 or 12 h. After 6 h of recovery, the dose-dependent TEM defect could still be 
detected (Fig. 4.2A, grey bars). The maximum decrease was 37.5 ± 12.8% (5 mM), 
which was smaller than in H20 2-treated cells without recovery (Fig. 4.2A, black 
bars), but the trend was the same. The TEM defect was not abolished until 12 h 
after treatment (Fig. 4.2A, white bars). At this time-point only 0.5 mM H20 2 induced 
a 20.2 ± 6.7% decrease in TEM.
Adhesion of THP-1 cells that had recovered for 6 h (Fig. 4.2B, grey bars) had 
an even more pronounced increase with rising H20 2 level than unrecovered cells 
(Fig. 4.2B, black bars). Recovered THP-1 cells also displayed a response with a 
peack at intermediate concentrations to H20 2, with highest adhesion at 0.1 mM 
(133 ± 16.8% of untreated). After 12 h of recovery the peak at intermediate 
concentrations was no longer present; 0.1, 1 and 5 mM H20 2 displayed a similar 
adhesion increase of about 16%, whereas adhesion for 0.5 mM was at control level 
and for 2 mM at 144 ± 17% (of untreated). The higher adhesion in THP-1 cells after 
recovery for 6 h suggests that the effect needs time to develop, which could indicate 
that de novo synthesis of adhesion molecules plays a role.
The expression levels of proteins involved in redox homeostasis were 
determined in H20 2-treated THP-1 cells with or without recovery. These were two 
important enzymes of the cellular antioxidant defence system: MnSOD, an enzyme 
catalysing the dismutation of two molecules of superoxide anion (0 2 ) into H20 2 and 
oxygen (02), and catalase, a H20 2-scavenging protein (Droge, 2002). No 
differences in their expression could be detected (Fig. 4.2C), suggesting that H20 2 
treatment does not induce upregulation of ROS-scavenging proteins in THP-1 cells. 
This is surprising since ROS have been shown to induce upregulation of 
antioxidants in other cells (An and Blackwell, 2003; Sablina et al., 2005). These
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Figure 4.1: Conditioned medium from H20 2-treated THP-1 cells does not 
inhibit TEM or induce adhesion
THP-1 cells were incubated with 0 - 5  mM H20 2 (30 min, 37°C) and H20 2 was 
removed by centrifugation before incubation with fresh medium for 2 h. Cells were 
pelleted and the supernatant (conditioned medium) used for subsequent TEM and 
adhesion experiments with untreated THP-1 cells. A: THP-1 cells were allowed to 
transmigrate across TNF-a-activated (10 ng/ml, 15 - 18 h) HUVECs in a 
Transwell™-based TEM assay for 2 h in the absence (C) or presence of THP-1- 
conditioned medium. B: THP-1 cells labelled with CellTracker™ dye (1 pM, 30 min, 
37°C) were allowed to adhere to TNF-a-activated (10 ng/ml, 15 - 18 h) HUVECs for 
15 min. Non-adherent cells were washed off and remaining fluorescence detected 
using a Fusion™ a-FP plate reader.
Results were normalised to untreated control. Bars represent SEM. n = 3. 
★ p < 0.05 determined by Student’s t-test and Bonferroni post-test, as compared to 
untreated control.
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Figure 4.2: Recovery of THP-1 cells from H20 2 treatment
H20 2-treated THP-1 cells ( 0 - 5  mM, 30 min, 37°C) were allowed to recover for 0, 6 
or 12 h. A: A Transwell™-based TEM assay across TNF-a-activated (10 ng/ml, 15 - 
18 h) HUVECs was carried out. Cells from the lower chamber were counted after 2 
h and transmigration rate was calculated. B: THP-1 cells labelled with CellTracker™ 
dye (1 |jM, 30 min, 37°C) were allowed to adhere to TNF-a-activated (10 ng/ml, 15 - 
18 h) HUVECs for 15 min. Non-adherent cells were washed off and remaining 
fluorescence detected using a Fusion™ a-FP plate reader. C: Cell lysates were 
immunoblotted with antibodies against MnSOD, Catalase and (3-Actin (loading 
control).
Results were normalised to respective untreated control. Bars represent SEM. 
n = 3. ★★★ p<  0.001, ★★ p < 0.01, ★ p < 0.05 determined by two-way ANOVA and 
Bonferroni post-test.
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results could indicate an excess of antioxidant enzymes in THP-1 cells at resting 
conditions that do not require upregulation in order to prevent toxic intracellular ROS 
level.
The recovery experiments indicate that transient exposure of THP-1 cells to 
high levels of ROS induce long-term changes in their ability to adhere and 
transmigrate, which suggests that targets are either irreversibly modified or 
modifications have a long half-life. Modifications could include oxidation of redox- 
sensitive proteins at cysteine residues.
4.4 Effects of N-acetyl-L-cysteine on THP-1 TEM
Protein modifications such as cysteine oxidation are reversible: either introducing 
reducing agents or removal of the oxidant is sufficient to reverse the reaction. 
Oxidants can be neutralised by introduction of antioxidants. The synthetic cysteine 
and GSH precursor NAC was used as an antioxidant. TEM of NAC-treated THP-1 
cells was unchanged for low concentrations and only slightly and non-significantly 
increased by 11 ± 18.3% for high levels (Fig. 4.3A). Adhesion to HUVECs was also 
only marginally increased (max. 8.5 ± 3.1%) (Fig. 4.3B). These data indicate that 
NAC treatment has little significant effect on THP-1 cell TEM and adhesion.
To determine if treatment with antioxidants could rescue the H20 2-induced 
TEM defect, THP-1 cells were treated with H20 2 before subsequent treatment with 
NAC. THP-1 cells treated with H20 2 and NAC did not display a higher TEM rate 
than THP-1 cells treated with H20 2 alone (Fig. 4.3C). The increase in adhesion 
observed in H20 2-treated cells was not observed in samples treated with H20 2 and 
NAC (Fig. 4.3D), although no statistically significant difference could be determined 
between H20 2 only and H20 2 and NAC treated samples. These data indicate that 
NAC has little significant effect on the response of THP-1 cells to H20 2.
4.5 PMA and AT inhibit THP-1 cell TEM
In the previous chapter the effects of exogenous H20 2 on leukocyte TEM were 
characterised. Although H20 2 is able to diffuse across membranes, exogenously 
added H20 2 has been shown to be less effective at mediating intracellular signalling 
responses than endogenously produced ROS (Choi et al., 2005a). To determine 
how changes in intracellular ROS level influence TEM and adhesion, THP-1 cells 
were treated with PMA, a stimulus of NADPH oxidase-induced ROS production,
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Figure 4.3: Effects of N-acetyl-L-cysteine on THP-1 TEM and adhesion
NAC-treated THP-1 cells ( 0 - 1 0  mM, 30 min, 37°C) were either allowed to 
transmigrate across TNF-a-stimulated HUVECs for 2 h in a Transwell™-based TEM 
assay (A) or were pre-treated with CellTracker™ dye (1 pM, 30 min, 37°C) and 
allowed to adhere to HUVECs for 15 min (B). n = 4 (A) or 5 (B). C, D: H20 2-treated 
THP-1 cells ( 0 - 5  mM, 30 min, 37°C) were incubated with or without 10 pM NAC 
(30 min, 37°C). Cells were either allowed to transmigrate across TNF-a-stimulated 
HUVECs for 2 h in a Transwell™-based TEM assay (C) or were pre-treated with 
CellTracker™ dye (1 pM, 30 min, 37°C) and allowed to adhere to HUVECs for 
15 min (D). n = 4 (C) or 6 (D).
Results were normalised to untreated control. Bars represent SEM. ★ p < 0.05 
determined by Student’s t-test and Bonferroni post-test, as compared to untreated 
control.
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or AT, an inhibitor of the ROS-scavenging enzyme catalase, and compared to 
untreated and H20 2-treated THP-1 cells. TEM was significantly decreased in PMA- 
treated cells (max. 97 ± 3%, Fig. 4.4A), and for high AT concentrations (z 20 mM; 
Fig. 4.4C). TEM was completely inhibited at 50 and 100 mM AT. Adhesion was 
unchanged for PMA- as well as AT-treated THP-1 cells (Fig. 4.4 B, D). In order to 
correlate inhibition of TEM with intracellular ROS level, the ROS level in PMA and 
AT-treated THP-1 cells should be quantified in future experiments.
PMA and AT are non-physiological inducers of ROS, it was therefore 
interesting to look at whether physiological inducers of ROS change TEM and 
adhesion. To this end, THP-1 cells were incubated with various biological agents 
that have been implicated in ROS production, including fMLP (Zhu et al., 2005), ang 
II (Lassegue et al., 2001), VEGF (Ushio-Fukai et al., 2002), thrombin (Choi et al., 
2005b) (Begonja et al., 2005) and TNF-a (Defer et al., 2007). THP-1 cells were 
treated with these agents and used in Transwell™-based TEM and adhesion 
assays. Preliminary results suggested that low concentrations of fMLP induced a 
similar TEM defect and increase in adhesion as H20 2, while TNF-a only decreased 
TEM but had no effect on adhesion (Fig. 4.5A, C). Treatments with VEGF, ang II, 
thrombin or DMSO either had no effect or opposing effects to H20 2. To follow up on 
these results, lower concentrations of fMLP and the same concentrations of TNF-a 
and H20 2 were used in Transwell™-based TEM and adhesion assays. The effect of 
fMLP on TEM was not reproducible, which suggests that it does not affect TEM 
(Fig. 4.5D). TNF-a induced a small and statistically not significant reduction in TEM.
Further investigations are needed to determine how effective these reagents 
are at inducing intracellular ROS and whether they influence TEM.
4.6 High intracellular ROS levels coincide with low TEM
To elucidate whether application of H20 2 alters intracellular ROS levels, THP-1, 
MM6 cells, monocytes and T lymphoblasts were treated with H20 2 levels that were 
previously determined to be non-toxic (see Chapter 3.5) and intracellular ROS 
levels determined by FACS analysis using carboxy-H2DCFDA. H20 2 induced a 
dose-dependent increase in intracellular ROS in THP-1 and MM6 cells, with 
maximal increases of 62.1 ± 30.6% and 28.1 ± 23.6%, respectively at 5 mM (Fig. 
4.6A). While monocytes did not show a change in intracellular ROS levels, 
T lymphoblasts displayed significantly decreased ROS level for H20 2 concentrations 
> 0.1 mM (max. 40 ± 3.5%).
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Figure 4.4: PMA and AT inhibit THP-1 cell TEM
THP-1 cells were either treated with 1 mM H20 2 (30 min, 37°C) and 100 or 
200 ng/ml PMA or 1 mM H20 2and 10 -  100 mM AT (60 min, 37°C). A, C: H20 2- and 
PMA- or AT-treated THP-1 cells were allowed to transmigrate across TNF-a- 
activated (10 ng/ml, 15 - 18 h) HUVECs for 2 h and TEM rate was determined from 
the time-lapse movies. B, D: CellTracker™-labelled (1 pM, 30 min, 37°C) and 
subsequently H20 2- and PMA- or AT-treated THP-1 cells were allowed to adhere to 
TNF-a-activated (10 ng/ml, 15 - 18 h) HUVECs for 15 min. Adhesion was detected 
measuring fluorescence using a Fusion™ a-FP plate reader.
Results were normalised to untreated control. Bars represent SEM. n > 3.
p < 0.001, ★★ p < 0.01, ★ p < 0.05 determined by Student’s t-test and 
Bonferroni post-test, as compared to untreated control.
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Figure 4.5: Effect of various stimuli on TEM and adhesion
THP-1 cells were treated with H20 2 (1 mM, 30 min, 37°C), or for 60 min (37°C) with 
fMLP (2, 5, 10 or 50 pM), VEGF (100 or 200 ng/ml), ang II (2 or 10 pM), thrombin 
(0.5 or 2 U/ml), TNF-a (10 ng/ml) or DMSO (0.5%) before being used in Transwell™- 
based TEM and adhesion assays. A, B: Cells were allowed to transmigrate across 
TNF-a-activated (10 ng/ml, 15 - 18 h) HUVECs for 2 h. Transmigration rate was 
determined by counting cells from the lower chamber, n = 1 (A) or 4 (B). C, D: Prior 
to exposure to ROS-stimulating reagents cells were labelled with CellTracker™ dye 
(1 pM, 30 min, 37°C) before adhering to HUVECs for 15 min. Adhesion was 
detected measuring fluorescence using a Fusion™ a-FP plate reader, n = 1 (C) or 5 
(D).
Results were normalised to untreated control. Bars represent SEM. ★★ p < 0.01, 
★ p < 0.05 determined by Student’s t-test and Bonferroni post-test, as compared to 
untreated control.
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Figure 4.6: High intracellular ROS levels correlate with low TEM rate
A: THP-1, MM6 cells, monocytes and T lymphoblasts were treated with 0 - 5  mM 
H20 2 before labelling with 5 pM H2DCFDA (30 min, 37°C). ROS level were 
determined by FACS analysis and normalised to the respective untreated control, 
n £ 3. ★★ p < 0.01, ★ p < 0.05 determined by Student’s t-test and Bonferroni post­
test. B: THP-1, MM6 cells, monocytes and T lymphoblasts were labelled with 5 pM 
H2DCFDA (30 min, 37°C) before ROS level were determined by FACS analysis, 
n > 3. C: Transmigration rate of THP-1, MM6 cells, monocytes and T lymphoblasts 
was determined by TLM-based TEM assays and displayed as percentage of input. 
D: Correlation analysis of ROS level vs. TEM rate, p < 0.05 determined by Student’s 
t-test.
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These results show that different leukocytes react differently in response to 
H20 2. While 0.1 and 0.5 mM H20 2 led to a small increase in intracellular ROS in the 
monocytic cell lines THP-1 and MM6, it led to a significant decrease in 
T lymphoblasts. When interpreting these results it has to be taken into account that 
not only H20 2, but also peroxynitrite and peroxyl radicals will be detected by this 
method. This apparent discrepancy could be due to differences in the cellular redox 
state of unstimulated leukocytes and in the production of secondary ROS, e.g. 
peroxynitrite.
To investigate the relationship between intracellular ROS levels and TEM, 
ROS levels in untreated leukocytes were determined and compared to their TEM 
rate. ROS levels were detected using carboxy-H2DCFDA and FACS analysis (Fig. 
4.6B). The transmigration rates were determined by TLM-based TEM assays and 
calculated as percentage of total cell input (Fig. 4.6C). Leukocytes with similar ROS 
levels displayed similar TEM rates, whereas high levels of ROS coincided with low 
TEM and vice versa. This observation was confirmed by statistical analysis, 
revealing a significant negative correlation between ROS level and TEM, with a 
Pearson’s coefficient of r = -  0.6949 and r2 = 0.4829. The Pearson’s coefficient is a 
measure for correlation, where r = 1 is a perfect positive correlation and r = -1 a 
perfect negative correlation. The coefficient r2 = 0.4829 can be interpreted as 48% 
of the variance in TEM can be explained by variations in ROS levels. The 
assumption that different redox states in leukocytes could be responsible for the 
differences in intracellular ROS after H20 2 treatment could not be confirmed from 
this experiment. THP-1 cells and primary monocytes had similar levels of resting 
ROS, but unlike to THP-1 cells, primary monocytes did not display an increase in 
intracellular ROS at the H20 2 concentrations tested. However, since different H20 2 
level had to be used for the leukocytes tested, it is difficult to compare them directly.
4.7 Role of NO in transmigration
ROS have been reported to stimulate NO production in ECs via transient activation 
of eNOS (Boulden et al., 2006). In chondrocytes, ROS has been shown to induce 
iNOS expression (Mendes et al., 2003). Leukocytes also express iNOS, but nothing 
is known about its regulation by ROS in these cells. To investigate if the intracellular 
level of NO changed with H20 2 treatment and how this compared to intracellular 
ROS, THP-1 cells were either treated with H20 2 or PMA before labelling with 
carboxy-H2DCFDA to visualise ROS, or were first incubated with DAF before 
incubation with H20 2 or PMA to visualise NO. PMA, a known stimulator of NADPH 
oxidase (Jagnandan et al., 2007), was used as a positive control for intracellular
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ROS production. ROS and NO level were detected using FACS analysis (Fig. 4.7A, 
B). Intracellular ROS levels were only increased for 5 mM H20 2) whereas NO levels 
were increased for H20 2 concentrations £ 0.5 mM (Fig. 4.7C). PMA induced high 
levels of ROS but no production of NO. NO displayed a dose-dependent increase in 
response to H20 2. The higher responsiveness of the NO increase suggests that NO 
might play a critical role in mediating the effects of H20 2.
NO is produced by NOS; with iNOS being the predominant isoform in 
leukocytes. The expression of iNOS was determined by immunoblotting, and 
increased in a dose-dependent manner after H20 2 treatment in THP-1 cells with or 
without 6 h of recovery, by maximal 228% and 219% for 0 and 6 h recovery 
respectively (Fig. 4.8). Twelve hours after removal of H20 2, iNOS levels were lower 
in H20 2-treated than in control THP-1 cells. From these results, it is feasible to 
assume that elevated iNOS levels after 30 min of H20 2 treatment lead to the 
observed increase in NO.
4.7.1 Effects of NOS inhibition and an NO donor on THP-1 TEM and adhesion
To elucidate if NO is a mediator of H20 2-induced TEM and adhesion changes, the 
effects of a non-selective NOS inhibitor (L-NAME) (Oka et al., 2005) and a NO 
donor (SNAP) (Sun et al., 2006) on THP-1 TEM and adhesion were determined. 
Pre-treatment with L-NAME did not prevent the dose-dependent decrease in TEM 
after H20 2 treatment. However, SNAP treatment inhibited leukocyte TEM 
significantly by 22.2 ± 5.6% (Fig. 4.9A). Similarly, L-NAME treatment did not prevent 
the increase in adhesion after H20 2 incubation (Fig. 4.9B) but SNAP induced an 
increase in adhesion to a similar level as 1 mM H20 2 (108 ± 7.1% vs. 105 ± 8.2%).
Although pre-treatment of THP-1 cells with L-NAME did not prevent the 
H20 2-induced alterations in TEM and adhesion, the results of the NO donor indicate 
that NO is likely to play a role in the observed H20 2 phenotype. The efficiency of the 
inhibitor has to be tested before it is possible to draw conclusions about the actual 
involvement of NO in this process.
4.7.2 Formation of THP-1 cellular protrusions is prevented by SNAP
Previous results (see Fig. 3.16) have indicated that H20 2 inhibits the formation of 
cellular protrusions. NO has also been shown to play a role in regulating cellular 
protrusions (Lee et al., 2005; Lindsay et al., 2007). The preliminary results from 
Chapter 3 were verified and quantified and the involvement of NO in this process 
was investigated. The cellular protrusions from THP-1 cells treated with H20 2 or
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Figure 4.7: Intracellular NO levels are increased upon H20 2 treatment 
THP-1 cells were treated with 0 - 5  mM H20 2 (30 min, 37°C) or 100 ng/ml PMA 
(60 min, 37°C). A: Representative FACS trace for cells labelled with 5 pM 
H2DCFDA (30 min, 37°C) to detect ROS. B: Prior to incubation with H20 2 and PMA, 
THP-1 cells were incubated with 5 pM DAF (30 min, 37°C). NO levels were detected 
using FACS analysis and representative FACS trace is shown. C: Graphical display 
of all experiments. Results are normalised to the respective untreated control, n = 7.
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Figure 4.8: iNOS expression is H20 2-regulated
H20 2-treated THP-1 cells ( 0 - 5  mM, 30 min, 37°C) were washed to remove H20 2 
and incubated for 0, 6 or 12 h (37°C) before being lysed. A: Cell lysates were 
immunoblotted with antibodies against iNOS and ERK1. Equal amount of protein 
were loaded within each group of recovery. B: Densitometric quantification of iNOS 
expression. iNOS levels were normalised to ERK1 levels and respective untreated 
control. Mean of two experiments.
SNAP were determined from fluorescent microscopy images (Fig. 4.10A -  G). 
Cellular protrusions were significantly decreased for H20 2 concentrations £ 0.5 mM, 
with a maximum decrease of 46.1 ± 10.5% (Fig. 4.1 OH). SNAP exhibited a similar 
degree of protrusion inhibition (33.2 ± 2.1%). This result indicates that NO could 
participate in mediating the H20 2-induced decrease in cellular protrusions.
4.8 Role o f ty ros ine  phosphoryla tion in leukocyte H2O2 s ignalling
As previously mentioned, some proteins are prone to cysteine oxidation and redox 
regulation. This phenomenon has been well studied for phosphatases, where 
oxidation leads to protein inactivation, resulting in an increase in protein 
phosphorylation (Salmeen and Barford, 2005). Protein serine-threonine kinases and 
PTKs also appear to be under redox control (Rhee et al., 2000). Although the 
mechanism has not been elucidated yet, it is also likely to involve cysteine 
oxidation.
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Figure 4.9: Effects of NOS inhibition and an NO donor on THP-1 TEM and 
adhesion
THP-1 cells were pre-treated with or without L-NAME (400 pM, 60 min, 37°C) before 
incubation with 0 - 5  mM H20 2 or 250 pM SNAP (30 min, 37°C). A: Transmigration 
was determined in a Transwell™-based TEM assay, n = 6. B: Prior to treatment with 
reagents, THP-1 cells were labelled with CellTracker™ dye (1 pM, 30 min, 37°C) 
before adhesion to TNF-a-activated (10 ng/ml, 15 - 18 h) HUVECs was measured 
using a Fusion™ a-FP plate reader, n = 5.
Results were normalised to untreated control. Bars represent SEM. ★★ p < 0.01, 
★ p < 0.05 determined by Student’s t-test and Bonferroni post-test, as compared to 
untreated control.
Phospho-tyrosine (pTyr) levels and localisation were determined by 
immunofluorescence in H20 2-treated THP-1 cells adherent to VCAM-1 or HUVECs. 
On VCAM-1 pTyr staining was found throughout the cell, with intense punctate 
staining, mainly in clusters, at the basal surface (Fig. 4.11). This staining is likely to 
represent podosomes, adhesive structures found in cells of the monocyte lineage. 
The amount of pTyr-containing structures displayed a dose-dependent increase with 
H20 2 treatment. On HUVECs, no punctate pTyr staining could be observed in THP- 
1 cells; pTyr staining was found throughout the cell with accumulations at the 
leading edge (Fig. 4.12 arrows). Levels of THP-1 pTyr were highest at 1 and 2 mM. 
HUVECs also displayed pTyr staining in particular in the junctions, where junctional 
proteins such as VE-cadherin and p-catenin are known to be tyrosine 
phosphorylated, thereby regulating junction disassembly (Allingham et al., 2007; 
van Buul et al., 2005).
These preliminary data indicate that pTyr levels are changed upon H20 2 
treatment. While pTyr is accumulated in adhesive structures on VCAM-1, pTyr is 
found in the leading edge in THP-1 cells adherent to HUVECs.
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Figure 4.10: Number of cells with cellular protrusions is significantly reduced 
with H20 2 and SNAP treatment
CellTracker™-labelled THP-1 cells (1 pM, 30 min, 37°C) were treated with 0 - 5  mM 
H20 2 or 250 pM SNAP (30 min, 37°C) and added to TNF-a-activated (10 ng/ml, 15 - 
18 h) HUVECs for 25 min. A -  G: Fixed cells were visualised using a Zeiss 
Axiophot. Bar = 20 pm. H: The percentage of cells with protrusions (arrow) was 
determined from the fluorescent images. Results were normalised to untreated 
control. Bars represent SEM. n £ 3. ★★ p < 0.01, ★ p < 0.05 determined by 
Student’s t-test and Bonferroni post-test.
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Figure 4.11: H20 2 treatment increases pTyr levels in adhesive structures when 
bound to VCAM-1
THP-1 cells were incubated with H20 2 ( 0 - 5  mM, 30 min, 37°C). H20 2 was removed 
and cells were allowed to adhere to VCAM-1-coated coverslips for 1 h, before cells 
were fixed and stained for pTyr. A -  F: Additionally, differential interference contrast 
(DIC) images were taken to visualise outline of the cells. Bar = 50 pm. A’ -  F’ : 
Details of images A -  F, localisation is indicated by white box.
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Figure 4.12: pTyr levels are increased in H20 2-treated THP-1 cells on ECs
THP-1 cells were incubated with H20 2 ( 0 - 5  mM, 30 min, 37°C). H20 2 was removed 
and cells were added to TNF-a-stimulated HUVECs for 25 min, before cells were 
fixed and stained for pTyr. A -  F: Additionally, differential interference contrast (DIC) 
images were taken to visualise outline of the cells. White arrows indicate pTyr 
accumulation at the leading edge. Bar = 50 pm. A’ -  F’ : Details of images A -  F, 
localisation in is indicated by white box.
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4.9 Role of Rho GTPases in H202-mediated decrease in leukocyte TEM
Rho GTPases play distinct roles in every step of TEM from adhesion to 
translocation and diapedesis (see Chapter 1.4.2). The most studied Rho GTPases, 
RhoA, Rac1 and Cdc42, have recently been postulated to be redox-sensitive due to 
a unique Cys, Cys18 (Rac1 numbering), located at the end of the P-loop 
(GXXXXGK(S/T), residues 10 to 17, Rad numbering) (Heo and Campbell, 2005). It 
was therefore crucial to look into the regulation of Rho GTPases in THP-1 cells after 
H20 2 treatment.
4.9.1 Rho GTPase expression level in response to H20 2
As a starting point to investigating the roles of Rho GTPases in H20 2-mediated TEM 
decrease, total levels of Rho GTPases after H20 2 treatment were determined. 
Specific antibodies against RhoA, Rad and ERK1 (loading control) were used. 
Preliminary results suggest that RhoA levels display a dose-dependent increase 
with H20 2 treatment, while Rad showed some variability but no obvious trend (Fig. 
4.13 left panel and histogram). Cdc42 was not detectable under these experimental 
conditions, which could be due to differences in the composition of the lysis buffer.
Some proteins are known to undergo redox-mediated changes in their 
susceptibility towards proteasomal degradation (Grune et al., 1997). To elucidate if 
Rho GTPase stability was redox-regulated in THP-1 cells, cells were incubated with 
the proteasome inhibitor MG132 prior to treatment with H20 2. These preliminary 
results suggest that RhoA levels peak at 1 mM H20 2, while Rad level were 
decreased slightly (Fig. 4.13 right panel and histogram). These results might 
tentatively suggest that RhoA stability could be regulated by H20 2 in THP-1 cells.
4.9.2 Rho GTPase activity is modified by H20 2 treatment
To investigate whether H20 2 affects Rho GTPase activity, GST-pull-downs of active 
RhoA, R ad and Cdc42 were carried out using H20 2-treated adherent or 
suspension THP-1 cells and appropriate GST-fusion proteins. Upon H20 2 treatment, 
suspension cells displayed a small increase in activity at low concentrations, 
followed by a decrease for RhoA, Rad, Cdc42 (Fig. 4.14A, C). RhoA activity 
peaked at 1 mM with 122 ± 63% (of untreated) and was decreased by 45 ± 22% at 
5 mM. Rad activity was only increased for 0.5 mM H20 2 (130 ± 60% of untreated), 
while all other concentrations led to a decrease in activity (max. 23 ± 17%). Cdc42 
activity peaked at 0.5 mM with 123% (of untreated) and was decreased by 39% at 2 
mM.
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Figure 4.13: Rho GTPase expression levels in H20 2 treated cells
THP-1 cells in suspension were either treated with or without MG132 (10 pM, 24 h, 
37°C) before incubation with 0 - 5  mM H20 2 (30 min, 37°C). Cells were then lysed 
and immunoblotting using antibodies against RhoA, Rac1 and ERK1 (loading 
control) was carried out. Representative immunoblots of two experiments are 
shown. Histogram shows densitometric quantification of two experiments. Results 
were normalised to ERK level and control without H20 2.
Adherent THP-1 cells exhibited similar changes in RhoA activity as 
suspension cells, with an slight increase at 0.5 mM H20 2 with 142 ± 55% (of 
untreated) and a maximal decrease of 45 ± 26% at 5 mM (Fig. 4.14B, D), whereas 
Rac1 activity was differently regulated in these cells. Rad activity displayed a high 
activation peak of 207 ± 123% (of untreated) at 1 mM. Rad activation level 
decreased by 15 ± 25% for high H20 2 concentrations. Cdc42 activity was only 
slightly increased for low H20 2 concentrations (109 ± 37% of untreated, 0.1 mM) 
and decreased for high H2Q2 concentrations, by a maximum of 68 ± 17% (5 mM).
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Figure 4.14: RhoA, Rac1 and Cdc42 activities are altered by H20 2
H20 2-treated THP-1 cells ( 0 - 5  mM, 30 min, 37°C) were either centrifuged onto FN- 
coated 6-well dishes or used in suspension. Control cell lysates were treated with 
100 pM GTPyS (15 min, 30 °C) before incubation with immobilised GST-fusion 
proteins (60 min, 4 °C). GST-fusion proteins of rhotekin Rho-binding domain (RhoA) 
and the p21-binding domain (PBD) of PAK (Rac1 and Cdc42) were used. A, B: 
Representative western blots for GST-pull-downs with suspension (A) and adherent 
(B) THP-1 cells. C, D: Densitometric quantification of GST-pull-down experiments 
from suspension (C) and adherent (D) cells. Results are normalised to respective 
untreated control. Bars represent SEM. n £ 3, except suspension Cdc42, where the 
means of two experiments are displayed. Numbers above GTPyS samples (C, D) 
indicate values of discontinued bars for RhoA and Rac1 (underlined).
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The Rho GTPases RhoA, Rac1 and Cdc42 appear to be regulated by H20 2, 
although the variability in pull-down assays was too high to achieve statistically 
significant results.
4.9.3 RhoA regulation by H20 2
In addition to regulation of Rho GTPase activity by turnover of GTP, activity is 
regulated by binding to the cytoplasmic inhibitor RhoGDI. RhoGDI sequesters Rho 
GTPases away from the membrane and prevents nucleotide exchange, thereby 
preventing activation (DerMardirossian and Bokoch, 2005).
Co-immunoprecipitation of RhoGDI was carried out and samples were 
probed for RhoA to determine if H20 2 treatment influenced the binding between 
RhoA and RhoGDI. Analysis of these preliminary data revealed a dose-dependent 
decrease by a maximum of 85% in the interaction between RhoA and RhoGDI after 
normalising RhoA levels to RhoGDI (Fig. 4.15). This potential decrease is not 
mirrored in the activation status of RhoA (Fig. 4.14), indicating that further regulatory 
mechanisms are in place.
4.10 Intracellular calcium level are increased upon H2O2 treatment
Rho GTPases have been shown to be regulated by cytoplasmic Ca2+ in different cell 
types (Jin et al., 2005; Price et al., 2003). Elevation of Ca2+ levels has also been 
reported after ROS exposure in various other experimental settings (Ermak and 
Davies, 2002; Touyz, 2005). To determine if increase in Ca2+ levels occurs in THP-1 
cells after H20 2 treatment, the Fluo-4 NW Ca2+ assay kit (Molecular Probes) was 
used with H20 2-treated THP-1 cells. After H20 2 treatment, Ca2+ levels increased in a 
dose-dependent manner, with a maximal increase of 276 ± 75% (5 mM; Fig. 4.16). 
Changes in Ca2+ levels could play an important role in the regulation of Rho 
GTPases in response to H20 2.
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Figure 4.15: Interaction between RhoA and RhoGDI by H20 2
Cell lysates of H20 2-treated THP-1 cells ( 0 - 5  mM, 30 min, 37°C) were used for 
immunoblotting (WCL) or further incubated with immobilised RhoGDI and c-myc 
(negative control) antibodies (2 h, RT). Samples were immunoblotted with 
antibodies against RhoA and RhoGDI. A: Representative blot for RhoA 
immunoprecipitation with RhoGDI. B: Densitometric quantification: RhoA level were 
normalised to RhoGDI level and untreated control. Means of two experiments are 
displayed.
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Figure 4.16: H20 2 induces Ca2+-influx into THP-1 cells
Fluo-4 NW Ca2+ assay kit (Molecular Probes) was used according to the 
manufacturer’s instructions with THP-1 cells treated with 0 - 5  mM H20 2 (30 min, 
37°C) or 10 pM Ca2+ ionophore A23187 (C). Results are normalised to untreated 
control. Bars represent SEM. n = 3. Number above C indicates value of 
discontinued bar.
152
4 Results
4.11 Discussion
In this chapter the signalling pathways responsible for the H20 2-induced decrease in 
TEM in THP-1 cells were investigated, including tyrosine phosphorylation, 
intracellular ROS, NO and Rho GTPases.
Endothelial barrier function can be influenced not only by binding of 
leukocytes but also by leukocyte secretion of pro- and anti-inflammatory mediators, 
e.g. TNF-a or nucleotides such as ATP (Eltzschig et al., 2003; Kofler et al., 2005). It 
was therefore important to determine if H20 2-induced release of mediators by THP- 
1 cells could contribute to the observed TEM defect. Conditioned medium from 
H20 2-treated THP-1 cells did not reduce transmigration of untreated cells. Instead, 
conditioned medium from cells treated with 5 mM H20 2 increased TEM significantly. 
Inadvertent carryover of small amounts of H20 2 could be responsible for this result, 
as it has been shown that low concentrations of H20 2 can induce signalling events, 
such as upregulation of MMPs, in ECs thereby promoting TEM (Deem and Cook- 
Mills, 2004). However, adhesion of THP-1 cells to HUVECs was not influenced by 
conditioned medium, arguing against carryover of H20 2. Taken together, this 
experiment demonstrates that H20 2-treated THP-1 cells do not secrete any anti­
inflammatory mediators that could be responsible for the observed TEM defect in 
culture. However, it has to be taken into account that the concentrations of a 
potentially secreted mediator could be higher in the close proximity between THP-1 
cell and endothelium. Although THP-1 cells seem to have a pro-inflammatory effect 
on HUVECs at high H20 2 concentrations, the H20 2-induced defects in the THP-1 
cells do not allow efficient TEM.
Interestingly, transient H20 2 treatment led to prolonged decrease in 
TEM, which was still detectable after 6 h of recovery. Adhesion did not return to 
control levels within 12 h of recovery; this could indicate that long-term upregulation 
of adhesion molecules, such as integrins, upon H20 2 treatment occurred at later 
timepoints than determined in the FACS experiment (30 min) (see Fig. 3.11). 
Further FACS analysis would need to be carried out to determine the integrin cell 
surface levels at these later timepoints. In addition, these results indicated that 
targets of H20 2 either have a very slow recovery rate (reversible modifications) or 
need to be turned over (irreversible modifications). Reversible modifications could 
include oxidation of proteins, most likely of cysteine residues (Salmeen and Barford, 
2005{Rhee, 2000 #361)Redox-sensitive proteins include PTPs, whose inactivation 
leads to a general increase in protein phosphorylation. It was therefore interesting to 
determine the phosphorylation status in H20 2-treated THP-1 cells. Preliminary and
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non-quantitative data suggest that pTyr levels are elevated in H20 2-treated THP-1 
cells when bound to VCAM-1 or HUVECs in response to H20 2, particularly in 
adhesive and motile structures such as podosomes and lamellipodia. To further 
investigate the role of Tyr phosphorylation in H20 2-treated THP-1 cells, the 
immunofluorescence images should be quantified to determine the increase in pTyr 
in different areas of the cell. Additionally, pTyr immunoblotting should be carried out 
to verify the total increase of tyrosine phosphorylation. To determine target proteins 
of H20 2-induced Tyr phosphorylation, co-immunoprecipitations with pTyr antibodies 
could be carried out and proteins with altered pTyr level identified by mass 
spectrometry. The role of individual phosphorylated proteins could be investigated 
by knocking them down using siRNA and possibly reintroducing the protein (e.g. the 
mouse homolog to prevent k-d) with point mutations that prevent phosphorylation. 
The role of Tyr phosphorylation in the H20 2-mediated decrease of THP-1 cell TEM 
could also be more generally investigated by preventing Tyr phosphorylation using 
specific inhibitors against kinases that are likely to play a role in the H20 2-mediated 
response, e.g. the redox-sensitive kinases Src and Pyk2 (Frank et al., 2000; 
Griendling et al., 2000).
Oxidation of cysteine residues can be reversed by reducing agents or by 
neutralising oxidants with antioxidants. Antioxidants can be broadly classified into 
hydrophilic and hydrophobic antioxidants; examples include ascorbic acid 
(vitamin C) and GSH or carotenes and a-tocopherol (vitamin E). An antioxidant 
commonly used in medical studies as well as cellular systems is NAC. NAC is a 
precursor of GSH, which provides the reducing equivalent for the reduction of H20 2 
to H20  (Veal et al., 2007). In THP-1 cells, NAC caused only marginal, statistically 
insignificant changes in TEM and adhesion. This could indicate that either NAC is 
not the right antioxidant to use or under resting conditions the cellular redox state 
inhibits TEM slightly, which can be reversed by antioxidants. For future experiments 
it would be interesting to use other antioxidants, e.g. the above mentioned vitamins 
or the recently developed cell-permeable peptide antioxidant SS-31 (Cho et al., 
2007). However, if the redox state is relatively balanced with only a small excess in 
oxidants, adding antioxidants would only have a marginal effect. It was not possible 
to rescue the H20 2-induced TEM defect with subsequent NAC treatment, but the 
increase in adhesion at low H20 2 concentration was not observed in NAC-treated 
cells. Also, the use of PMA and AT, both substances that should increase the 
intracellular ROS level, led to more drastic inhibition of TEM than exogenous H20 2, 
while adhesion was unchanged. However, the intracellular ROS level in response to
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PMA and AT were not measured, and it is therefore not possible to draw any 
conclusions about the involvement of intracellular ROS at this point. The 
intracellular ROS level in response to the various substances used (PMA, AT, fMLP, 
VEGF, ang II, thrombin, TNF-a and the solvent DMSO) should be measured to 
determine effective substances and concentrations. If intracellular ROS levels are 
indeed increased in response to PMA and AT, the results could suggest that 
production of intracellular ROS is more effective in reducing TEM, probably due to 
the increased proximity to its targets, as ROS concentration will be rapidly 
diminished with increasing diffusion distance.
This and the NAC data indicate that TEM and adhesion could be differently 
regulated by H20 2, e.g. by targeting different molecules. H20 2 could induce 
signalling cascades leading to the TEM defect that cannot be reversed by addition 
of antioxidants, whereas adhesion could be influenced by direct oxidative 
modification of adhesion proteins, which are reversible by antioxidants. To test the 
latter, specific dyes could be used; these label cysteine thiols (Cys-SH), but are 
unable to bind oxidised cysteine residues. Two-dimensional difference gel 
electrophoresis (2-D DIGE)-based redox proteomics and mass spectrometry can be 
used to determine targets of H20 2 treatment (Chan et al., 2005). However, 2-D 
DIGE of cell surface proteins has proven to be difficult due to the hydrophobic 
transmembrane domain of these proteins, making the use of specific detergents and 
procedures necessary.
Treatment of THP-1 cells with H20 2 led to a dose-dependent rise in NO. The 
NO increase was more prominent than ROS increase, suggesting that NO might 
play a crucial role in mediating H20 2 effects. However, limitations of the approach 
used might have prevented the detection of an early increase in intracellular ROS. 
Ryu et al. have reported an approximately 3-fold increase in intracellular ROS 
production when THP-1 cells were stimulated with 10 pM H20 2 for 1 h. In contrast to 
the approach taken in this study, Ryu et al. labelled with 5 pM H2DCFDA prior to the 
stimulation with H20 2. This allows the detection of all the H20 2-induced ROS even at 
early time points, whereas in the case of this study the early increase in ROS during 
the H20 2 treatment phase might already have disappeared when the cells are 
subsequently labelled with H2DCFDA. This approach was taken to define the 
intracellular redox state at the same time point when THP-1 cells are usually used in 
TEM and adhesion assays. However, to understand the dynamics of intracellular 
ROS levels in response to H20 2 treatment it would be advisable to label the cells
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first with H2DCFDA and then carry out a time-course of H20 2 treatment to determine 
intracellular ROS levels.
NO can be produced by NOS, which oxidise L-arginine to L-citrullin (Alderton 
et al., 2001). The major NOS present in leukocytes is iNOS. In THP-1 cells, 
preliminary data suggest that iNOS expression is rapidly upregulated upon H20 2 
treatment. This dose-dependent upregulation was still detectable 6 h after H20 2 
treatment, but was reversed within 12 h. In chondrocytes, 0 2' has been shown to 
mediate IL-1-induced IkB-o degradation and consequent NFkB activation and iNOS 
expression (Mendes et al., 2003). Additionally, iNOS is positively regulated by 
tyrosine phosphorylation (Pan et al., 1996), which is dependent on Src kinase 
(Hausel et al., 2006). The phosphorylation status of iNOS was not determined in this 
study, but it is tempting to speculate that iNOS is also activated via this pathway, as 
general tyrosine phosphorylation was increased after H20 2 treatment.
The involvement of NO in THP-1 TEM and adhesion was demonstrated by 
using a NO donor, which induced a similar TEM defect and increase in adhesion to 
H20 2. It was not possible to prevent the H20 2-induced decrease in TEM or increase 
in adhesion by pre-treating the cells with a NOS inhibitor. Although there is not 
enough evidence to conclude that NO mediates the observed H20 2 effects, the NO 
donor result is a strong indicator. Findings by others have also suggested a 
negative role of NO in TEM. Oka et al. have shown that NO derived from HUVECs 
accumulates in neutrophils and inhibits TEM, at least in part by activating soluble 
GC (Oka et al., 2005). NO has also been reported to reduce adhesion and TEM in 
spleen T cells by downregulating (31 integrin and matrix metalloprotease-9 (MMP9) 
expression (Sun et al., 2006). In a hepatic cell line, NO has been reported to inhibit 
PDGF-induced and Rac1-driven migration by preventing formation of filopodia (Lee 
et al., 2005). Application of the NO donor SNAP resulted in a comparable decrease 
in cellular protrusions as H20 2, suggesting that NO is mediating this event. Cellular 
protrusions are dependent on actin polymerisation, a process regulated by a large 
number of proteins. Key regulators of this process are EnaA/ASP family members 
(Small et al., 2002). Application of NO donors led to rapid retraction of lamellipodia 
together with cell rounding in epithelial cells (Lindsay et al., 2007). This process was 
dependent on GC and type II cGMP-dependent protein kinase (PKG ll)-mediated 
VASP phosphorylation at Ser239 (Lindsay et al., 2007), which has been shown to 
reduce its actin anti-capping and filament bundling activity (Barzik et al., 2005). NO 
is known to stimulate the production of cGMP (Katsuki et al., 1977). It is tempting to 
speculate that a similar pathway is activated in H20 2-treated THP-1 cells, leading to
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the observed decrease in cellular protrusions. To demonstrate convincingly that NO 
mediates the H20 2-induced decrease in protrusions, it would be necessary to show 
that inhibition of NO production prevents this event. As L-NAME gave highly 
variable results, it is advisable to test different NOS inhibitors or NO scavengers to 
set up a rescue experiment.
These data suggest, that NO could be a mediator of the H20 2 effects in 
THP-1 cells. It is feasible to assume that the defect in TEM is at least partly due to 
the reduction in cellular protrusions. Cellular protrusions are important during TEM, 
by acting as exploratory extensions of the cell to probe the endothelium for suitable 
sites for diapedesis (Carman et al., 2007; Millan et al., 2006). Loss of these 
extensions is likely to reduce TEM, as was shown with H20 2 treatment.
Cellular protrusions are also regulated by Rho GTPases (Chapter 1.3.2.1). 
The regulation of Rho GTPase after H20 2 treatment was investigated. Preliminary 
data suggest that total levels of Rac1 were unaltered upon H20 2 treatment, whereas 
RhoA levels appeared to be increased. The high increase of RhoA levels at 5 mM 
was abrogated when cells were pre-treated with a proteasome inhibitor. ROS have 
been reported to cause modifications of proteins that may lead to changes in their 
susceptibility to proteolytic attack (Davies, 1987; Dean et al., 1986; Grune et al., 
1997). Additionally, proteolysis can be inhibited by millimolar concentrations of H20 2 
(Grune et al., 1997). These results could tentatively indicate a redox regulation of 
proteasomal degradation for RhoA. To address the question of proteasomal 
degradation further, the above described experiment should be repeated to confirm 
the results, other proteasome inhibitors (e.g. lactacystin) should be used and 
approaches should be taken to prevent polyubiquitination, e.g. by knocking-down 
components of the ubiquitination system, such as a RhoA-specific E3 ligase.
Rho GTPase activity in THP-1 cells after H20 2 treatment was investigated in 
adherent and suspension cells. RhoA, Rac1 and Cdc42 displayed similar, activation 
patterns in suspension cells with activation peaks at intermediate concentrations, 
whereas Rac1 and Cdc42 showed very different activation patterns in adherent 
THP-1 cells, while RhoA activation pattern remained similar. Rad activity was only 
marginally changed in suspension cells, but displayed a high activation peak at 
intermediate concentrations for adherent cells. Cdc42 activity was strongly 
decreased in a dose-dependent manner when cells were adherent, which was not 
observed in suspension cells. Rad and Cdc42 are known to be activated upon 
integrin binding (Ridley, 2001), which could explain the observed differences 
between suspension and adherent THP-1 cells.
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Heo and Campbell have shown that in an in vitro system RhoA, Rac1 and 
Cdc42 are redox-sensitive, due to a unique motif containing the redox-sensitive 
Cys18 (Rac1 numbering) (Heo and Campbell, 2005). Oxidation of this site leads to 
GDP dissociation, but GTP association occurs only when the oxidative reagent is 
removed. RhoA has been shown to be subsequently inactivated through formation 
of an intramolecular disulphide bond thereby preventing activation by GTP binding 
(Fig. 4.17) (Heo et al., 2006). Rad has been shown to be activated in response to 
H20 2 in rat fibroblasts, leading to increased cell motility (Alexandrova et al., 2006). 
Rad is also activated in response to Ca2+-elevating reagents, however, this 
activation is abrogated at high levels of Ca2+ (Jin et al., 2005; Price et al., 2003). 
Rad activity can also be regulated in a Ras- and Tiaml-dependent manner 
(Yamauchi et al., 2005). Ras has been shown to be S-nitrosylated at Cys118 by 
NO, leading to activation and downstream signalling (Lander et al., 1997). The 
observed increase in NO in this study could therefore induce Ras-dependent Rad 
activation. The pattern of Rad activation in adherent THP-1 cells reflected the 
changes in cell motility (see Fig. 3.13), in agreement with the well-characterised role 
of Rad as a regulator of cell migration (Ridley, 2001). Cdc42 has been shown to be 
involved in formation of cellular protrusions. For example, neutrophils from 
cdc42GAP-deficient mice display increased cdc42 activity and an increase in 
cellular protrusions and motility (Szczur et al., 2006). Cdc42 has also been shown to 
be important in chemokine-induced monocyte TEM, where expression of mutant 
Cdc42 led to a decrease in filopodia and subsequent TEM (Weber et al., 1998). The 
increased Ca2+ level could additionally contribute to the decrease in cellular 
protrusions by increasing contractility in a MLCK-dependent manner (Pfitzer, 2001). 
The observed decrease in Cdc42 activity in H20 2-treated THP-1 cells would 
therefore explain the reduction in cellular protrusions and consequential defect in 
TEM. The decrease in Cdc42 activity could be due to the oxidation of the redox- 
sensitive Cys18, which would lead to dissociation of GDP but due to the presence of 
the oxidant no GTP binding, i.e. no activation occurs.
RhoA has been shown to be important during monocyte TEM. Inhibition of 
RhoA in monocytes with C3 transferase results in a TEM defect, while adhesion is 
not affected (Worthylake et al., 2001). RhoA inhibition leads to formation of long 
tails, which can not be retracted by migrating cells. Formation of long tails was not 
observed in H20 2-treated THP-1 cells, even at levels where RhoA activation was 
lowest. This indicates that H20 2-regulated RhoA activity is not likely to be important 
for the decrease in TEM. Nimnual et al. reported a redox regulation of RhoA activity
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via ROS-dependent inactivation of LMW-PTP, leading to increased phosphorylation 
of p190RhoGAP and consequential downregulation of RhoA activity (Nimnual et al., 
2003). RhoA has been shown to be phosphorylated at Ser188 by PKA or PKG 
(Ellerbroek et al., 2003). Serine phosphorylation leads to increased binding of 
RhoGDI, independent of nucleotide binding. RhoA is not only extracted from the 
plasma membrane and localises to the cytoplasm, but it has also been shown to be 
protected from ubiqutin/proteasome-mediated degradation by binding to RhoGDI 
(Rolli-Derkinderen et al., 2005). It could be speculated that H20 2-induced increase 
in NO could lead to PKG activation and subsequent RhoA phosphorylation, which 
could induce increased binding to RhoGDI. Preliminary data from RhoGDI co- 
immunoprecipitiation experiments did not confirm this; in fact, RhoA/RhoGDI 
interaction was decreased in H20 2-treated THP-1 cells in a dose-dependent 
manner. However, this decrease only became apparent when RhoA levels were 
normalised to RhoGDI levels. Further experiments are needed to confirm these 
observations. The pattern of potentially decreased interaction between RhoGDI and 
RhoA did not mirror the pattern of RhoA activity. While the increase in activity for 
0 . 1 - 2  mM could be caused by decreased RhoGDI binding, inactivation at high 
levels must occur via different mechanisms. The downregulation by increased 
p190RhoGAP activity and inactivation of RhoA by formation of disulphide bonds 
might play a role at high H20 2 concentrations. RhoA activity has also been shown to 
be downregulated by cytoplasmic Ca2+ (Jin et al., 2005), which could explain the 
decrease in RhoA activity at high H20 2 levels, where a 4-fold increase in Ca2+ was 
observed.
RhoGDIs maintain Rho GTPases as soluble cytosolic proteins by forming 
complexes that shield the geranylgeranyl group, which normally targets the protein 
to the membrane (DerMardirossian and Bokoch, 2005). Prenylation of Rho 
GTPases is necessary to bind the respective RhoGDI (Nomanbhoy and Cerione, 
1996) and has been shown to be negatively regulated by ROS in other proteins 
(Clark et al., 2004). It is tempting to speculate that RhoA binding to RhoGDI is 
decreased due to redox-induced changes in the prenylation status in H20 2-treated 
THP-1 cells. Additionally, RhoGDI has been shown to be phosphorylated at Tyr156 
by Src, which causes a decrease in the ability to bind RhoA, Rac1 and Cdc42 
(DerMardirossian et al., 2006). H20 2-induced Src activation could therefore lead to 
RhoGDI phosphorylation and a consequential decrease in RhoGDI/RhoA binding. It 
would be interesting to investigate the binding of Rac1 and Cdc42 to their respective 
GDIs in response to H20 2.
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Figure 4.17: Regulation of Rho GTPases by H20 2 and NO
See text for details. Red: active Rho GTPase; green: inactive Rho GTPase.
In conclusion, H20 2 has multiple effects on THP-1 cells that lead to a dose- 
dependent decrease in TEM. The increase in intracellular NO is likely to play a 
crucial role by reducing formation of cellular protrusions, possibly through PKG- 
mediated phosphorylation of VASP. Additionally, downregulation of Cdc42 activity 
and a potential Ca2+-induced contractility are likely to participate in the reduction of 
cellular protrusions. Rac1 activation at intermediate H20 2 concentrations, possibly 
Ca2+-induced, probably accounts for the observed increase in motility, which might 
contribute to the decrease in TEM. On the other hand high Ca2+ levels at 5 mM 
H20 2 might be responsible for the decrease in Rho GTPase activity, particularly 
Rac1, which would have negative effects on TEM. Taken together, H20 2 has 
concentration-dependent effects on Rho GTPase activity in THP-1 cells, which 
could mediate the defects in motility and TEM.
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Regulation of leukocyte transendothelial 
migration by the cell-surface enzyme CD73
5.1 Introduction
Ecto-5’-nucleotidase (CD73) is a GPI-anchored 70 kDa glycoprotein that is 
abundantly expressed on ECs, whereas only ~ 20% of peripheral blood 
lymphocytes express this protein (Airas et al., 1993; Thomson et al., 1990). It 
belongs to a group of ecto-enzymes and is involved in purine metabolism by 
hydrolysing extracellular AMP to adenosine (Yegutkin, 2008). Although lymphocytes 
and ECs express structurally similar molecules, the function and regulation appears 
to be different in these cell types. Engagement of lymphocyte CD73 leads to rapid 
surface shedding and induces LFA-1 clustering, thereby promoting lymphocyte 
binding to the endothelium (Airas et al., 2000; Airas et al., 1997). These events have 
not been observed in ECs and are thought to be independent of the enzymatic 
activity of CD73 (Jalkanen and Salmi, 2008). The enzymatic activity of CD73 
produces adenosine, a highly anti-inflammatory purine, which exerts its effects via 
P1 type of purino-receptors (Hasko and Cronstein, 2004). Four types of adenosine 
receptors exist: A1( A z * ,  A 2 b  and A3. Activation of endothelial adenosine receptor A 2 b  
leads to cAMP-dependent activation of ERK1/2 and MLC phosphorylation (Lennon 
et al., 1998; Srinivas et al., 2004). However, elevated cAMP levels also activate 
pathways involving the inactivation of MLCK and/or ROCK leading to MLC 
dephosphorylation. This pathway seems to be dominant, since the net result of 
elevated cAMP levels is MLC dephosphorylation, which leads to relaxation of the 
endothelium, thereby increasing endothelial barrier function. Adenosine-induced 
cAMP also increases barrier function by PKA-mediated phosphorylation of VASP, 
which thereupon is localised to junctions and co-localises with ZO-1 (Comerford et 
al., 2002). In addition to increasing endothelial barrier function, adenosine inhibits 
NF-xB-mediated upregulation of adhesion molecules including P-selectin, E-selectin 
and VCAM-1 (De Martin et al., 2000; McPherson et al., 2001; Minguet et al., 2005; 
Walker et al., 1999). The regulation of ICAM-1 by adenosine is unclear; while 
Bouma et al. did not see an adenosine-mediated decrease in ICAM-1 levels (Bouma
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et al., 1996), others have demonstrated inhibition of ICAM-1 expression in response 
to adenosine analogues/A^ receptor antagonists (McPherson et al., 2001; Walker 
et al., 1999).
Endothelial CD73 activity has been shown to be inhibited upon leukocyte 
binding (Henttinen et al., 2003). The residual adenosine is rapidly degraded to 
inosine by ADA, a soluble enzyme that is bound to the lymphocyte surface via CD26 
(Gorrell et al., 2001; Martin et al., 1995). This leukocyte-mediated CD73 inhibition is 
cell number-dependent and is likely to occur by selective masking and inhibition of 
the catalytic site, presumably via a temporal and non-competitive mechanism and 
might be a requisite for subsequent leukocyte TEM into the tissue. The exact 
mechanism of inhibition is currently unknown, but the structure of CD73 has given 
some hints as to how it might be achieved. A sequence comparison between E. coli 
and vertebrate 5’-nucleotidase has revealed a sequence identity of only > 20%, but 
several clusters of highly conserved residues were found (Knofel and Strater, 1999). 
X-ray crystallography has shown that E. coli 5’-nucleotidase consists of two 
domains: the N-terminal domain coordinates two catalytic divalent metal ions, 
whereas the C-terminal domain provides the substrate specificity pocket for the 
nucleotide. These domains are conserved in mammalian CD73 and a homology 
model predicted a similar domain structure (Strater, 2006). E. coli 
5’-nucleotidase has been shown to undergo a hinge-bending domain rotation of 96° 
in order to hydrolyse AMP to adenosine, presumably to allow substrate binding and 
product release (Schultz-Heienbrok et al., 2005). From the predicted homology 
model it seems likely that mammalian CD73 undergoes a similar rotation and 
regulation of the enzymatic activity (Strater, 2006).
CD73 is highly expressed in many tumour cells, but its specific function in 
tumourigenesis is unclear. Sadej et al. showed that among different melanoma 
cells, upregulated CD73 expression is associated with a highly invasive phenotype 
(Sadej et al., 2006). It correlates with a number of metastasis-related markers and 
might therefore have a role in this process. Overexpression of CD73 in two breast 
cancer cell lines (T-47D and MB-MDA-231) leads to increased invasion, migration 
and adhesion to ECM, which can be blocked by a specific CD73 inhibitor (Wang et 
al., 2008). RNA interference (RNAi) of CD73 in a breast cancer cell line (MB-MDA- 
231) has been shown to inhibit cell growth, invasion and migration (Zhi et al., 2007). 
This confirms a role for CD73 in tumourigenesis. RNAi has rapidly become the 
predominant means of assessing loss of gene function (Sen and Blau, 2006). It 
allows quick and selective knock-down (k-d) of the gene of interest by transiently
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introducing short interfering RNA (siRNA), a class of 20-25 nucleotide-long double­
stranded RNA molecules, or by transiently or stably transfecting cells with vector- 
based short hairpin RNAs (shRNA) (Leung and Whittaker, 2005).
The aim of this chapter is to investigate the role of endothelial CD73 in 
inflammation. I aim to further the understanding of the protein’s enzymatic and non- 
enzymatic functions during the binding and transendothelial migration of leukocytes.
5.2 CD73 is localised in lipid rafts
There are multiple 5’-nucleotidases: five cytoplasmic 5’-nucleotidases, one 
mitochondrial and one extracellular ecto-5’-nucloetidase, which is bound to the 
plasma membrane via a GPI anchor. This study will focus on the function of ecto-5’- 
nucleotidase and the term ‘CD73’ will be used to refer to this protein only.
The localisation of CD73 in HUVECs was determined by 
immunofluorescence. In a confluent monolayer, where cells were not permeabilised, 
the staining pattern was evenly distributed and dot-like with accumulations at the 
cell periphery (Fig. 5.1 A). This could indicate that CD73 is localised in cell-cell 
junctions. To determine if this was the case, HUVECs were seeded at a lower 
density and stained with antibodies against CD73 and the junctional marker (3- 
catenin. CD73 was accumulated around the cell edges even if there was no contact 
to neighbouring HUVECs (Fig. 5.1B, arrow). Additionally, no co-localisation with (3- 
catenin or similar distribution pattern could be detected. This indicates, that CD73 is 
not localised in endothelial junctions. The seeming localisation to cell junctions 
could be due to the membrane curvature at the cell edges, which could lead to the 
impression of an accumulation.
CD73 has been reported to be localised in microdomains such as caveolae 
and lipid rafts in other cell types (Ludwig et al., 1999; Monastyrskaya et al., 2003; 
Sadej et al., 2006; Strohmeier et al., 1997). To address if endothelial CD73 was 
localised in such microdomains, HUVECs were labelled with antibodies against 
CD73 and the caveolar marker Cav-1 or the lipid raft marker CD59 (Fig. 5.2A, B). 
While no co-localisation with Cav-1 could be detected, CD73 partially co-localised 
with CD59 indicating that some CD73 is localised in CD59-containing rafts. This 
result was verified by raft fractionation using OG-selective solubility. CD73 was 
mainly localised in the soluble fraction, but a small portion could be detected in the 
raft fraction (Fig. 5.2C). Catalase was used as a marker for cytosolic proteins in the 
raft fractionation and was only detected in the soluble fraction, indicating a clean
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Figure 5.1: CD73 is not localised in endothelial junctions
HUVECs were sequentially labelled with an antibody for CD73 (4°C, 30 min) and 
AlexaFluor488-conjugated secondary antibody (4°C, 20 min), before being fixed and 
either mounted onto microscopy slides (A) or further labelled with antibodies against 
(3-Catenin (B). Arrows indicate sites of CD73 accumulation. Bar = 20 pm.
fractionation. CD59 was mainly found in the raft fraction with some localisation in 
the soluble as well as the nuclear fraction. The nuclear localisation could be 
artefactual since CD59 is not known to localise in the nucleus.
5.3 CD73 appears to be localised around transm igrating leukocytes
In order to determine the role of CD73 in TEM, CellTracker™-labelled THP-1 cells 
or unlabelled T lymphoblasts were allowed to transmigrate across TNF-a-stimulated 
HUVECs. Co-cultures of HUVECs and T lymphocytes were labelled with antibodies 
against CD73 and Cav-1, which has been shown to localise around transmigrating 
T lymphocytes (Millan et al., 2006), and z-stacks were acquired using a confocal 
microscope. Cav-1 and CD73 both appeared to accumulate around adherent 
T lymphocytes, but no co-localisation could be detected confirming that CD73 is not 
localised in caveolae (Fig. 5.3). Co-cultures of HUVECs and THP-1 cells were 
labelled with antibodies against CD73 and z-stacks were acquired. CD73 appeared 
to accumulate around transmigrating THP-1 cells, in particular at the area of 
interaction between the apical surface of the leukocyte protrusion and the basal
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Figure 5.2: CD73 is partially localised in lipid rafts
HUVECs were sequentially labelled with an antibody for CD73 (4°C, 30 min) and 
AlexaFluor488-conjugated secondary antibody (4°C, 20 min), before being fixed and 
further labelled with antibodies against Cav-1 (A) or CD59 (B). Bar = 20 pm. C: For 
raft fractionation by OG-selective solubility, HUVECs were lysed in OG-free buffer, 
lysates were centrifuged at 18 500 g and supernatants were retained as soluble 
fraction (sol), while the pellet was further lysed with a buffer containing OG. Lysates 
were centrifuged at 18 500 g and supernatants were retained as raft fraction (raft), 
while the pellet was further lysed and represented the nuclear fraction (nuc). 
Samples were immunoblotted with antibodies against CD73, catalase (soluble 
marker) and CD59 (raft marker).
Caveolin-1
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surface of HUVECs (Fig. 5.4 arrow). This could be indicative for a role of CD73 as 
an adhesion protein or in guidance during TEM. To determine the exact localisation 
of CD73 during leukocyte TEM, transmission electron microscopy and immunogold 
labelling would need to be carried out.
5.4 Detection of CD73 activity by radio-thin layer chromatography
The enzymatic activity of CD73 converts AMP to adenosine. The activity can be 
assayed by radio-TLC using tritium-labelled AMP (3H-AMP) and unlabelled AMP, 
separation of the nucleotides by TLC and detection by tritium-sensitive film. To 
determine optimal conversion of 3H-AMP, different timepoints and concentrations of 
unlabelled AMP were tested. As expected, the conversion of 3H-AMP was slower 
with increasing concentration of unlabelled AMP (Fig. 5.5A). After 45 min a second 
product could be detected for low unlabelled AMP concentrations, which is likely to 
be inosine. The intermediate concentration of 200 pM unlabelled AMP was chosen 
for future experiments, as the conversion was at a good rate. The enzymatic activity 
was calculated as 3H-adenosine/3H-AMP and results were normalised to the 
respective control.
The non-hydrolysable CD73 inhibitor AMP-CP was used to inhibit the 
enzymatic activity. HUVECs were incubated with various concentrations of AMP-CP 
before the enzymatic activity was determined by radio-TLC. A concentration of 
50 pM AMP-CP gave the best inhibitory effect, with 57% inhibition (Fig. 5.5B). This 
concentration was used in future experiments. The less efficient inhibition at high 
AMP-CP concentrations could be due to decreased specificity, where other 
pathways could be activated/inhibited.
The binding of leukocytes to the endothelium has been shown to inhibit 
endothelial CD73 in a cell number-dependent manner (Henttinen et al., 2003). To 
determine the optimal number of THP-1 cells for future experiments, different cell 
numbers were allowed to adhere to TNF-a-activated (10 ng/ml, 15 - 18 h) HUVECs 
before the enzymatic activity was determined. THP-1 cells have no detectable CD73 
activity under these conditions (data not shown). As expected, endothelial CD73 
activity was decreased in a cell number-dependent manner, with a maximal 
decrease of 63%. For future experiments, 3 x 105 THP-1 cells per 24-well were 
chosen since this cell number had a leukocyte/HUVEC ratio of roughly 1.5:1. This 
number of THP-1 cells inhibited the enzymatic activity by -  20%. Under conditions 
where higher inhibition was needed, 1 x 106 THP-1 cells were used, resulting in a 
leukocyte/HUVEC ratio of roughly 5:1 and ~ 50% inhibition.
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Figure 5.3: CD73 appears to be accumulated around adherent T lymphoblasts
T lymphoblasts were added to TNF-a-stimulated HUVECs for 12 min, before cells 
were fixed and stained with antibodies against CD73 and Cav-1. Z-stack confocal 
sections were taken using a Zeiss LSM510. A: Schematic of adherent 
T lymphoblast and HUVEC monolayer. B - D: Z-stacks of the same cell are 
displayed for different values of Y. E: Projection of Z-stack. Dotted lines indicate the 
approximate localisation of sections B -  D.
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Figure 5.4: CD73 appears to be accumulated around transmigrating THP-1 
cells
CellTracker™-labelled THP-1 cells (1 pM, 30 min, 37°C) were allowed to adhere to 
TNF-a-stimulated HUVECs for 25 min, before cells were fixed and stained with 
antibodies against CD73. Z-stack confocal sections were taken using a Zeiss 
LSM 510. A: Schematic of transmigrating THP-1 cell and HUVEC monolayer. 
B: Z-stack of THP-1 cell in zy-plane. C: Projection of Z-stack. Bar = 20 pm.
5.5 C ross-link ing  o f ICAM-1 and VCAM-1 does not induce inh ib ition  o f 
CD73
Since one of the first steps of leukocyte binding is the interaction of leukocyte 
integrins with endothelial adhesion molecules such as ICAM-1 and VCAM-1, the 
effect of engagement of ICAM-1 or VCAM-1 on CD73 inhibition was tested. To this 
end, ICAM-1, VCAM-1 and CD73 were clustered with antibodies and CD73 
enzymatic activity was determined. Cross-linking of adhesion molecules has been 
shown to induce intracellular signalling, by mimicking leukocyte binding (van 
Wetering et al., 2003). Clustering of ICAM-1 and VCAM-1 with antibodies did not 
induce CD73 inhibition when compared to \qG, control (Fig. 5.6A). Only cross- 
linking with CD73 antibodies induced inhibition of the enzymatic activity by 65.1 ± 
2.9% of IgGi control, or 55.8 ± 2.9% of untreated control. Binding of CD73 antibody 
without cross-linking induced a similar inhibition. These results indicate that ICAM-1
CD73
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Figure 5.5: Endothelial CD73 enzymatic activity is inhibited by THP-1 cell 
binding
CD73 activity was determined by radio-TLC procedures. HUVECs were incubated 
with 3H-AMP (180 pM) and unlabelled AMP. Aliquots of the supernatant were 
applied to TLC plates and nucleotides were separated using isobutyl 
alcohol/isoamyl alcohol/2-ethoxyethanol/ammonia/H20  (ratio 9:6:18:9:15) as a 
solvent. 3H-nucleotides were visualised using 3H-sensitive film. CD73 activity was 
calculated as 3H-adenosine/3H-AMP and results were normalised to untreated 
control. A: HUVECs were incubated for 0 - 4 5  min with 3H-AMP and 20 -  900 pM 
unlabelled AMP. A representative autoradiograph is shown. B: HUVECs were 
treated with CD73 inhibitor AMP-CP (0 -  500 pM, 60 min, 37°C) before incubation 
with 3H-AMP/AMP (180/200 pM, 10 min, 37°C) and subsequent detection of CD73 
activity by TLC. Mean of two experiments is shown. C: Indicated numbers of THP-1 
cells were added to TNF-a-stimulated HUVECs for 25 min, before incubation with 
3H-AMP/AMP (180/200 pM, 10 min, 37°C) and subsequent detection of CD73 
activity by TLC.
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and VCAM-1 signalling are not involved in CD73 inhibition after leukocyte binding. It 
remains to be determined if antibody binding to CD73 (cross-linked or not) inhibits 
the enzymatic activity due to induction of conformational changes or by steric 
hindrance of the active site.
The binding partner of CD73 on leukocytes is currently unknown, but 
homophilic interactions between endothelial and leukocyte CD73 have been 
suggested (Airas et al., 1993). To investigate a possible role for homophilic 
interactions in the inhibition of the enzymatic activity, THP-1 cells were treated with 
CD73 antibody before adhesion to HUVECs and subsequent detection of CD73 
activity. CD73 antibody binding did not alter the inhibitory effect of leukocyte binding 
(Fig. 5.6B). This indicates that either antibody binding does not prevent homophilic 
interactions, or homophilic interactions do not play a role in leukocyte-induced 
inhibition of CD73.
5.6 H2O2 treatment attenuates leukocyte-induced inhibition of CD73 
activity
In rat hepatocytes, CD73 has been shown to be susceptible to oxidative 
modification (Kocic et al., 2001) and ROS-scavenging substances decreased the 
elevated CD73 activity in patients with obese type 2 diabetes (Stefanovic et al., 
2005). To investigate if endothelial CD73 was regulated by H20 2, CD73 enzymatic 
activity was determined in HUVECs that had previously been treated with or without 
H20 2 or been incubated with H20 2-treated THP-1 cells. HUVECs were treated with 
10 pM H20 2, this concentration was chosen since ECs have been shown to produce 
ROS in the low pM range (Deem and Cook-Mills, 2004). HUVEC treatment with 
H20 2 had no effect on the enzymatic activity at the tested concentration (Fig. 5.6C). 
Treatment of THP-1 cells with increasing concentrations of H20 2 though had a 
significant effect on their ability to inhibit endothelial CD73 compared to untreated 
THP-1 cells. Untreated THP-1 cells induced 52.5 ± 5.6% inhibition; whereas THP-1 
cells treated with 5 mM H20 2 induced only 30 ± 9.9% inhibition, resulting in a 22.5% 
difference between untreated and H20 2-treated cells.
This result indicates that CD73 inhibition could be mediated by direct 
interaction with a cell surface molecule on the leukocyte surface. This binding 
partner could be modified by H20 2 treatment, which would lead to less effective 
inhibition after binding to the endothelium.
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Figure 5.6: Regulation of CD73 activity in ECs
A: TNF-a-stimulated HUVECs were washed and cross-linking was carried out with 
antibodies against ICAM-1 (1/100), VCAM-1 (1/100), RhoE (undiluted) or CD73 
(undiluted) (30 min, 4°C). Monolayers were washed and either incubated with FITC- 
conjugated anti-mouse antibody (1/100) or PBS only (20 min, 37°C). Controls 
included HUVECs incubated with no antibody, only secondary antibody or IgG-i 
negative control (30 min, 4°C). CD73 activity was detected by radio-TLC. n > 3, 
except for RhoE and CD73 without cross-linking, where mean of two experiments is 
shown. B: THP-1 cells (3 x 105) were either incubated with IgGi or CD73 antibodies 
(30 min, 4°C) or left untreated before cells were washed and added to TNF-a- 
stimulated HUVECs for 25 min. Unbound THP-1 cells were washed off and CD73 
activity determined by radio-TLC. Means of two experiments are shown. C: 1 x 106 
THP-1 cells were treated with H20 2 ( 0 - 5  mM, 30 min, 37°C) before being added to 
TNF-a-stimulated HUVECs for 25 min. HUVECs were treated with or without 0.01 
mM H20 2 (30 min, 37°C). CD73 activity in all samples was measured using radio- 
TLC. n = 6. Results are normalised to ‘no Ab’ (A), ‘-THP-1’ (B) or '-THP-1 0 H20 2’ 
(C). Bars represent SEM. ★★★ p < 0.001, ★★ p < 0.01, ★ p < 0.05 determined by 
Student’s t-test and Bonferroni post-test, compared to ‘no Ab’ (A), or ‘-THP-1 
0 H20 2* (C); # p < 0.05 determined by two-way ANOVA.
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5.7 Localisation does not influence enzymatic activity and vice versa
The cell surface enzyme CD39 has been shown to be partially localised in lipid rafts 
and cholesterol-depletion with M(3CD results in a strong inhibition of the enzymatic 
activity (Papanikolaou et al., 2005). To test if CD73 activity is dependent on the raft 
localisation, ECs were subjected to cholesterol-depletion before CD73 activity was 
determined. To demonstrate effective cholesterol depletion, HUVECs were labelled 
with filipin, a highly fluorescent cholesterol marker. After 15 min of incubation with 
M(3CD, a large proportion of membrane cholesterol was depleted (Fig. 5.7A). The 
proportion increased with longer incubation times, but since these can also lead to 
cell damage the 15 min incubation time was used in all future experiments. The 
enzymatic activity of CD73 was determined in cholesterol-depleted HUVECs either 
in the absence (- s) or presence (+ s) of serum. Serum is a source of cholesterol 
and can therefore interfere with the depletion, but at the same time contributes to 
the viability of the cells. Cholesterol-depletion had no effect on CD73 activity 
(Fig. 5.7B), indicating that unlike CD39, CD73 activity is not dependent on raft 
localisation.
To determine if inhibition of CD73 leads to relocalisation of the protein, 
immunofluorescence staining with AMP-CP-treated HUVECs was carried out. 
Confluent HUVEC monolayers were incubated with different concentrations of 
AMP-CP and cells were stained for CD73 and F-actin (Fig. 5.8A - C). CD73 
localisation was not detectably altered by the inhibitor, but HUVECs appeared more 
elongated when treated with AMP-CP. To determine if CD73 inhibition influenced 
the localisation during TEM, HUVECs were incubated with different concentrations 
of AMP-CP before THP-1 cells were allowed to transmigrate. Cells were fixed and 
stained for CD73, the junctional marker ZO-1 and F-actin. CD73 localisation was not 
changed upon incubation of the inhibitor: it was still localised around transmigrating 
leukocytes (Fig. 5.8D - F). Therefore, CD73 enzymatic activity does not influence 
localisation of the protein.
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Figure 5.7: Raft localisation is not obligatory for CD73 activity
HUVECs were cholesterol-depleted by treatment with 4 mg/ml M(3CD. A: Efficiency 
of cholesterol depletion (0 -  25 min, 37°C) was visualised by filipin staining and 
fluorescent microscopy. Bar = 50 pm. B: CD73 activity was determined in 
cholesterol-depleted HUVECs (15 min, 37°C) by radio-TLC either in the presence 
(MpCD + s) or absence (MpCD - s) of serum.
5.8 CD73 inh ib ito r reduces transendothelia l m igration
Having characterised CD73 in HUVECs, it was interesting to investigate the role of 
CD73 enzymatic function in leukocyte TEM by studying the effects of AMP-CP. To 
this end, TNF-a-activated (10 ng/ml, 15 - 18 h) HUVECs were incubated with 
different concentrations of AMP-CP before addition of THP-1 cells or 
T lymphoblasts. TEM was monitored by TLM and results were normalised to the 
respective untreated control. Preliminary data suggest that THP-1 TEM is 
decreased for 50 -  250 pM AMP-CP and increased for high concentrations 
(Fig. 5.9A). For T lymphocytes, TEM was not altered significantly (Fig. 5.9B). The 
discrepancy between the two cell types could be due to two factors: firstly, different 
expression levels of leukocyte CD73; and secondly, differences in the expression 
level of ADA leading to different concentrations of remaining adenosine.
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Figure 5.8: CD73 localisation is independent of enzymatic activity
HUVECs were treated with TNF-a for 15 -  18 h and subsequently with AMP-CP (0 -  
500 pM, 60 min, 37°C). A -  C: HUVECs were labelled with specific antibodies 
against CD73 and phalloidin to visualise F-actin. D - F: CellTracker™-labelled 
THP-1 cells were added to TNF-a-stimulated HUVECs for 25 min before cells were 
fixed and stained for CD73, ZO-1 and F-actin. Bar = 20 pm.
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5.9 CD73 is only partially cleaved by PI-PLC
Having shown that inhibition of CD73 enzymatic activity influences TEM, it was 
interesting to investigate how removal of CD73 from the surface would influence 
TEM. CD73 has been proposed to have functions independent of its enzymatic 
activity (Airas et al., 1995; Airas et al., 2000; Airas et al., 1993). To address the 
question of whether these functions could play a role in leukocyte TEM, PI-PLC was 
used to cleave CD73 from the surface. PI-PLC has been shown to cleave GPI- 
anchored proteins and lead to their shedding from the surface (Ferguson and 
Williams, 1988; Low and Saltiel, 1988). PI-PLC efficiency in HUVECs was 
determined by immunofluorescence staining, FACS analysis and immunoblotting. 
PI-PLC treatment did not alter HUVEC morphology, as revealed by F-actin staining 
(Fig. 5.10A, B). CD73 on the surface was reduced, but FACS analysis showed that 
levels were only decreased by 54.2 ± 6.8% (Fig. 5.10C). To examine if PI-PLC- 
treatment was efficient, lysates from treated HUVECs were immunoblotted against 
CD59, a GPI-anchored marker of lipid rafts. CD59 was almost completely shed from 
the surface at 0.05 U/ml PI-PLC, indicating that the treatment was efficient (Fig. 
5.10D). It has been shown that some GPI-anchored proteins are resistant to 
cleavage by PI-PLC due to an inositol acylation of the GPI anchor at an early stage 
in their biosynthesis (Englund, 1993; Wong and Low, 1992). The results from the PI- 
PLC treatment suggest that CD73 could contain this modification.
5.10 Knock-down of CD73 in HUVECs by RNAi
Since removal of CD73 from the surface with PI-PLC was not efficient, a k-d 
approach using siRNA was carried out. Multiple siRNA oligonucleotides from 
different companies (Dharmacon oligos #1 - #4, Ambion oligo (A), Qiagen oligos 
#1 - #5) were used (separately) per gene. Since the majority of the experiments 
were carried out with the oligos from Dharmacon, the term ‘oligo xy’ refers to the 
Dharmacon oligo numbering only. The use of multiple oligos allows distinction 
between k-d and off-target effects. As controls, HUVECs were mock-transfected or 
transfected with a non-targeting siRNA control oligo (siControl; siC). In all 
experiments HUVECs were used 72 h after transfection and results were 
normalised to siControl sample, unless otherwise stated.
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Figure 5.9: Inhibition of CD73 enzymatic activity reduces THP-1 cell TEM
TNF-a-stimulated HUVECs were incubated with AMP-CP (50 |jM, 60 min, 37°C). 
THP-1 cells (A) or T lymphoblasts (B) were allowed to transmigrate for 2 h in a TLM- 
based TEM assay. Transmigration rate was determined from the time-lapse movies 
and results were normalised to untreated control. Means of two experiments are 
shown.
5.10.1 Expression level of cell adhesion proteins
CD73-deficient (CD73 7 ) mice have been shown to exhibit increased VCAM-1 levels 
in carotid arteries and cultured aortic ECs (Zernecke et al., 2006). To investigate the 
cell surface levels of adhesion molecules in CD73 k-d ECs and to determine the k-d 
efficiency, HUVECs were labelled with specific antibodies for CD73, ICAM-1, 
VCAM-1, E- and P-selectin and analysed by FACS analysis. Representative FACS 
traces show that CD73 RNAi induced a clear reduction of CD73 levels for all oligos 
(Fig. 5.11A). To be able to determine the k-d efficiency for CD73 from the total 
protein content rather than just the cell surface levels, HUVECs were fixed and 
permeabilised before staining with CD73 antibodies. Background staining with IgGi 
negative control was very high under these conditions. Again, CD73 siRNA induced 
a shift of the whole population for all oligos (Fig. 5.11B). Representative FACS 
traces for ICAM-1 showed a relatively broad curve for siC HUVECs, indicating 
varying expression levels under control conditions (Fig. 5.11C). CD73 siRNA 
induced an upwards shift of the ICAM-1-positive cell population, while the broad 
curve was maintained. In agreement with the literature, VCAM-1 was not expressed 
above IgGi negative control level in samples that were not TNF-a-stimulated (Fig. 
5.11D). CD73 siRNA induced a slight shift in the VCAM-1-positive population for 
most oligos. One oligo (#2, brown trace) displayed a shift and a second
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Figure 5.10: CD73 is partially resistant to PI-PLC-mediated shedding
HUVECs were incubated with 0 -  0.5 U/ml PI-PLC (15 min, 37°C). A, B: Cells were 
fixed and stained for CD73 and F-actin. Bar = 50 pm. C: Cells were labelled with 
antibodies against CD73 and CD73-positive cells were determined by FACS 
analysis, n = 3. D: Lysates of PI-PLC-treated HUVECs were used for 
immunoblotting using antibodies against CD59.
population with higher VCAM-1 expression. E- and P-selectin, similar to VCAM-1, 
are not expressed under non-inflammatory conditions. CD73 siRNA induced a slight 
shift in the E- and P-selectin-positive population for most oligos (Fig. 5.11E). For 
E-selectin, one oligo (#2, brown trace) displayed a shift and a second population 
with higher E-selectin expression.
The k-d level and the changes in expression level were calculated from the 
FACS data by normalising the mean fluorescence of the total population of 
individual samples to the mean fluorescence of the total population of the siControl 
sample. CD73 was knocked-down maximally by 78.5 ± 2.7% (#3) (Fig. 5.12A), while
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CD73 RNAi induced upregulation of cell surface expression of ICAM-1 maximally by 
66 ± 15% (#1) (Fig. 5.12B), VCAM-1 maximally by 62.8 ± 15.3% (#4) (Fig. 5.12C), 
E-selectin maximally by 144 ± 35.8% (#2) (Fig. 5.12D) and P-selectin maximally by 
122% (#2) (Fig. 5.12E). It is interesting to note that even though all siRNAs used 
effectively knock-down CD73, the effect on the expression level of endothelial 
adhesion molecules is variable. In particular oligo 3, which has the best CD73 
knock-down, induces the least increase in expression level of adhesion molecule, 
except for P-selectin, where oligo 1 shows no expression upregulation.
As TNF-a up-regulates the same adhesion molecules, it was interesting to 
see how TNF-a treatment influenced the expression level of adhesion molecules in 
CD73 k-d cells. The actual differences in expression level for TNF-a-treated and 
untreated HUVECs are displayed in Table 5.1. For relative protein levels referring to 
the respective siControl sample with or without TNF-a, the increase in ICAM-1 
levels in TNF-a-treated cells was 19.6 ± 17% and was therefore lower than in 
untreated cells (41.4 ± 9.5%). Similarly, the increase was also lower for VCAM-1 
(41 ± 12.3% vs. 56.8 ± 2.9%) and E-selectin (36.7 ± 20.3% vs. 70.3 ± 22.6%) when 
treated with TNF-a. This could indicate that TNF-a- and k-d-induced upregulation of 
adhesion molecules are antagonistic.
Zernecke et al. have shown an increase in NF-kB activity in CD73'/' ECs 
(Zernecke et al., 2006). To test if NF-kB activity was increased in k-d HUVECs, 
immunoblotting against the NF-kB inhibitor IkB-o was carried out. The analysis of 
very preliminary results suggests that IkB-o level decreased in most of the k-d 
samples when compared to the loading control, although other oligos (Qiagen #2 
and #4) induced an increase in IkB-o level (Fig. 5.13). These results might 
tentatively suggest a role for NFkB activation in mediating effects of CD73 k-d, but 
much further work is required to establish this and to correlate activation of NFkB 
with the observed changes in adhesion molecule expression. Again, the knock­
down level of CD73 for the different oligos used do not seem to be directly related to 
the expression level of IkB-o , since oligo 3 (Dharmacon), which has the best knock­
down efficiency does not induce a decrese in IkB-o level.
These results suggest that CD73 k-d induces a pro-inflammatory phenotype 
in HUVECs, as indicated by the up-regulation of adhesion molecules.
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Figure 5.11: Expression of adhesion molecules is upregulated after CD73 k-d
CD73 was knocked-down in HUVECs using specific oligonucleotides (oligos #1 - 
#4, ambion). As controls, cells were treated with a non-targeting siControl oligo 
(siControl). Cells were analysed 72 h after transfection; representative FACS traces 
are shown. Live HUVECs were stained for CD73, ICAM-1, VCAM-1 and E- and 
P-selectin, except for (B), where cells were fixed and permeabilised prior to staining.
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Figure 5.12: Quantification of changes in cell surface expression level after 
CD73 knock-down
CD73 was knocked down in HUVECs using specific oligos (#1 - #4, A (ambion)). As 
controls, cells were mock-transfected (m) or treated with a non-targeting siControl 
oligo (siC). Cells were analysed 72 h after transfection. A -  E: HUVECs were either 
stimulated with TNF-a for 15 -  18 h (grey bars) or left untreated (black bars). Cell 
surface expression levels of CD73, ICAM-1, VCAM-1, E- and P-selectin were 
determined by FACS analysis. Results are normalised to the respective siControl. 
Bars represent SEM. n £ 3, except for P-selectin, where mean of two experiments 
are shown. ★★★ p < 0.001, ★★ p < 0.01, ★ p < 0.05 determined by Student’s t-test 
and Bonferroni post-test, compared to siC.
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oligos Relative adhesion molecule expression (% of siControl)
CD73 ICAM-1 VCAM-1 E-selectin
P-
selectin
- TNF -a + TNF-a -TN F-a + TNF-a - TNF-a + TNF-a -TNF -a + TNF-a - TNF-a
m 108.0 ± 18.3 132.0 ±47.6 91.2 ±7 .3 411.8 ±121.3 124.7 ±27.6 611.7 ±507.4 111.4 + 16.1 772.8 95.0
c siC 100.0 ± 0.0 91.3 ±8 .6 100.0 ±0 .0 432.9 ±46.4 100.0 ±0 .0 622.2 ±226.8 100.0 ± 0.0 551.4 ±211.6 100.0o
O
<Q #1 24.7 ± 3.2 27.0 ±5 .8 167.6 ±14.7 923.2 ± 167.5 150.3 ±17.0 1180 ±484.8 171.0 ± 27.1 734.2 ±310.3 108.6
E
( 0 #2 33.7 ± 4.6 36.7 ±9 .4 150.0 ±15.8 522.8 ±89.0 158.8 ± 16.7 557.5 ± 169.3 244.0 ± 35.9 731.9 ±240.9 156.2
a #3 21.5 ± 2.7 n.d. 116.0 ±9 .4 397.9 ±152.3 149.5 ±19.8 n.d. 105.4 + 13.0 n.d. 119.0
#4 35.3 ± 4.3 38.8 ±9 .8 122.9 ±9 .0 368.9 ±44.7 162.8 ±15.3 718.5 ±220.8 181.5 ± 16.2 292.9 ±34.3 222.1
Am Dion (A) 42.4 ± 4.0 n.d. 150.6 ±25.3 n.d. 162.6 ±21.8 n.d. 149.7 ± 26.7 n.d. n.d.
m 103.5 n.d. 85.1 n.d. 88.6 n.d. 179.6 n.d. 94.0
siC 100.0 n.d. 100.0 n.d. 100.0 n.d. 100.0 n.d. 100.0
c
0 ) #1 46.6 n.d. 149.3 n.d. 182.9 n.d. 159.8 n.d. 207.1
CO
o
#2 21.2 n.d. 96.0 n.d. 97.7 n.d. 99.2 n.d. 84.4
#4 31.6 n.d. 194.7 n.d. 163.1 n.d. 132.7 n.d. 146.2
#5 35.1 n.d. 89.4 n.d. 190.5 n.d. 201.7 n.d. 185.5
Table 5.1: Relative adhesion molecule expression in CD73 knock-down HUVECs
CD73 was knocked down in HUVECs using specific oligonucleotides (oligos). As controls, cells were mock-transfected (m) or treated with a 
non-targeting siControl oligo (siC). Cells were analysed for expression levels of CD73, ICAM-1, VCAM-1, E- and P-selectin by FACS analysis 
72 h after transfection. Mean fluorescence of total cell population is normalised to siC. n £ 3, except for Qiagen oligos and P-selectin, where 
means of two experiments are shown.
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5.10.2 CD73 enzymatic activity is reduced in k-d cells
The enzymatic activity of CD73 in CD73 k-d cells was determined by radio-TLC. As 
expected the enzymatic activity was significantly reduced maximally by
92.2 ±6.48% (#4; Fig. 5.14).
5.10.3 Morphological changes in CD73 k-d HUVECs
There was an obvious change in the morphology of HUVECs following CD73 k-d. 
Cells knocked down with oligos #1, #2 and #4 exhibited an elongated morphology 
not unlike morphological changes occurring after TNF-a treatment, while oligo #3, 
which so far has given the weakest results, displayed a phenotype more similar to 
the siControl sample (Fig. 5.15). This could indicate that oligo 3 induces off-target 
effects which prevent the development of the CD73 phenotype, despite the high 
knock-down efficiency. This further strengthens the previous observation that CD73 
k-d induces a pro-inflammatory phenotype.
To follow up on this result, confluent monolayers of CD73 siRNA-, siControl- 
and mock-transfected cells were fixed and stained for tubulin and F-actin to 
visualise morphological changes (Fig. 5.16). The tubulin network appeared less 
prominent in all transfected samples, including siControl, indicating that this might 
be a transfection artefact. The elongated phenotype previously observed by phase- 
contrast microscopy on tissue culture plastic was less obvious under conditions on 
glass coverslips, but an increase in stress fibres was detected, similar to, but less 
than TNF-a-treated samples (see Fig. 3.2).
5.10.4 Leukocyte adhesion and TEM to and across CD73 k-d HUVECs is 
increased
The pro-inflammatory phenotype of CD73 k-d cells suggests that leukocyte 
adhesion and TEM could be affected by the knock-down. Adhesion and TEM of 
untreated THP-1 and CCRF-CEM cells was determined in adhesion and 
Transwell™-based TEM assays with TNF-a-stimulated and unstimulated CD73 k-d 
HUVECs. THP-1 TEM was increased for most of the oligos tested, by a maximum of 
21.9 ± 6.6% (#2), while others induced a decrease in TEM, by a maximum of 42.3 ± 
5.3% (#1) (Fig. 5.17A). TNF-a-treated samples displayed higher transmigration 
rates throughout. CCRF-CEM cell TEM was only slightly changed by CD73 k-d with 
a maximal increase of 8.7 ± 5.3% (#1), while oligo A induced a decrease of
182
5 Results
Dharmacon Qiagen
I k B - q
GAPDH
B 250
m siC #1 #2 #3 #4 m siC #1 #2 #4 #5
s a a s i s ■ * -
m *  rnm m m m m m m
a. 100
m sic 1 2 3 4 m sic 1 2 4 5
Figure 5.13: CD73 knock-down decreases IkB-o level
CD73 was knocked down in HUVECs using specific oligos. As controls, cells were 
mock-transfected (m) or treated with a non-targeting siControl oligo (siC). Cells 
were lysed 72 h after transfection and cell lysates were used for immunoblotting 
with specific antibodies against IkB-o and GAPDH as loading control (A). 
Densitometric quantification: IkB-o levels were normalised to GAPDH (B). Results 
from one experiment are shown.
28.4 ± 2.9% (Fig. 5.17C). Adhesion was increased for THP-1 and CCRF-CEM cells 
under non-inflammatory conditions by a maximum of 26.5 ± 10.8% (#2) and 241 ± 
153% (#3), respectively, but no increase could be observed with TNF-a-treated 
HUVECs (Fig. 5.17B, D). Again, not all oligos displayed the same trend. The actual 
changes between TNF-a and unstimulated HUVECs are shown in Table 5.2. These 
results indicate that TNF-a treatment overrides the CD73 k-d effects for adhesion, 
hence no differences in adhesion can be observed, while TEM seems to require 
additional regulatory mechanisms. In conclusion, no consistent differences in 
leukocyte TEM following CD73 k-d could be detected. Interestingly, not only did the 
different oligos used display a variability in the extent of the effect seen, but in the 
case of TEM displayed opposing results. It would be interesting to determine how 
these are achieved and what role possible and different off-target effects induced by 
the oligos play.
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Figure 5.14: CD73 enzymatic activity is decreased in CD73 knock-down cells
CD73 was knocked down in HUVECs using specific oligos (#1 - #4, A). As controls, 
cells were mock-transfected (m) or treated with a non-targeting siControl oligo (siC). 
CD73 activity was determined by radio-TLC 72 h after transfection. Results are 
normalised to siC. Bars represent SEM. n = 3. ★ ★★ p < 0.001, ★★ p < 0.01 
determined by Student’s t-test and Bonferroni post-test, compared to siC.
5.10.5 H20 2-induced TEM defect is not dependent on CD73
As previously demonstrated, the ability to induce inhibition of CD73 was 
compromised in H20 2-treated THP-1 cells, and thus it was tempting to speculate 
that CD73 activity plays a role in the TEM defect of H20 2-treated THP-1 cells 
discussed in the previous chapters. Thus, the H20 2-induced TEM defect should not 
be as pronounced with CD73 k-d HUVECs as seen in control conditions. To test this 
hypothesis, H20 2-treated THP-1 cells were allowed to transmigrate across CD73 
siRNA (#2)- or siControl-transfected HUVECs. The results were normalised to the 
respective untreated control (Fig. 5.18). The decrease in TEM was similar for control 
cells and CD73 k-d, although the overall TEM rate was higher for k-d HUVECs. This 
indicates that the reduced ability of H20 2-treated cells to inhibit CD73 does not 
influence TEM. Thus, endothelial CD73 does not seem to play a role in the H20 2- 
mediated decrease in leukocyte TEM.
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Figure 5.15: CD73 knock-down induces pro-inflammatory phenotype
CD73 was knocked-down in HUVECs using specific oligos (#1 - #4). As controls, 
cells were mock-transfected (m) or treated with a non-targeting siControl oligo (siC). 
Cells were either treated with or without TNF-a for 15 -  18 h and were analysed 
72 h after transfection. Representative phase-contrast images of at least five 
experiments are shown. Bar = 50 pm.
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Figure 5.16: HUVECs display more stress fibres after CD73 knock-down
CD73 was knocked-down in HUVECs using specific oligos (#1 - #4). As controls, 
cells were mock-transfected (m) or treated with a non-targeting siControl oligo (siC). 
Cells were fixed 72 h after transfection and stained for tubulin and F-actin. 
Representative images of three experiments are shown. Bar = 50 pm.
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Figure 5.17: Leukocyte TEM and adhesion are affected by CD73 k-d
CD73 was knocked-down in HUVECs using specific oligos (#1 - #4, A). As controls, 
cells were mock-transfected (m) or treated with a non-targeting siControl oligo (siC). 
HUVECs were used in Transwell™-based TEM assays or adhesion assays using 
THP-1 and CCRF-CEM cells. A: THP-1 transmigration rate across TNF-a- 
stimulated (grey bars) or unstimulated (black bars) HUVECs. n £ 5. B: THP-1 
adhesion to TNF-a-stimulated (grey bars) or unstimulated (black bars) HUVECs. n > 
4. C: CCRF-CEM cell transmigration rate across HUVECs. n = 3. D: CCRF-CEM 
cell adhesion to TNF-a-stimulated (grey bars) or unstimulated (black bars) 
HUVECs. n = 3.
Results are normalised to the respective siControl. Bars represent SEM. 
★ ★★ p < 0.001, ★★ p < 0.01, ★ p < 0.05 determined by Student’s t-test and 
Bonferroni post-test, compared to siC.
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oligos Relative TEM (% of siControl) Relative adhesion (% of siControl)
- TNF-a + TNF-a -TNF-a + TNF-a
m 100.8 ±8.0 92.6 ± 15.9 87.7 ±6.8 145.8 ±28
c siC 100.0 ±0.0 87.8 ±8.3 100.0 ±0.0 218.0 ±39.3
TH
P-
1 
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lls
Dh
ar
m
ac
o #1
#2
#3
#4
57.7 ±5.3  
121.9 ±6.6  
108.2 ±8.8
79.7 ±6.8
70.3 ±8.7
98.4 ±8.4  
121.6
75.7 ±7.9
119.7 ±8.4  
126.5 ± 10.8 
66.8 ± 10.2 
103.1 ± 10.3
216.9 ±54.1 
272.2 ±64.8
187.5
274.5 ±71.7
Ambion (A) 114.4 ±32.2 106.5 108.7 ±10.5 153.7
m 100.0 n.d. 96.7 n.d.
W siC 87.6 n.d. 100.0 n.d.
TH
P-
1 
ce
ll ca>o>(0
a
#1
#2
#4
81.1
105.6
86.9
n.d.
n.d.
n.d.
102.4
110.0
107.1
n.d.
n.d.
n.d.
#5 86.3 n.d. 88.1 n.d.
mock 96.7 ± 8.2 n.d. 95.4 ±6.6 187.5 ±35.1
w siC 100.0 ±0.0 n.d. 100.0 ±0.0 232.9 ±38.3
CC
RF
-C
EM
 
ce
l
Dh
ar
m
ac
on #1
#2
#4
#5
108.7 ±5.3  
97.8 ±6.2  
104.9 ±10.3  
98.2 ±9.1
n.d.
n.d.
n.d.
n.d.
105.2 ±6.3
223.3 ±112.3  
340.7 ±152.6
251.4 ±142.7
n.d.
238.3 ±17.5  
n.d.
250.5 ±23.7
A 71.6 ±2.9 n.d. 327.4 ±152.7 n.d.
Table 5.2: Relative leukocyte TEM and adhesion to and across CD73 knock­
down HUVECs
CD73 was knocked-down in HUVECs using specific oligonucleotides (oligos). As 
controls, cells were mock-transfected (m) or treated with a non-targeting siControl 
oligo (siC). HUVECs were used in Transwell™-based TEM assays or adhesion 
assays using THP-1 and CCRF-CEM cells, n > 3, except for Qiagen oligos and 
samples #3 and A plus TNF-a, where means of two experiments are shown.
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Figure 5.18: H20 2 treatment of THP-1 cells decreases TEM across CD73 knock­
down HUVECs
CD73 was knocked-down in HUVECs using oligo #2 (grey bars); control cells were 
transfected with non-targeting siRNA (siC; black bars). Cells were used 72 h after 
transfection in Transwell™-based TEM assays with H20 2-treated THP-1 cells ( 0 - 5  
mM, 30 min, 37°C), which were allowed to transmigrate for 2 h before cells were 
collected from the lower chamber and the TEM rate was calculated. Results from 
each group are normalised to the respective control without H20 2. Bars represent 
SEM. n = 3. ★ p < 0.05 determined by Student’s t-test and Bonferroni post-test.
5.10.6 Endothelial permeability is increased in CD73 k-d cells
Adenosine, the product of CD73 enzymatic activity, has been shown to increase 
endothelial barrier function (Comerford et al., 2002; Lennon et al., 1998; Srinivas et 
al., 2004). The lack of adenosine due to CD73 k-d should therefore lead to a 
decrease in endothelial barrier function, i.e. an increase in permeability. This was 
tested with a FITC-dextran-based permeability assay using mock-, siControl and 
CD73 siRNA-transfected HUVECs. The permeability was increased by a maximum 
of 94.7 ± 24.1% (#2) 40 min after FITC-dextran addition and 45.6 ± 19.6% (#2) after 
80 min (Fig. 5.19). These results indicate that the lack of adenosine is likely to 
induce increased permeability in HUVECs.
5.10.7 Junctional organisation is changed following CD73 k-d
To further investigate the pro-inflammatory phenotype induced by CD73 k-d, the 
junctional organisation was investigated. To this end, mock-, siControl- and CD73 
siRNA-transfected HUVECs were fixed and stained for junctional markers: ZO-1,
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Figure 5.19: Permeability is increased in CD73 k-d HUVECs
HUVECs were transfected with oligos targeting CD73 (#1 - #4, A), non-targeting 
siRNA (siC) or mock-transfected (m). HUVECs were grown on Transwell™ filters 
(0.4 pm pore size) until confluency (72 h after transfection). FITC-dextran (100 
pg/ml) was added to the upper chamber and samples were taken from the lower 
chamber at 40 and 80 min. Fluorescence was measured using a Fusion™ a-FP 
plate reader and results were normalised to the respective control. Bars represent 
SEM. n = 5. ★ ★ p < 0.01 determined by Student’s t-test and Bonferroni post-test.
(3-catenin, VE-cadherin, JAM-A and PECAM-1 with tubulin and F-actin staining as 
cytoskeletal markers. In control cells, ZO-1 staining was localised in the junctions in 
a rather continuous line, whereas junctional ZO-1 staining in k-d cells was 
discontinuous (Fig. 5.20). All samples, including the controls showed a punctate 
nuclear staining, which is likely to be non-specific binding, since it is not abolished 
by ZO-1 k-d (Jaime Millan, unpublished data). Staining with antibodies against 
(3-catenin showed a slight general decrease of (3-catenin in the junctions of k-d cells, 
while the distribution remained similar to control samples (Fig. 5.21). All k-d 
samples, except oligo #3, displayed an increase in actin stress fibres, as described 
previously (Fig. 5.16). The junctional protein VE-cadherin has previously been 
shown to be localised in ‘reticular junctions’ as well as non-reticular junctions 
(Mamdouh et al., 2003). The proportion and breadth of VE-cadherin-containing 
'reticular junctions’ seemed to be increased in CD73 k-d cells, in particular with oligo 
#2 and #4 (Fig. 5.22). JAM-A staining on the other hand appeared decreased for 
most oligos, when compared to the siControl. Preliminary results with PECAM-1 
staining did not show a clear phenotype, while some oligos appeared to have
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Figure 5.20: ZO-1 staining is discontinuous in CD73 k-d cells
HUVECs were transfected with oligos targeting CD73 (#1 - #4), non-targeting siRNA 
(siC) or mock-transfected (m) and stained for ZO-1 and F-actin. Arrows indicate 
discontinuous junctional staining. Representative images of three experiments are 
shown. Bar = 50 pm. A’ -  F’: Details of images A -  F, as indicated by white box.
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Figure 5.21: (3-catenin levels appear to be reduced in CD73 k-d cells
HUVECs were transfected with oligos targeting CD73 (#1 - #4), non-targeting siRNA 
(siC) or mock-transfected (m). HUVEC monolayers were stained for (3-catenin and 
F-actin. Representative images of two experiments are shown. Bar = 50 pm.
merge
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Figure 5.22: VE-containing ‘reticular junctions’ appear to be increased
HUVECs were transfected with oligos targeting CD73 (#1 - #4), non-targeting siRNA 
(siC) or mock-transfected (m) and stained for VE-cadherin, JAM-A and F-actin. 
Representative images of two experiments are shown. Bar = 50 pm.
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Figure 5.23: PECAM-1 staining in CD73 k-d cells
HUVECs were transfected with oligos targeting CD73 (#1 - #4), non-targeting siRNA 
(siC) or mock-transfected (m). HUVEC monolayers were stained for PECAM-1 and 
F-actin. Bar = 50 |jm.
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decreased junctional PECAM-1 expression (#1 and #2), others showed a stronger 
junctional staining, with decreased cell surface staining (#3) or no change compared 
to siControl samples (#4) (Fig. 5.23).
These results indicate that CD73 k-d influences the junctional make-up, 
which is likely to play a role in the observed increase in permeability.
5.10.8 Summary o f siRNA results
To understand the relationship between protein levels of CD73, enzymatic activity, 
levels of adhesion molecules, adhesion, TEM and permeability in TNF-a-treated and 
untreated HUVECs, a correlation analysis was carried out (Table 5.3). Significantly 
negative correlation was found for CD73 k-d and ICAM-1, VCAM-1 and E-selectin 
level, as well as permeability in untreated HUVECs. CD73 activity was significant 
positively correlated with CD73 k-d. P-selectin levels were not included in the 
analysis, since the experiment was carried out only twice. However, no significant 
correlation between CD73 k-d and adhesion and TEM could be detected.
Taken together the siRNA experiments indicate that CD73 activity retains 
ECs in a non-inflammatory state. CD73 k-d ECs exhibit a pro-inflammatory 
phenotype with elongated cells and increased stress fibres and expression of 
adhesion molecules.
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oligonucleotide all #1
no Tl 
#2
NF-a
#3 #4 A all #1
with TN 
#2
F-a
#3 #4 A
CD73 (kd) 70% 76% 67% 79% 65% 58% 6 6 % 72% 64% n.d. 62% n.d.
ICAM-1 -0.4 -0.6 -0.5 -0.2 -0.3 -0.4 -0.4 -0.6 -0.6 n.d. -0.2 n.d.
VCAM-1 -0.3 -0.5
C
DO1 -0.7 -0.5 -0.7 -0.2 -0.6 0.1 n.d. -0.4 n.d.
E-selectin -0.4 -0.5 -0.8 -0.1 -0.6 -0.7 -0.3 -0.8 -0.7 n.d. 0.3 n.d.
transmigration 0.1 0.7 0.5 0.2 0.4 -0.1 -0.1 0.5 -0.4 n.d. 0.5 n.d.
adhesion -0.2 -0.2 -0.1 0.8 0.1 0.4 -0.4 -0.1 -0.4 n.d. -0.1 n.d.
permeability -0.4 -0.9 -0.6 -1 -0.7 1 n.d. n.d. n.d. n.d. n.d. n.d.
CD73 activity 0.9 1 1 1 0.9 1 n.d. n.d. n.d. n.d. n.d. n.d.
Table 5.3: Correlation analysis for Dharmacon CD73 oligonucleotides
CD73 was knocked-down in HUVECs using specific oligonucleotides (#1 - #4, A (Ambion)). As controls, cells were mock-transfected or 
treated with a non-targeting siControl oligo. HUVECs were used 72 h after transfection treated with or without TNF-a for 15 -  18h in 
several assays to determine expression level of CD73, ICAM-1, VCAM-1 and P-selectin. Additionally, k-d HUVECs were used in 
transmigration, adhesion, permeability and CD73 activity assays. Results were normalised to siControl and a correlation analysis was 
carried out. Values represent Pearson’s coefficient (r) unless otherwise labelled. Orange background indicates significant negative 
correlation (p < 0.05); green background indicated significant positive correlation (p < 0.05), while grey background indicates no statistical 
significance, n > 3.
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5.11 Discussion
In this chapter the role of CD73 in leukocyte TEM was investigated. The effects of 
adhesion molecule cross-linking and leukocyte binding on CD73 subcellular 
distribution and enzymatic activity in HUVECs were explored. Specific inhibitors and 
k-d using RNAi was utilised to dissect the role of CD73 in adhesion of leukocytes 
and their subsequent TEM.
Immunofluorescence of HUVECs revealed a discrete punctate staining of 
CD73, which could indicate localisation in microvilli, which are one of the first points 
of contact with leukocytes (Carman et al., 2003). The endothelium has been shown 
to generate ICAM-1- and VCAM-1-enriched microvillus-like structures in response to 
leukocyte binding (Barreiro et al., 2002; Carman et al., 2003). CD73 localisation in 
microvilli could therefore indicate a role in adhesion and TEM. In HUVECs, CD73 
was primarily localised on the apical surface, but CD73 has been reported to be 
present on the apical and basolateral membrane in cultured ECs from capillaries 
isolated from rat epididymal fat (Roberts and Sandra, 1993). CD73 has been shown 
to be localised to caveolae in 165 glioblastoma cells (Ludwig et al., 1999) and in 
polarised intestinal epithelial monolayers (T84) (Strohmeier et al., 1997). In the 
present study, localisation to caveolae could not be detected in HUVECs, instead 
endothelial CD73 partially co-localised with the raft marker CD59. Raft fractionation 
confirmed that a proportion of CD73 was localised in rafts. To determine the raft- 
localised CD73 as a portion of the surface CD73 only, a plasma membrane 
preparation with subsequent raft fractionation would need to be carried out. Raft 
localisation of CD73 has been reported by other groups for other ECs 
(Monastyrskaya et al., 2003) and various melanoma cell lines (Sadej et al., 2006).
The enzymatic activity of the ecto-nucleotidase CD39, which converts ATP 
to AMP, has been shown to be dependent on the localisation of this protein in lipid 
rafts in MDCK cells (Papanikolaou et al., 2005). CD73 activity was not influenced by 
cholesterol-depletion, indicating that endothelial CD73 enzymatic activity is not 
dependent on the raft localisation.
The enzymatic activity of endothelial CD73 has been shown to be inhibited 
by binding of leukocytes (Henttinen et al., 2003). The inhibitory effect is cell number- 
dependent and is likely to occur by masking the catalytic site. The exact mechanism 
is currently unknown. These results were confirmed in the present study, where 
binding of THP-1 cells induced a decrease in adenosine production in a cell 
number-dependent manner. Adenosine promotes endothelial barrier function by 
autocrine stimulation of A2b receptors, leading to relaxation of the actin cytoskeleton
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(Srinivas et al., 2004) and strengthening of the junctions (Comerford et al., 2002). 
The decline in adenosine production after leukocyte binding has been shown to 
decrease endothelial barrier function, which was hypothesised to facilitate leukocyte 
TEM (Henttinen et al., 2003). Leukocytes bind to the endothelium via ICAM-1 and 
VCAM-1 on the ECs (Ley et al., 2007). It was therefore interesting to see if 
engagement of these adhesion molecules could contribute to the inhibition of CD73. 
Neither ICAM-1 nor VCAM-1 cross-linking decreased adenosine production, only 
antibody binding or cross-linking of CD73 did. Antibody-induced inhibition of CD73 
has also been shown for peripheral blood lymphocytes, where antibody binding 
reduced the enzymatic activity by 22 ± 1.5% (Airas et al., 1995). The possible 
involvement of homophilic interactions between CD73 on leukocytes and 
endothelium was investigated by pre-treating THP-1 cells with CD73 antibody. Pre­
treated THP-1 cells induced a similar inhibition of endothelial CD73 as untreated 
cells, indicating that either antibody binding does not prevent homophilic interactions 
or leukocyte CD73 does not play a role in the leukocyte-induced inhibition of 
endothelial CD73. Taken together, these findings suggest that mechanisms other 
than ICAM-1 or VCAM-1 signalling are involved in CD73 inhibition after leukocyte 
binding. Signalling by other adhesion molecules such as selectins could play a role. 
CD73 inhibition could also be mediated by direct binding of an unknown ligand on 
the leukocyte surface. E. coli 5’-nucleotidase has been shown to undergo a hinge- 
bending domain rotation of 96° in order to hydrolyse AMP to adenosine, presumably 
to allow substrate binding and product release (Schultz-Heienbrok et al., 2005). It is 
tempting to speculate that binding of CD73 ligand on the leukocytes or antibody 
binding/cross-linking prevents this domain rotation due to steric hindrance, thereby 
inhibiting adenosine production.
CD73 activity has also been shown to be regulated by oxidative 
modifications (Kocic et al., 2001). In rat liver, 5’-nucleotidase is susceptible to Fe2+ 
ion catalysed oxidative modification. In patients with obese type 2 diabetes, 
increased CD73 activity was found to be reduced by treatment with ROS- 
scavengers (Stefanovic et al., 2005). Regulation of endothelial CD73 through 
oxidative modification could not be detected in the present study following H20 2 
addition. However, only one H20 2 concentration was tested. Liu and Sok have 
reported only a marginal inhibition of CD73 with H20 2 alone, while H20 2 plus Fe2+ 
induced 21.5 ± 2.8% inhibition (Liu and Sok, 2000). This was verified by Kocic et al., 
who have also shown a Fe2+-mediated oxidative inhibition of CD73 activity (Kocic et 
al., 2001). Surprisingly, pre-treatment of THP-1 cells with increasing H20 2
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concentration led to a dose-dependent decrease in their ability to inhibit endothelial 
CD73 after binding. This suggests an oxidative modification of the CD73 ligand on 
the leukocyte surface, which possibly prevents binding or at least inhibition of the 
enzymatic activity. Taken together, these results suggest that endothelial CD73 is 
inhibited via direct interaction with a ligand on the leukocyte surface that undergoes 
oxidative modification and is likely to be different from leukocyte CD73. The identity 
of this ligand remains to be determined.
CD73 is thought to have non-enzymatic functions, such as promoting 
leukocyte binding to the endothelium (Airas et al., 1995; Airas et al., 2000; Airas et 
al., 1993). Engagement of lymphocyte CD73 has been shown to induce LFA-1 
clustering and lead to increased adhesion to ECs. Non-quantitative data from 
immunofluorescence stainings of CD73 in the present study has suggested a 
possible role in leukocyte TEM. Endothelial CD73 appears to be accumulated 
around adherent and transmigrating leukocytes. This could indicate a direct 
involvement of CD73 in diapedesis, possibly as an adhesion molecule. Pre­
treatment of ECs with CD73 antibody has been shown to decrease lymphocyte 
binding by 20% (Airas et al., 1993). Thus, CD73 could have opposing roles in TEM: 
while the enzymatic activity reduces TEM, the enzyme-independent functions 
promote adhesion and diapedesis.
To further investigate the role of CD73 in leukocyte TEM, CD73 enzymatic 
activity was inhibited using a specific, non-hydrolysable inhibitor. The subcellular 
distribution of CD73 was not altered upon inhibitor treatment, confirming that CD73 
activity and localisation are not interdependent. Preliminary data suggest that 
inhibition of CD73 enzymatic activity reduces leukocyte TEM for most 
concentrations of AMP-CP, while TEM is increased for 500 pM AMP-CP.
To remove CD73 from the endothelial surface a k-d approach employing 
specific siRNAs was used. CD73 k-d induced a pro-inflammatory phenotype in 
HUVECs with elongated cells and an increase in actin stress fibres for most oligos 
used. The pro-inflammatory phenotype was confirmed by FACS analysis, where 
increased ICAM-1, VCAM-1 and E- and P-selectin level could be detected. 
However, even though all oligos knocked-down CD73 efficiently, the extent of the 
increase in expression was highly variable between oligos. This variability could be 
observed for most experiments, in particular the adhesion and TEM assays. Even 
though adhesion and TEM was increased for some oligos, no clear overall effect 
could be detected, strongly suggesting that off-target effects play an important role 
for these events. This indicates that a pro-inflammatory phenotype is not sufficient
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to increase adhesion and TEM and other regulatory mechanisms are needed, e.g. 
presentation of chemokines. Data from this study compare well with findings from 
CD73_/' mice (Koszalka et al., 2004), where ECs displayed increased VCAM-1 level 
(Zernecke et al., 2006). Monocyte arrest was increased in CD73'/_ ECs and 
predominantly mediated by VLA-4/VCAM-1. ICAM-1 levels were not increased in 
CD73'/_ ECs, in contrast to findings in the present study, where ICAM-1 levels were 
upregulated following CD73 k-d.
The exact molecular mechanism by which CD73 RNAi induces a pro- 
inflammatory phenotype remains to be solved, but the NF-kB pathway seems to be 
a likely candidate. Minguet et al. have shown that stimuli known to enhance 
intracellular cAMP, such as adenosine, are potent inhibitors of the NF-kB pathway 
(Minguet et al., 2005). NF-kB is one of the main transcriptional regulators in ECs 
activated by inflammatory stimuli such as LPS, IL-1 or TNF-a (De Martin et al., 
2000). Zernecke et al. reported an increase in NF-kB activity in CD73'/_ ECs 
(Zernecke et al., 2006). Preliminary results indicated lower levels of IkB-o after 
transfection with some of the oligos used to knock-down CD73 in HUVECs in the 
present study. This might tentatively suggest NF-kB activation. In future 
experiments, the activation of NF-kB could be demonstrated by ChIP (chromatin 
cross-linking immunoprecipitation), EMSA (electrophoretic mobility shift assay) or by 
investigating nuclear translocation of NF-kB by immunofluorescence. The proposed 
NF-kB activation following CD73 k-d would imply that the decrease of adenosine 
receptor activation in CD73 RNAi or CD73'/_ ECs leads to a constitutive activation of 
NF-kB and transcriptional upregulation of downstream targets. These include cell 
adhesion receptors such as ICAM-1 (Balyasnikova et al., 2000; Collins et al., 1995), 
VCAM-1 (Collins et al., 1995), E-selectin (Collins et al., 1995; Hallahan et al., 1995) 
and MAdCAM (De Martin et al., 2000). To determine whether the observed increase 
in cell surface level of ICAM-1, VCAM-1 and E- and P-selectin in CD73 RNAi 
HUVECs in the present study are achieved by NF-kB activation, NF-kB inhibitors 
should be used in CD73 k-d HUVECs to prevent the development of the observed 
phenotype. Also, to establish the link between adenosine and NF-kB activation, 
adenosine should be added to CD73 k-d HUVECs and the inflammatory phenotype 
as well as NF-kB activity assessed.
It is interesting to note that Zernecke et al. observed decreased ICAM-1 
levels in CD73'/_ arteries, but unaltered mRNA expression (Zernecke et al., 2006). 
The relationship between adenosine/A2A receptor activation and expression of 
adhesion molecules such as ICAM-1, VCAM-1, E-selectin and P-selectin is
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controversial. Bouma and colleagues showed that in activated HUVECs, adenosine 
decreased E-selectin and VCAM-1, but not ICAM-1 expression (Bouma et al., 
1996). However, they could only demonstrate these differences in submaximally 
activated HUVECs (0.01 ng/ml TNF-a for 20 h). Surprisingly, ICAM-1 expression 
was not markedly increased at this concentration, whereas E-selectin and VCAM-1 
expression was. This is contradictory to results from other groups, where ICAM-1 
level shows a stronger increase even at low TNF-a concentrations, and a dose- 
dependent decrease in expression level after adenosine or adenosine-analogue 
addition was observed for ICAM-1 (Zhou et al., 2007). By contrast, Walker et al. 
reported that treatment of mice with the adenosine analogue 3-deazaadenosine led 
to inhibition of ICAM-1 and VCAM-1 expression as well as monocyte adhesion and 
infiltration (Walker et al., 1999). In concordance with these results, McPherson et al. 
showed decreased expression level of ICAM-1, VCAM-1 and P-selectin in mice 
treated with the A 2 a  antagonist ATL-146e (McPherson et al., 2001). Taken together, 
these results and results from the present study suggest that VCAM-1, E-selectin 
and P-selectin expression are negatively regulated by adenosine, whereas 
regulation of ICAM-1 remains controversial.
Interestingly, the pro-inflammatory phenotype was not mirrored in increased 
adhesion and TEM. The oligos used exhibited different, sometimes opposite effects 
on adhesion and TEM, even though they all induced a pro-inflammatory phenotype 
to some degree. This indicates that the oligos induce additional off-target effects in 
the ECs that could interfere with the on-target effect, leading to different outcomes.
In the case where adhesion and TEM were higher, the effects were likely to 
be due to the elevated levels in adhesion molecules on the surface. TEM could 
additionally benefit from the increase in endothelial permeability, although higher 
permeability does not induce TEM per se, as has been shown for H20 2-treated 
THP-1 cells (see Chapter 3). The increase in permeability is thought to result from 
the reduction in adenosine, which has been shown to strengthen endothelial barrier 
function (Srinivas et al., 2004). Interestingly, changes in leukocyte adhesion were 
only apparent under non-inflammatory conditions. TNF-a treatment activates the 
NF-kB pathway, inducing upregulation of cell adhesion receptors involved in 
adhesion and TEM (De Martin et al., 2000; MacEwan, 2002). NF-kB activation is 
likely to be a great deal higher in TNF-a-treated HUVECs than in CD73 k-d cells, as 
can be assumed from the changes in expression level of adhesion molecules (Table 
5.2). Thus, TNF-a treatment seems to override the effects of CD73 RNAi, inducing 
similar levels of adhesion. TNF-a induces upregulation of chemokines (Alom-Ruiz et
201
5 Results
al., 2008; De Martin et al., 2000), which induce integrin activation and leukocyte 
adhesion (Bos, 2005). Chemokine production in CD73 k-d cells has not been 
determined and it is therefore possible that insufficient leukocyte integrin activation 
accounts for the differences in adhesion. However, TNF-a-stimulated CD73 k-d cells 
do have higher expression level of ICAM-1, VCAM-1 and E-selectin, indicating that 
increasing adhesion molecule levels above a certain threshold does not necessarily 
increase adhesion further. Transmigration, which is dependent on more than 
adhesion molecules, seems to be less influenced by CD73 k-d, indicating that CD73 
plays a role in the first step of TEM, adhesion, but not necessarily in diapedesis as 
well. Interestingly, the adhesion of CCRF-CEM cells was increased more than for 
THP-1 cells, indicating differential usage of adhesion molecules between the 
different cell types. The potential changes in the junctional composition in CD73 k-d 
cells could support the general pro-inflammatory phenotype. However, further 
investigations including quantifications of junctional proteins and the ratio of reticular 
to non-reticular junctions are necessary to confirm the preliminary results and to 
understand the implications of these changes.
In conclusion, this study of CD73 has shown that the ecto-enzyme is involved in 
leukocyte TEM. CD73 is likely to have a non-enzymatic function in TEM as it 
appears to be accumulated around adherent and transmigrating leukocytes. The k-d 
of CD73 by RNAi has shown that this ecto-enzyme normally maintains a non­
inflammatory phenotype in HUVECs. Knocking-down CD73 leads to a pro- 
inflammatory phenotype with upregulation of adhesion molecules such as ICAM-1, 
VCAM-1, E- and P-selectin, and increased leukocyte adhesion. These events are 
possibly mediated by NF-kB, which could be activated in CD73 k-d cells due to the 
absence of the inhibitory effect of adenosine (Minguet et al., 2005). However, no 
direct link between the pro-inflammatory phenotype and leukocyte TEM could be 
detected.
These data and work by others indicate that CD73 is crucially involved in the 
regulation of pro- and anti-inflammatory mechanisms in the endothelium. Mimicking 
or increasing CD73 activity could provide protection against atherosclerosis and 
inflammation. Taken together, findings from the present study complement data 
from CD73'7' mice and may help to provide a molecular basis for the therapeutic 
modulation of CD73, in order to prevent or attenuate vascular inflammation.
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Concluding remarks
Oxidative stress has been shown to be involved in the development of a range of 
diseases and has also been implicated in aging. In addition, oxidative stress can 
occur in pathological conditions such as cancer. Oxidative stress can also be 
induced by several other factors, including environmental pollution and personal 
lifestyle choices such as poor diet, smoking and alcohol consumption (Das and 
Vasudevan, 2007; El-Zayadi, 2006; Stone et al., 2007).
Results from this study have demonstrated that H20 2 reduce leukocyte TEM, 
while increasing adhesion to TNF-a-stimulated endothelial cells. It has been 
previously reported in the literature that different concentrations of ROS can have 
different and sometimes even opposing effects (Droge et al., 1994). Similar 
observations were found in this study and are depicted in Figures 6.1a and 6.1b. 
This study has investigated the concentration-dependent effects of H20 2 on 
leukocyte TEM and relevant signalling pathways. I have shown for the first time that 
H20 2 induces two patterns of response in THP-1 cells: 1) a progressive 
increase/decrease with increasing H20 2 concentrations; 2) a response to increasing 
H20 2 concentrations that displays a peak at intermediate concentrations around 0.5 
to 1 mM. A concentration-dependent decrease was observed for TEM, number of 
cellular protrusions and Cdc42 activity, while an increase occurred for intracellular 
ROS, NO and Ca2+ levels. Responses with a peak at intermediate concentrations 
included adhesion to the endothelium, migration velocity, Rac1 activity (in adherent 
cells) and tyrosine phosphorylation. It is tempting to speculate that adhesion and 
TEM, which fall into different pattern categories, are regulated by signalling 
molecules from their respective category.
6.1 Responses with a progressive increase or decrease to H2O2
The TEM defect was most likely mediated by a decrease in cellular protrusions. 
Exploratory protrusions play an important role in TEM, where they probe the 
endothelium for suitable sites of diapedesis (Barreiro et al., 2007). Loss of these 
protrusions could therefore reduce TEM significantly. The decrease in TEM and 
cellular protrusions was accompanied by increased NO levels. Treatment of TFIP-1
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Figure 6.1a: Proposed signal transduction in THP-1 cells at intermediate H20 2 
concentrations
Incubation of THP-1 cells with intermediate concentrations of H20 2 (0.5 -  1 mM, 30 
min, 37°C) increases adhesion and migration speed, while TEM is decreased. 
These events are likely to be mediated by intracellular signalling mechanisms as a 
consequence of direct oxidative modifications. Increased adhesion and motility 
could be mediated by higher Rac1 activity, leading to actin polymerisation, and 
increased tyrosine phosphorylation of adhesion proteins, e.g. paxillin and Src, 
leading to increased adhesion. Direct oxidative modification of adhesion receptors 
could additionally increase adhesion and signal to Rac1. The decrease in TEM 
could be mediated by decreased Cdc42 activity leading to reduction in protrusions. 
Increases in NO levels via up-regulation of iNOS could also contribute to this 
pathway, possibly via increased VASP phosphorylation. Additionally, the H20 2- 
induced increase of intracellular Ca2+ levels could induce contraction of protrusions.
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Figure 6.1b: Proposed signal transduction in THP-1 cells at high H20 2 
concentrations
Incubation of THP-1 cells with high concentrations of H20 2 ( 2 - 5  mM, 30 min, 37°C) 
decreases TEM, while adhesion and motility are unchanged. Adhesion receptors at 
the surface could be oxidised (S-OH) as well as hyperoxidised (S-OOH) in the 
presence of high H20 2 levels, which might reduce adhesion to control levels. 
Decreased RhoA activity could counterbalance the Ca2+-induced increase in 
actomyosin contraction, since no change in motility can be observed under these 
conditions. The decrease in TEM is probably mediated by the same pathways as for 
intermediate H20 2 concentrations, although responses are stronger. These 
pathways include reduction in protrusions due to decreased Cdc42 activity and 
increased NO level via up-regulation of iNOS, possibly leading to increased VASP 
phosphorylation and thus VASP inhibition. Additionally, high levels of intracellular 
Ca2+ could induce contraction of the protrusions.
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cells with a NO donor induced similar effects as H20 2 on adhesion and TEM, 
leading to the assumption that NO plays a role in mediating H20 2 responses. To 
demonstrate a link between H20 2-induced NO and the defect in TEM, L-NAME was 
used to prevent H20 2-induced NO production. L-NAME is a widely used inhibitor of 
NOS. Pre-treatment with L-NAME did not prevent the H20 2-induced decrease in 
TEM, although a small increase in TEM could be observed when compared to cells 
without L-NAME. Since the effectiveness of the inhibitor in reducing NO levels was 
not determined, it is possible that the inhibition of NO production achieved was 
insufficient to prevent NO-mediated effects. To clarify the role of NO in this process, 
the effectiveness of L-NAME should be determined and/or different inhibitors of 
NOS used. Also, when interpreting data from this study, it has to be taken into 
account that H20 2 influences a range of biological responses and the observed 
phenotype is therefore likely to be mediated by several H20 2-induced effects, and 
inhibition of one pathway might therefore not be sufficient to prevent the TEM 
defect. The increased NO level could play a role in the decrease of cellular 
protrusions, since the NO donor SNAP induced a reduction in protrusions similar to 
H20 2, and NO has been shown to induce retraction of cellular protrusions, by 
stimulating PKG phosphorylation of VASP at Ser239 (Lindsay et al., 2007). This 
phosphorylation inhibits the anti-capping and filament bundling activity of VASP, 
which are crucial for protrusion formation (Barzik et al., 2005). It would therefore be 
interesting to investigate the phosphorylation status of VASP in H20 2-treated THP-1 
cells. High Ca2+ levels could additionally contribute to the reduction in cellular 
protrusions by increasing contractility via activation of MLCK, leading to increased 
MLC phosphorylation (Hansen et al., 2000). This hypothesis could be tested by 
carrying out the experiments under conditions without Ca2+ present in the medium, 
since H20 2 has been shown to increase influx of extracellular Ca2+ as well as 
release from intracellular stores (Yan et al., 2006). To prevent release of Ca2+ from 
intracellular stores, thapsigargin, which depletes intracellular Ca2+ stores, or 
xestospongin C, which prevents Ca2+ release by inhibiting the inositol 1,4,5- 
trisphosphate (lnsP3) receptor, could be used (Zhao et al., 2008). Cellular 
protrusions are also regulated by the Rho GTPases Rac1 and Cdc42, with Rac1 
being the main driver of lamellipodium protrusion via WAVE and Arp2/3, while 
Cdc42 induces filopodium formation via mDia/Drf (Ladwein and Rottner, 2008; 
Ridley, 2001). However, Cdc42 has also been shown to feed into the Arp2/3 
pathway via IRSp53. It is therefore possible that the decrease in Cdc42 activity 
observed in H2Q2-treated cells is responsible for the reduction of cellular
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protrusions. This hypothesis could be tested by over-expressing a ‘fast-cycling’ 
mutant of Cdc42 (F28) (Fidyk et al., 2006) in THP-1 cells and investigating whether 
it rescues cellular protrusions and TEM rate following H20 2 treatment. The F28 
mutant has proven effective at mediating Cdc42-induced effects, since Cdc42 
needs to cycle between the GTP- and GDP-bound state in order to function.
6.2 Responses to H2O2 with a peak at intermediate concentrations
Rac1 activity is directly involved in promoting actin polymerisation and migration 
(Ridley, 2001). At intermediate H20 2 concentrations (0.5 to 1 mM) Rac1 activity was 
high, which was mirrored in increased adhesion and migration. Additionally, tyrosine 
phosphorylation was increased at these concentrations. Tyrosine phosphorylation of 
proteins at adhesion sites, e.g. paxillin, is important in increasing migration and 
adhesion turnover (Nayal et al., 2006). However, leukocytes do not form focal 
adhesions and due to the faster migration velocity adhesion sites are less stable 
(Sanchez-Madrid and del Pozo, 1999). Adhesion strength and migration velocity 
have been shown to be dependent on each other (DiMilla et al., 1993; Huttenlocher 
et al., 1996; Palecek et al., 1997), and optimised adhesive conditions at 
intermediate H20 2 concentrations could therefore promote migration.
At high H20 2 concentrations (2 to 5 mM), adhesion and migration are at 
control levels and Rac1 activity is decreased. The decrease in Rac1 activity could 
be due to the high NO levels. NO can decrease Rad activity by activating PTP- 
PEST (protein tyrosine phosphatase-proline, glutamate, serine, and threonine-rich 
domain), which induces de-phosphorylation of p130CAS and thereby decreases 
formation of the Crkll-p130CAS-Dock180 complex and subsequent Rad activation 
(Ceacareanu et al., 2006; Cote and Vuori, 2007). Since PTP-PEST is also sensitive 
to redox-inactivation (Salmeen and Barford, 2005), it remains to be determined 
whether PTP-PEST is active or inactive under conditions where H20 2 and NO are 
present. The decrease in pTyr at high H20 2 concentrations could contribute to the 
reduced migration and adhesion observed under these conditions. How pTyr levels 
are decreased are unclear, but hyperoxidation (formation of sulphinic acid) of Cys 
residues of tyrosine kinases or phosphatases could play a role. Additionally, high 
levels of Ca2+ could decrease RhoA activity (Jin et al., 2005), thereby reducing 
motility.
6.3 Does H2O2 modulate TEM and motility by different mechanisms?
These observations indicate that TEM and motility, including adhesion and 
migration speed, are regulated by separate H20 2-induced events. This hypothesis
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was further strengthened by the observation that the antioxidant NAC prevented the 
increase in adhesion of H20 2-treated leukocytes, but could not rescue the TEM 
defect. Additionally, intracellular ROS production via inhibition of catalase or 
stimulation of NADPH oxidase reduced only TEM, while adhesion was unchanged. 
These results indicate different mechanisms of regulation for adhesion and TEM. 
The different mechanisms can be divided into outside and/or outside-in and 
intracellular signalling. Outside and outside-in signalling could include direct 
oxidative modifications of adhesion molecules, leading to increased or decreased 
adhesion. For example, VLA-4 activation is regulated by oxidation of a thiol group in 
the a4 chain (Liu et al., 2008). Redox-modified integrins could then induce outside- 
in signalling, e.g. to Rac1, which has been shown to be activated upon integrin 
binding (del Pozo et al., 2000). Intracellular signalling includes all signalling 
pathways that are activated or inhibited as a consequence of increased intracellular 
ROS or NO levels. Events possibly mediated by outside signalling, e.g. adhesion, 
were reversible by application of antioxidants, while intracellular signalling, leading 
to decreased TEM, was not. However, since adhesion is also influenced by factors 
such as protein phosphorylation and Rac1 activity, which could require outside-in 
and/or intracellular signalling, it is unlikely that the observed phenotypes are 
dependent on only one route of signal transduction. It is much more likely that 
adhesion and TEM are regulated predominantly, but not exclusively, by one or the 
other mechanism.
6.4 Physiological relevance of H20 2-regulated leukocyte TEM
Under physiological conditions, the H20 2-induced effects on TEM and adhesion 
could play a role when an acute increase in ROS occurs in the tissue, for example 
induced by chemotherapeutics (Schumacker, 2006) or alcohol (Das and 
Vasudevan, 2007), in particular in the liver (Wu et al., 2006), or cigarette smoke- 
induced ROS in the lung (Yao et al., 2007). Under these circumstances, circulating 
leukocytes could be exposed to high levels of ROS, leading to adhesion and TEM 
defects. Although decreased TEM can be beneficial under conditions of chronic 
inflammation, it also reduces the organism’s capacity for immune surveillance, 
thereby increasing the risk of uncleared infections. A compromised immune 
surveillance is particularly problematic in the lung, where an enormous surface is in 
constant contact with inhaled air, which potentially contains a whole range of 
pathogens. To understand the consequences of the H20 2-induced TEM defect, it 
would be interesting to investigate the effect of H20 2 on other leukocytes that play 
an important role in innate immunity, e.g. neutrophils. Neutrophils are the first
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leukocytes to respond to an infection and transmigrate rapidly into the infected site. 
A H20 2-induced TEM defect in neutrophils would therefore severely compromise the 
innate immune response, which would be relevant for lung infections.
For future studies, it would be intriguing to investigate the effects of long­
term treatment with low doses of ROS. This would simulate conditions where 
leukocytes encounter mild to intermediate levels of oxidative stress during their 
circulation in the blood before they enter the tissues. Previous studies have shown 
that long-term treatment with sub-lethal doses of H20 2 can protect against 
cytotoxicity induced by lethal doses of H20 2 (Chen et al., 2005). This protection is 
mediated by increased levels of catalase and Gpx activity. It could be speculated 
that mild to intermediate levels of oxidative stress could protect cells against high 
ROS levels in tissues/organs such as in the lung and liver and thus prevent the TEM 
defect and increase in adhesion at these sites. It would therefore be interesting to 
compare the TEM of THP-1 cells pre-treated with low levels of H20 2 to untreated 
cells under conditions when they are pulsed with high concentration of ROS.
The lung is, due to its enormous surface and toxic components in inhaled 
air, susceptible to oxidative stress, in particular the lung of smokers. Inhaled toxic 
agents stimulate the production of ROS and RNS and provoke inflammatory 
responses leading to the release of pro-inflammatory cytokines and chemokines 
(Azad et al., 2008). Inflammation is an important response to lung injury and is vital 
as a protective mechanism. However, an inflammatory response that is inefficiently 
resolved can lead to chronic inflammation, which is characterised by the continued 
infiltration of leukocytes into tissue by leukocytes, tissue destruction, angiogenesis 
and fibrosis (Kindt et al., 2006). Under these conditions a H20 2-induced decrease in 
TEM would prevent excessive extravasation into the tissue and could therefore be 
beneficial for the pathogenesis of the condition.
6.5 Role of CD73 as a suppressor of inflammation
The inflammatory reaction in the endothelium is not only regulated by pro- and anti­
inflammatory cytokines, but also by purine signalling (Yegutkin, 2008). One 
modulator of purine signalling is the ecto-enzyme CD73, which has also been 
implicated in leukocyte TEM (Salmi and Jalkanen, 2005). Results from the present 
study have demonstrated the role of CD73 in maintaining endothelial cells in a non­
inflammatory state. RNAi knock-down of CD73 in HUVECs induced a pro- 
inflammatory phenotype similar to the response with pro-inflammatory cytokines 
such as TNF-a, with elongated cells exhibiting increased stress fibres and increased 
cell surface levels of adhesion molecules such as ICAM-1, VCAM-1, E- and
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P-selectin. The increase in adhesion molecules was likely to be mediated by NF-kB, 
since a reduction of IKK-a levels was observed in CD73 k-d cells. These results are 
in concordance with findings from CD73_/' mice, where Zernecke et al. demonstrated 
NF-kB activation and increased VCAM-1 surface expression in aortic endothelial 
cells and monocyte adhesion (Zernecke et al., 2006). Adenosine and other cAMP- 
inducing agents are potent inhibitors of the NF-kB pathway (Minguet et al., 2005). 
Decreased adenosine levels in k-d and CD73'/_ ECs therefore allow NF-kB 
activation, e.g. by GFs present in the tissue or cell culture medium.
Adhesion and TEM of THP-1 cells to and across CD73 k-d HUVECs in this 
study was not directly dependent on the pro-inflammatory phenotype. While it could 
be expected that adhesion and TEM are increased under conditions with a CD73 
k-d-induced pro-inflammatory phenotype, the different oligos used to knock-down 
CD73 did not give consistent results. Even though all oligos induced a pro- 
inflammatory phenotype to some extent, adhesion and TEM was only increased for 
some oligos, while decreased for others. The results demonstrate that a pro- 
inflammatory phenotype in HUVECs is not sufficient to induce an increase in 
leukocyte adhesion and TEM per se; leukocytes seemingly need additional signals 
to bind and transmigrate efficiently. These signals could include chemokines that 
are presented on the endothelium under inflammatory conditions and are necessary 
to activate integrins. Chemokine production and presentation was not investigated 
in CD73 k-d HUVECs, and could be carried out in future studies.
6.6 Oxidative stress in pathological conditions
Oxidative stress has been implicated in the generation of neurodegenerative 
diseases and the activity of CD73 has been shown to be reduced in the brain of 
Alzheimer’s patients (Kanfer et al., 1986). In an in vitro system, Liu and Sok have 
demonstrated the oxidative inactivation of brain CD73 by Fe2+ (Liu and Sok, 2000), 
which has also been shown for rat liver cytosolic 5’-nucleotidase (Kocic et al., 2001). 
Liu and Sok demonstrated that H20 2 alone is not sufficient to induce oxidative 
inactivation of CD73, which was confirmed in the present study. Patients with 
alcoholic liver disease frequently exhibit high levels of iron, and even mild to 
moderate alcohol consumption has been shown to induce increases in iron 
(Harrison-Findik, 2007). Oxidative stress in the liver or lung could therefore not only 
directly induce inflammatory reactions by ROS, but also indirectly by inactivating 
CD73 and thereby inducing a pro-inflammatory phenotype in the endothelium. It 
could be speculated that under these conditions, ROS-exposed leukocytes bind to 
the endothelium, but their TEM is inhibited thereby possibly leading to accumulation
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of leukocytes attached to the vessel wall. It would be interesting to investigate if 
H20 2-treated leukocytes display the same behaviour under shear flow or if the 
increased adhesion is abolished under these conditions. Additionally, different 
conditions involving H20 2-treated THP-1 cells (short/high or long/low H20 2) and 
CD73 k-d endothelial cells could be tested to determine the adhesion and TEM rate.
Interestingly different types of leukocytes displayed big differences in the 
susceptibility to the toxic effects of H20 2; the leukaemia cell lines THP-1 and CCRF- 
CEM were much more resistant than primary monocytes and T lymphoblasts. For 
future studies it would be interesting to investigate whether these differences are 
due to the cancerous nature of the leukaemia cell lines. ROS have been proposed 
to be involved in tumour metastasis (Wu, 2006) and cancer cells have been shown 
to have increased ROS levels (Schumacker, 2006). Indeed, increased ROS 
production in cancer cells can be exploited to selectively kill oncogenically 
transformed cells (Trachootham et al., 2006). Disabling the GSH system with 
(3-phenylethyl isothiocyanate (PEITC) causes severe ROS accumulation and cell 
death due to oxidative damage to mitochondria preferentially in transformed cells. It 
would be interesting to test PEITC or other inhibitors of the antioxidant defence 
system to determine whether they regulate adhesion and TEM differently in 
leukaemic versus non-leukaemic leukocytes.
Even though the mechanisms of leukocyte TEM and cancer cell 
extravasation are different in some respects, they do share enough common 
features to speculate that H20 2 might reduce cancer cell extravasation and therefore 
inhibit metastasis formation. Leukocytes as well as cancer cells bind to E- and 
P-selectin on the endothelium using sialyl LewisX and sialyl LewisA glycoproteins 
(Miles et al., 2008). Additionally, both cell types use VLA-4 to bind to 
immunoglobulin superfamily receptors, although ICAM-1 is used rather than VCAM- 
1 for cancer cells. When discussing cancer cell extravasation it has to be 
considered that the exact mechanism may be unique for different cancer cell types. 
Increasing intracellular ROS levels in cancer cells by inhibiting the antioxidant 
defence system could have two beneficial effects: reduction of extravasation and 
induction of apoptosis.
In conclusion, this study has identified H20 2 as a novel regulator of leukocyte 
adhesion and TEM. Additionally, the role of the redox-regulated ecto-enzyme CD73 
in maintaining endothelial cells in a non-inflammatory state was shown. The H20 2- 
induced inhibition could have different and opposite effects on the organism
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depending on the health condition: while a decrease in TEM could be beneficial in 
chronic inflammation, it could be harmful under conditions where infections need to 
be cleared.
Although this study has revealed new insights into the regulation of 
leukocyte TEM, it also raises many questions about the nature of this regulation and 
its physiological relevance. This study stresses the importance of preventing and 
treating oxidative stress as part of a healthy lifestyle and as a therapeutic 
application for several pathological conditions.
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